Financial Metrics
BSX BOSTON SCIENTIFIC CORPFinancial Statements
Grouped by statementIncome Statement
Metrics: 6Revenue
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 1964000000.0 | — | USD | 10-Q | 2017-05-03 |
| Quarterly | 2016-06-30 | 2126000000.0 | +8.2% | USD | 10-Q | 2017-08-03 |
| Quarterly | 2016-09-30 | 2105000000.0 | -1.0% | USD | 10-Q | 2017-11-02 |
| Quarterly | 2017-03-31 | 2160000000.0 | +2.6% | USD | 10-Q | 2018-05-01 |
| Quarterly | 2017-06-30 | 2257000000.0 | +4.5% | USD | 10-Q | 2018-07-31 |
| Quarterly | 2017-09-30 | 2222000000.0 | -1.6% | USD | 10-Q | 2018-10-29 |
| Quarterly | 2018-03-31 | 2379000000.0 | +7.1% | USD | 10-Q | 2019-04-29 |
| Quarterly | 2018-06-30 | 2490000000.0 | +4.7% | USD | 10-Q | 2019-07-30 |
| Quarterly | 2018-09-30 | 2393000000.0 | -3.9% | USD | 10-Q | 2019-11-05 |
| Quarterly | 2019-03-31 | 2493000000.0 | +4.2% | USD | 10-Q | 2020-05-06 |
| Quarterly | 2019-06-30 | 2631000000.0 | +5.5% | USD | 10-Q | 2020-08-05 |
| Quarterly | 2019-09-30 | 2707000000.0 | +2.9% | USD | 10-Q | 2020-11-05 |
| Quarterly | 2020-03-31 | 2543000000.0 | -6.1% | USD | 10-Q | 2021-05-06 |
| Quarterly | 2020-06-30 | 2003000000.0 | -21.2% | USD | 10-Q | 2021-08-06 |
| Quarterly | 2020-09-30 | 2659000000.0 | +32.8% | USD | 10-Q | 2021-11-04 |
| Quarterly | 2021-03-31 | 2752000000.0 | +3.5% | USD | 10-Q | 2022-05-05 |
| Quarterly | 2021-06-30 | 3077000000.0 | +11.8% | USD | 10-Q | 2022-08-04 |
| Quarterly | 2021-09-30 | 2932000000.0 | -4.7% | USD | 10-Q | 2022-11-03 |
| Quarterly | 2022-03-31 | 3026000000.0 | +3.2% | USD | 10-Q | 2023-05-04 |
| Quarterly | 2022-06-30 | 3244000000.0 | +7.2% | USD | 10-Q | 2023-08-03 |
| Quarterly | 2022-09-30 | 3170000000.0 | -2.3% | USD | 10-Q | 2023-11-01 |
| Quarterly | 2023-03-31 | 3389000000.0 | +6.9% | USD | 10-Q | 2024-05-01 |
| Quarterly | 2023-06-30 | 3599000000.0 | +6.2% | USD | 10-Q | 2024-08-01 |
| Quarterly | 2023-09-30 | 3527000000.0 | -2.0% | USD | 10-Q | 2024-11-01 |
| Quarterly | 2024-03-31 | 3856000000.0 | +9.3% | USD | 10-Q | 2025-05-01 |
| Quarterly | 2024-06-30 | 4120000000.0 | +6.8% | USD | 10-Q | 2025-08-01 |
| Quarterly | 2024-09-30 | 4209000000.0 | +2.2% | USD | 10-Q | 2025-11-03 |
| Quarterly | 2025-03-31 | 4663000000.0 | +10.8% | USD | 10-Q | 2025-05-01 |
| Quarterly | 2025-06-30 | 5061000000.0 | +8.5% | USD | 10-Q | 2025-08-01 |
| Quarterly | 2025-09-30 | 5065000000.0 | +0.1% | USD | 10-Q | 2025-11-03 |
| Annual | 2016-12-31 | 8386000000.0 | — | USD | 10-K | 2019-02-19 |
| Annual | 2017-12-31 | 9048000000.0 | +7.9% | USD | 10-K | 2020-02-25 |
| Annual | 2018-12-31 | 9823000000.0 | +8.6% | USD | 10-K | 2021-02-23 |
| Annual | 2019-12-31 | 10735000000.0 | +9.3% | USD | 10-K | 2022-02-23 |
| Annual | 2020-12-31 | 9913000000.0 | -7.7% | USD | 10-K | 2023-02-23 |
| Annual | 2021-12-31 | 11888000000.0 | +19.9% | USD | 10-K | 2024-02-20 |
| Annual | 2022-12-31 | 12682000000.0 | +6.7% | USD | 10-K | 2025-02-18 |
| Annual | 2023-12-31 | 14240000000.0 | +12.3% | USD | 10-K | 2026-02-17 |
| Annual | 2024-12-31 | 16747000000.0 | +17.6% | USD | 10-K | 2026-02-17 |
| Annual | 2025-12-31 | 20074000000.0 | +19.9% | USD | 10-K | 2026-02-17 |
Gross Profit
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 1391000000.0 | — | USD | 10-Q | 2017-05-03 |
| Quarterly | 2016-06-30 | 1487000000.0 | +6.9% | USD | 10-Q | 2017-08-03 |
| Quarterly | 2016-09-30 | 1511000000.0 | +1.6% | USD | 10-Q | 2017-11-02 |
| Quarterly | 2017-03-31 | 1510000000.0 | -0.1% | USD | 10-Q | 2018-05-01 |
| Quarterly | 2017-06-30 | 1625000000.0 | +7.6% | USD | 10-Q | 2018-07-31 |
| Quarterly | 2017-09-30 | 1585000000.0 | -2.5% | USD | 10-Q | 2018-10-29 |
| Quarterly | 2018-03-31 | 1707000000.0 | +7.7% | USD | 10-Q | 2019-04-29 |
| Quarterly | 2018-06-30 | 1751000000.0 | +2.6% | USD | 10-Q | 2019-07-30 |
| Quarterly | 2018-09-30 | 1720000000.0 | -1.8% | USD | 10-Q | 2019-11-05 |
| Quarterly | 2019-03-31 | 1763000000.0 | +2.5% | USD | 10-Q | 2020-05-06 |
| Quarterly | 2019-06-30 | 1873000000.0 | +6.2% | USD | 10-Q | 2020-08-05 |
| Quarterly | 2019-09-30 | 1930000000.0 | +3.0% | USD | 10-Q | 2020-11-05 |
| Quarterly | 2020-03-31 | 1737000000.0 | -10.0% | USD | 10-Q | 2021-05-06 |
| Quarterly | 2020-06-30 | 1212000000.0 | -30.2% | USD | 10-Q | 2021-08-06 |
| Quarterly | 2020-09-30 | 1790000000.0 | +47.7% | USD | 10-Q | 2021-11-04 |
| Quarterly | 2021-03-31 | 1858000000.0 | +3.8% | USD | 10-Q | 2022-05-05 |
| Quarterly | 2021-06-30 | 2132000000.0 | +14.7% | USD | 10-Q | 2022-08-04 |
| Quarterly | 2021-09-30 | 2032000000.0 | -4.7% | USD | 10-Q | 2022-11-03 |
| Quarterly | 2022-03-31 | 2071000000.0 | +1.9% | USD | 10-Q | 2023-05-04 |
| Quarterly | 2022-06-30 | 2233000000.0 | +7.8% | USD | 10-Q | 2023-08-03 |
| Quarterly | 2022-09-30 | 2191000000.0 | -1.9% | USD | 10-Q | 2023-11-01 |
| Quarterly | 2023-03-31 | 2349000000.0 | +7.2% | USD | 10-Q | 2024-05-01 |
| Quarterly | 2023-06-30 | 2542000000.0 | +8.2% | USD | 10-Q | 2024-08-01 |
| Quarterly | 2023-09-30 | 2426000000.0 | -4.6% | USD | 10-Q | 2024-11-01 |
| Quarterly | 2024-03-31 | 2648000000.0 | +9.2% | USD | 10-Q | 2025-05-01 |
| Quarterly | 2024-06-30 | 2850000000.0 | +7.6% | USD | 10-Q | 2025-08-01 |
| Quarterly | 2024-09-30 | 2897000000.0 | +1.6% | USD | 10-Q | 2025-11-03 |
| Quarterly | 2025-03-31 | 3210000000.0 | +10.8% | USD | 10-Q | 2025-05-01 |
| Quarterly | 2025-06-30 | 3424000000.0 | +6.7% | USD | 10-Q | 2025-08-01 |
| Quarterly | 2025-09-30 | 3542000000.0 | +3.4% | USD | 10-Q | 2025-11-03 |
| Annual | 2016-12-31 | 5962000000.0 | — | USD | 10-K | 2019-02-19 |
| Annual | 2017-12-31 | 6455000000.0 | +8.3% | USD | 10-K | 2020-02-25 |
| Annual | 2018-12-31 | 7011000000.0 | +8.6% | USD | 10-K | 2021-02-23 |
| Annual | 2019-12-31 | 7620000000.0 | +8.7% | USD | 10-K | 2022-02-23 |
| Annual | 2020-12-31 | 6448000000.0 | -15.4% | USD | 10-K | 2023-02-23 |
| Annual | 2021-12-31 | 8177000000.0 | +26.8% | USD | 10-K | 2024-02-20 |
| Annual | 2022-12-31 | 8727000000.0 | +6.7% | USD | 10-K | 2025-02-18 |
| Annual | 2023-12-31 | 9896000000.0 | +13.4% | USD | 10-K | 2026-02-17 |
| Annual | 2024-12-31 | 11490000000.0 | +16.1% | USD | 10-K | 2026-02-17 |
| Annual | 2025-12-31 | 13854000000.0 | +20.6% | USD | 10-K | 2026-02-17 |
Operating Income
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 293000000.0 | — | USD | 10-Q | 2017-05-03 |
| Quarterly | 2016-06-30 | -334000000.0 | -214.0% | USD | 10-Q | 2017-08-03 |
| Quarterly | 2016-09-30 | 348000000.0 | +204.2% | USD | 10-Q | 2017-11-02 |
| Quarterly | 2017-03-31 | 364000000.0 | +4.6% | USD | 10-Q | 2018-05-01 |
| Quarterly | 2017-06-30 | 225000000.0 | -38.2% | USD | 10-Q | 2018-07-31 |
| Quarterly | 2017-09-30 | 377000000.0 | +67.6% | USD | 10-Q | 2018-10-29 |
| Quarterly | 2018-03-31 | 407000000.0 | +8.0% | USD | 10-Q | 2019-04-29 |
| Quarterly | 2018-06-30 | 392000000.0 | -3.7% | USD | 10-Q | 2019-07-30 |
| Quarterly | 2018-09-30 | 388000000.0 | -1.0% | USD | 10-Q | 2019-11-05 |
| Quarterly | 2019-03-31 | 541000000.0 | +39.4% | USD | 10-Q | 2020-05-06 |
| Quarterly | 2019-06-30 | 384000000.0 | -29.0% | USD | 10-Q | 2020-08-05 |
| Quarterly | 2019-09-30 | 383000000.0 | -0.3% | USD | 10-Q | 2020-11-05 |
| Quarterly | 2020-03-31 | 146000000.0 | -61.9% | USD | 10-Q | 2021-05-06 |
| Quarterly | 2020-06-30 | -71000000.0 | -148.6% | USD | 10-Q | 2021-08-06 |
| Quarterly | 2020-09-30 | -205000000.0 | -188.7% | USD | 10-Q | 2021-11-04 |
| Quarterly | 2021-03-31 | 370000000.0 | +280.5% | USD | 10-Q | 2022-05-05 |
| Quarterly | 2021-06-30 | 262000000.0 | -29.2% | USD | 10-Q | 2022-08-04 |
| Quarterly | 2021-09-30 | 387000000.0 | +47.7% | USD | 10-Q | 2022-11-03 |
| Quarterly | 2022-03-31 | 466000000.0 | +20.4% | USD | 10-Q | 2023-05-04 |
| Quarterly | 2022-06-30 | 423000000.0 | -9.2% | USD | 10-Q | 2023-08-03 |
| Quarterly | 2022-09-30 | 358000000.0 | -15.4% | USD | 10-Q | 2023-11-01 |
| Quarterly | 2023-03-31 | 552000000.0 | +54.2% | USD | 10-Q | 2024-05-01 |
| Quarterly | 2023-06-30 | 514000000.0 | -6.9% | USD | 10-Q | 2024-08-01 |
| Quarterly | 2023-09-30 | 693000000.0 | +34.8% | USD | 10-Q | 2024-11-01 |
| Quarterly | 2024-03-31 | 675000000.0 | -2.6% | USD | 10-Q | 2025-05-01 |
| Quarterly | 2024-06-30 | 520000000.0 | -23.0% | USD | 10-Q | 2025-08-01 |
| Quarterly | 2024-09-30 | 733000000.0 | +41.0% | USD | 10-Q | 2025-11-03 |
| Quarterly | 2025-03-31 | 921000000.0 | +25.6% | USD | 10-Q | 2025-05-01 |
| Quarterly | 2025-06-30 | 819000000.0 | -11.1% | USD | 10-Q | 2025-08-01 |
| Quarterly | 2025-09-30 | 1048000000.0 | +28.0% | USD | 10-Q | 2025-11-03 |
| Annual | 2016-12-31 | 447000000.0 | — | USD | 10-K | 2019-02-19 |
| Annual | 2017-12-31 | 1285000000.0 | +187.5% | USD | 10-K | 2020-02-25 |
| Annual | 2018-12-31 | 1506000000.0 | +17.2% | USD | 10-K | 2021-02-23 |
| Annual | 2019-12-31 | 1518000000.0 | +0.8% | USD | 10-K | 2022-02-23 |
| Annual | 2020-12-31 | -80000000.0 | -105.3% | USD | 10-K | 2023-02-23 |
| Annual | 2021-12-31 | 1199000000.0 | +1598.8% | USD | 10-K | 2024-02-20 |
| Annual | 2022-12-31 | 1649000000.0 | +37.5% | USD | 10-K | 2025-02-18 |
| Annual | 2023-12-31 | 2343000000.0 | +42.1% | USD | 10-K | 2026-02-17 |
| Annual | 2024-12-31 | 2603000000.0 | +11.1% | USD | 10-K | 2026-02-17 |
| Annual | 2025-12-31 | 3613000000.0 | +38.8% | USD | 10-K | 2026-02-17 |
Net Income
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 202000000.0 | — | USD | 10-Q | 2017-05-03 |
| Quarterly | 2016-06-30 | -207000000.0 | -202.5% | USD | 10-Q | 2017-08-03 |
| Quarterly | 2016-09-30 | 228000000.0 | +210.1% | USD | 10-Q | 2017-11-02 |
| Quarterly | 2017-03-31 | 290000000.0 | +27.2% | USD | 10-Q | 2018-05-01 |
| Quarterly | 2017-06-30 | 146000000.0 | -49.7% | USD | 10-Q | 2018-07-31 |
| Quarterly | 2017-09-30 | 283000000.0 | +93.8% | USD | 10-Q | 2018-10-29 |
| Quarterly | 2018-03-31 | 298000000.0 | +5.3% | USD | 10-Q | 2019-04-29 |
| Quarterly | 2018-06-30 | 555000000.0 | +86.2% | USD | 10-Q | 2019-07-30 |
| Quarterly | 2018-09-30 | 432000000.0 | -22.2% | USD | 10-Q | 2019-11-05 |
| Quarterly | 2019-03-31 | 424000000.0 | -1.9% | USD | 10-Q | 2020-05-06 |
| Quarterly | 2019-06-30 | 154000000.0 | -63.7% | USD | 10-Q | 2020-08-05 |
| Quarterly | 2019-09-30 | 126000000.0 | -18.2% | USD | 10-Q | 2020-11-05 |
| Quarterly | 2020-03-31 | 11000000.0 | -91.3% | USD | 10-Q | 2021-05-06 |
| Quarterly | 2020-06-30 | -147000000.0 | -1436.4% | USD | 10-Q | 2021-08-06 |
| Quarterly | 2020-09-30 | -155000000.0 | -5.4% | USD | 10-Q | 2021-11-04 |
| Quarterly | 2021-03-31 | 341000000.0 | +320.0% | USD | 10-Q | 2022-05-05 |
| Quarterly | 2021-06-30 | 186000000.0 | -45.5% | USD | 10-Q | 2022-08-04 |
| Quarterly | 2021-09-30 | 419000000.0 | +125.3% | USD | 10-Q | 2022-11-03 |
| Quarterly | 2022-03-31 | 110000000.0 | -73.7% | USD | 10-Q | 2023-05-04 |
| Quarterly | 2022-06-30 | 260000000.0 | +136.4% | USD | 10-Q | 2023-08-03 |
| Quarterly | 2022-09-30 | 188000000.0 | -27.7% | USD | 10-Q | 2023-11-01 |
| Quarterly | 2023-03-31 | 314000000.0 | +67.0% | USD | 10-Q | 2024-05-01 |
| Quarterly | 2023-06-30 | 270000000.0 | -14.0% | USD | 10-Q | 2024-08-01 |
| Quarterly | 2023-09-30 | 504000000.0 | +86.7% | USD | 10-Q | 2024-11-01 |
| Quarterly | 2024-03-31 | 493000000.0 | -2.2% | USD | 10-Q | 2025-05-01 |
| Quarterly | 2024-06-30 | 322000000.0 | -34.7% | USD | 10-Q | 2025-08-01 |
| Quarterly | 2024-09-30 | 468000000.0 | +45.3% | USD | 10-Q | 2025-11-03 |
| Quarterly | 2025-03-31 | 672000000.0 | +43.6% | USD | 10-Q | 2025-05-01 |
| Quarterly | 2025-06-30 | 795000000.0 | +18.3% | USD | 10-Q | 2025-08-01 |
| Quarterly | 2025-09-30 | 755000000.0 | -5.0% | USD | 10-Q | 2025-11-03 |
| Annual | 2016-12-31 | 347000000.0 | — | USD | 10-K | 2019-02-19 |
| Annual | 2017-12-31 | 104000000.0 | -70.0% | USD | 10-K | 2020-02-25 |
| Annual | 2018-12-31 | 1671000000.0 | +1506.7% | USD | 10-K | 2021-02-23 |
| Annual | 2019-12-31 | 4700000000.0 | +181.3% | USD | 10-K | 2022-02-23 |
| Annual | 2020-12-31 | -82000000.0 | -101.7% | USD | 10-K | 2023-02-23 |
| Annual | 2021-12-31 | 1041000000.0 | +1369.5% | USD | 10-K | 2024-02-20 |
| Annual | 2022-12-31 | 698000000.0 | -32.9% | USD | 10-K | 2025-02-18 |
| Annual | 2023-12-31 | 1592000000.0 | +128.1% | USD | 10-K | 2026-02-17 |
| Annual | 2024-12-31 | 1846000000.0 | +16.0% | USD | 10-K | 2026-02-17 |
| Annual | 2025-12-31 | 2892000000.0 | +56.7% | USD | 10-K | 2026-02-17 |
EPS Basic
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 0.15 | — | USD/shares | 10-Q | 2017-05-03 |
| Quarterly | 2016-06-30 | -0.15 | -200.0% | USD/shares | 10-Q | 2017-08-03 |
| Quarterly | 2016-09-30 | 0.17 | +213.3% | USD/shares | 10-Q | 2017-11-02 |
| Quarterly | 2017-03-31 | 0.21 | +23.5% | USD/shares | 10-Q | 2018-05-01 |
| Quarterly | 2017-06-30 | 0.11 | -47.6% | USD/shares | 10-Q | 2018-07-31 |
| Quarterly | 2017-09-30 | 0.21 | +90.9% | USD/shares | 10-Q | 2018-10-29 |
| Quarterly | 2018-03-31 | 0.22 | +4.8% | USD/shares | 10-Q | 2019-04-29 |
| Quarterly | 2018-06-30 | 0.4 | +81.8% | USD/shares | 10-Q | 2019-07-30 |
| Quarterly | 2018-09-30 | 0.31 | -22.5% | USD/shares | 10-Q | 2019-11-05 |
| Quarterly | 2019-03-31 | 0.31 | +0.0% | USD/shares | 10-Q | 2020-05-06 |
| Quarterly | 2019-06-30 | 0.11 | -64.5% | USD/shares | 10-Q | 2020-08-05 |
| Quarterly | 2019-09-30 | 0.09 | -18.2% | USD/shares | 10-Q | 2020-11-05 |
| Quarterly | 2020-03-31 | 0.01 | -88.9% | USD/shares | 10-Q | 2021-05-06 |
| Quarterly | 2020-06-30 | -0.11 | -1200.0% | USD/shares | 10-Q | 2021-08-06 |
| Quarterly | 2020-09-30 | -0.12 | -9.1% | USD/shares | 10-Q | 2021-11-04 |
| Quarterly | 2021-03-31 | 0.23 | +291.7% | USD/shares | 10-Q | 2022-05-05 |
| Quarterly | 2021-06-30 | 0.12 | -47.8% | USD/shares | 10-Q | 2022-08-04 |
| Quarterly | 2021-09-30 | 0.28 | +133.3% | USD/shares | 10-Q | 2022-11-03 |
| Quarterly | 2022-03-31 | 0.07 | -75.0% | USD/shares | 10-Q | 2023-05-04 |
| Quarterly | 2022-06-30 | 0.17 | +142.9% | USD/shares | 10-Q | 2023-08-03 |
| Quarterly | 2022-09-30 | 0.12 | -29.4% | USD/shares | 10-Q | 2023-11-01 |
| Quarterly | 2023-03-31 | 0.21 | +75.0% | USD/shares | 10-Q | 2024-05-01 |
| Quarterly | 2023-06-30 | 0.18 | -14.3% | USD/shares | 10-Q | 2024-08-01 |
| Quarterly | 2023-09-30 | 0.34 | +88.9% | USD/shares | 10-Q | 2024-11-01 |
| Quarterly | 2024-03-31 | 0.34 | +0.0% | USD/shares | 10-Q | 2025-05-01 |
| Quarterly | 2024-06-30 | 0.22 | -35.3% | USD/shares | 10-Q | 2025-08-01 |
| Quarterly | 2024-09-30 | 0.32 | +45.5% | USD/shares | 10-Q | 2025-11-03 |
| Quarterly | 2025-03-31 | 0.46 | +43.8% | USD/shares | 10-Q | 2025-05-01 |
| Quarterly | 2025-06-30 | 0.54 | +17.4% | USD/shares | 10-Q | 2025-08-01 |
| Quarterly | 2025-09-30 | 0.51 | -5.6% | USD/shares | 10-Q | 2025-11-03 |
| Annual | 2016-12-31 | 0.26 | — | USD/shares | 10-K | 2019-02-19 |
| Annual | 2017-12-31 | 0.08 | -69.2% | USD/shares | 10-K | 2020-02-25 |
| Annual | 2018-12-31 | 1.21 | +1412.5% | USD/shares | 10-K | 2021-02-23 |
| Annual | 2019-12-31 | 3.38 | +179.3% | USD/shares | 10-K | 2022-02-23 |
| Annual | 2020-12-31 | -0.08 | -102.4% | USD/shares | 10-K | 2023-02-23 |
| Annual | 2021-12-31 | 0.69 | +962.5% | USD/shares | 10-K | 2024-02-20 |
| Annual | 2022-12-31 | 0.45 | -34.8% | USD/shares | 10-K | 2025-02-18 |
| Annual | 2023-12-31 | 1.08 | +140.0% | USD/shares | 10-K | 2026-02-17 |
| Annual | 2024-12-31 | 1.26 | +16.7% | USD/shares | 10-K | 2026-02-17 |
| Annual | 2025-12-31 | 1.96 | +55.6% | USD/shares | 10-K | 2026-02-17 |
EPS Diluted
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 0.15 | — | USD/shares | 10-Q | 2017-05-03 |
| Quarterly | 2016-06-30 | -0.15 | -200.0% | USD/shares | 10-Q | 2017-08-03 |
| Quarterly | 2016-09-30 | 0.17 | +213.3% | USD/shares | 10-Q | 2017-11-02 |
| Quarterly | 2017-03-31 | 0.21 | +23.5% | USD/shares | 10-Q | 2018-05-01 |
| Quarterly | 2017-06-30 | 0.11 | -47.6% | USD/shares | 10-Q | 2018-07-31 |
| Quarterly | 2017-09-30 | 0.2 | +81.8% | USD/shares | 10-Q | 2018-10-29 |
| Quarterly | 2018-03-31 | 0.21 | +5.0% | USD/shares | 10-Q | 2019-04-29 |
| Quarterly | 2018-06-30 | 0.4 | +90.5% | USD/shares | 10-Q | 2019-07-30 |
| Quarterly | 2018-09-30 | 0.31 | -22.5% | USD/shares | 10-Q | 2019-11-05 |
| Quarterly | 2019-03-31 | 0.3 | -3.2% | USD/shares | 10-Q | 2020-05-06 |
| Quarterly | 2019-06-30 | 0.11 | -63.3% | USD/shares | 10-Q | 2020-08-05 |
| Quarterly | 2019-09-30 | 0.09 | -18.2% | USD/shares | 10-Q | 2020-11-05 |
| Quarterly | 2020-03-31 | 0.01 | -88.9% | USD/shares | 10-Q | 2021-05-06 |
| Quarterly | 2020-06-30 | -0.11 | -1200.0% | USD/shares | 10-Q | 2021-08-06 |
| Quarterly | 2020-09-30 | -0.12 | -9.1% | USD/shares | 10-Q | 2021-11-04 |
| Quarterly | 2021-03-31 | 0.23 | +291.7% | USD/shares | 10-Q | 2022-05-05 |
| Quarterly | 2021-06-30 | 0.12 | -47.8% | USD/shares | 10-Q | 2022-08-04 |
| Quarterly | 2021-09-30 | 0.28 | +133.3% | USD/shares | 10-Q | 2022-11-03 |
| Quarterly | 2022-03-31 | 0.07 | -75.0% | USD/shares | 10-Q | 2023-05-04 |
| Quarterly | 2022-06-30 | 0.17 | +142.9% | USD/shares | 10-Q | 2023-08-03 |
| Quarterly | 2022-09-30 | 0.12 | -29.4% | USD/shares | 10-Q | 2023-11-01 |
| Quarterly | 2023-03-31 | 0.21 | +75.0% | USD/shares | 10-Q | 2024-05-01 |
| Quarterly | 2023-06-30 | 0.18 | -14.3% | USD/shares | 10-Q | 2024-08-01 |
| Quarterly | 2023-09-30 | 0.34 | +88.9% | USD/shares | 10-Q | 2024-11-01 |
| Quarterly | 2024-03-31 | 0.33 | -2.9% | USD/shares | 10-Q | 2025-05-01 |
| Quarterly | 2024-06-30 | 0.22 | -33.3% | USD/shares | 10-Q | 2025-08-01 |
| Quarterly | 2024-09-30 | 0.32 | +45.5% | USD/shares | 10-Q | 2025-11-03 |
| Quarterly | 2025-03-31 | 0.45 | +40.6% | USD/shares | 10-Q | 2025-05-01 |
| Quarterly | 2025-06-30 | 0.53 | +17.8% | USD/shares | 10-Q | 2025-08-01 |
| Quarterly | 2025-09-30 | 0.51 | -3.8% | USD/shares | 10-Q | 2025-11-03 |
| Annual | 2016-12-31 | 0.25 | — | USD/shares | 10-K | 2019-02-19 |
| Annual | 2017-12-31 | 0.08 | -68.0% | USD/shares | 10-K | 2020-02-25 |
| Annual | 2018-12-31 | 1.19 | +1387.5% | USD/shares | 10-K | 2021-02-23 |
| Annual | 2019-12-31 | 3.33 | +179.8% | USD/shares | 10-K | 2022-02-23 |
| Annual | 2020-12-31 | -0.08 | -102.4% | USD/shares | 10-K | 2023-02-23 |
| Annual | 2021-12-31 | 0.69 | +962.5% | USD/shares | 10-K | 2024-02-20 |
| Annual | 2022-12-31 | 0.45 | -34.8% | USD/shares | 10-K | 2025-02-18 |
| Annual | 2023-12-31 | 1.07 | +137.8% | USD/shares | 10-K | 2026-02-17 |
| Annual | 2024-12-31 | 1.25 | +16.8% | USD/shares | 10-K | 2026-02-17 |
| Annual | 2025-12-31 | 1.94 | +55.2% | USD/shares | 10-K | 2026-02-17 |
Balance Sheet
Metrics: 9Cash and Equivalents
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 338000000.0 | — | USD | 10-Q | 2017-05-03 |
| Quarterly | 2016-06-30 | 438000000.0 | +29.6% | USD | 10-Q | 2017-08-03 |
| Quarterly | 2016-09-30 | 237000000.0 | -45.9% | USD | 10-Q | 2017-11-02 |
| Quarterly | 2016-12-31 | 196000000.0 | -17.3% | USD | 10-Q | 2017-11-02 |
| Quarterly | 2017-03-31 | 156000000.0 | -20.4% | USD | 10-Q | 2017-05-03 |
| Quarterly | 2017-06-30 | 195000000.0 | +25.0% | USD | 10-Q | 2018-07-31 |
| Quarterly | 2017-09-30 | 210000000.0 | +7.7% | USD | 10-Q | 2018-10-29 |
| Quarterly | 2017-12-31 | 188000000.0 | -10.5% | USD | 10-Q | 2018-10-29 |
| Quarterly | 2018-03-31 | 287000000.0 | +52.7% | USD | 10-Q | 2019-04-29 |
| Quarterly | 2018-06-30 | 208000000.0 | -27.5% | USD | 10-Q | 2019-07-30 |
| Quarterly | 2018-09-30 | 168000000.0 | -19.2% | USD | 10-Q | 2019-11-05 |
| Quarterly | 2018-12-31 | 146000000.0 | -13.1% | USD | 10-Q | 2019-11-05 |
| Quarterly | 2019-03-31 | 139000000.0 | -4.8% | USD | 10-Q | 2020-05-06 |
| Quarterly | 2019-06-30 | 123000000.0 | -11.5% | USD | 10-Q | 2020-08-05 |
| Quarterly | 2019-09-30 | 277000000.0 | +125.2% | USD | 10-Q | 2020-11-05 |
| Quarterly | 2019-12-31 | 217000000.0 | -21.7% | USD | 10-Q | 2020-11-05 |
| Quarterly | 2020-03-31 | 370000000.0 | +70.5% | USD | 10-Q | 2021-05-06 |
| Quarterly | 2020-06-30 | 1724000000.0 | +365.9% | USD | 10-Q | 2021-08-06 |
| Quarterly | 2020-09-30 | 2022000000.0 | +17.3% | USD | 10-Q | 2021-11-04 |
| Quarterly | 2020-12-31 | 1734000000.0 | -14.2% | USD | 10-Q | 2021-11-04 |
| Quarterly | 2021-03-31 | 2016000000.0 | +16.3% | USD | 10-Q | 2022-05-05 |
| Quarterly | 2021-06-30 | 2675000000.0 | +32.7% | USD | 10-Q | 2022-08-04 |
| Quarterly | 2021-09-30 | 1947000000.0 | -27.2% | USD | 10-Q | 2022-11-03 |
| Quarterly | 2021-12-31 | 1925000000.0 | -1.1% | USD | 10-Q | 2022-11-03 |
| Quarterly | 2022-03-31 | 325000000.0 | -83.1% | USD | 10-Q | 2023-05-04 |
| Quarterly | 2022-06-30 | 276000000.0 | -15.1% | USD | 10-Q | 2023-08-03 |
| Quarterly | 2022-09-30 | 338000000.0 | +22.5% | USD | 10-Q | 2023-11-01 |
| Quarterly | 2022-12-31 | 928000000.0 | +174.6% | USD | 10-Q | 2023-11-01 |
| Quarterly | 2023-03-31 | 570000000.0 | -38.6% | USD | 10-Q | 2024-05-01 |
| Quarterly | 2023-06-30 | 426000000.0 | -25.3% | USD | 10-Q | 2024-08-01 |
| Quarterly | 2023-09-30 | 952000000.0 | +123.5% | USD | 10-Q | 2024-11-01 |
| Quarterly | 2023-12-31 | 865000000.0 | -9.1% | USD | 10-Q | 2024-11-01 |
| Quarterly | 2024-03-31 | 2329000000.0 | +169.2% | USD | 10-Q | 2025-05-01 |
| Quarterly | 2024-06-30 | 2913000000.0 | +25.1% | USD | 10-Q | 2025-08-01 |
| Quarterly | 2024-09-30 | 2502000000.0 | -14.1% | USD | 10-Q | 2025-11-03 |
| Quarterly | 2024-12-31 | 414000000.0 | -83.5% | USD | 10-Q | 2025-11-03 |
| Quarterly | 2025-03-31 | 725000000.0 | +75.1% | USD | 10-Q | 2025-05-01 |
| Quarterly | 2025-06-30 | 534000000.0 | -26.3% | USD | 10-Q | 2025-08-01 |
| Quarterly | 2025-09-30 | 1275000000.0 | +138.8% | USD | 10-Q | 2025-11-03 |
| Annual | 2016-12-31 | 196000000.0 | — | USD | 10-K | 2019-02-19 |
| Annual | 2017-12-31 | 188000000.0 | -4.1% | USD | 10-K | 2020-02-25 |
| Annual | 2018-12-31 | 146000000.0 | -22.3% | USD | 10-K | 2021-02-23 |
| Annual | 2019-12-31 | 217000000.0 | +48.6% | USD | 10-K | 2022-02-23 |
| Annual | 2020-12-31 | 1734000000.0 | +699.1% | USD | 10-K | 2023-02-23 |
| Annual | 2021-12-31 | 1925000000.0 | +11.0% | USD | 10-K | 2024-02-20 |
| Annual | 2022-12-31 | 928000000.0 | -51.8% | USD | 10-K | 2025-02-18 |
| Annual | 2023-12-31 | 865000000.0 | -6.8% | USD | 10-K | 2026-02-17 |
| Annual | 2024-12-31 | 414000000.0 | -52.1% | USD | 10-K | 2026-02-17 |
| Annual | 2025-12-31 | 1965000000.0 | +374.6% | USD | 10-K | 2026-02-17 |
Accounts Receivable
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|
Inventory
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 1022000000.0 | — | USD | 10-Q | 2016-05-04 |
| Quarterly | 2016-06-30 | 981000000.0 | -4.0% | USD | 10-Q | 2016-08-03 |
| Quarterly | 2016-09-30 | 998000000.0 | +1.7% | USD | 10-Q | 2016-11-03 |
| Quarterly | 2016-12-31 | 955000000.0 | -4.3% | USD | 10-Q | 2017-11-02 |
| Quarterly | 2017-03-31 | 971000000.0 | +1.7% | USD | 10-Q | 2017-05-03 |
| Quarterly | 2017-06-30 | 1023000000.0 | +5.4% | USD | 10-Q | 2017-08-03 |
| Quarterly | 2017-09-30 | 1077000000.0 | +5.3% | USD | 10-Q | 2017-11-02 |
| Quarterly | 2017-12-31 | 1078000000.0 | +0.1% | USD | 10-Q | 2018-10-29 |
| Quarterly | 2018-03-31 | 1113000000.0 | +3.2% | USD | 10-Q | 2018-05-01 |
| Quarterly | 2018-06-30 | 1087000000.0 | -2.3% | USD | 10-Q | 2018-07-31 |
| Quarterly | 2018-09-30 | 1134000000.0 | +4.3% | USD | 10-Q | 2018-10-29 |
| Quarterly | 2018-12-31 | 1166000000.0 | +2.8% | USD | 10-Q | 2019-11-05 |
| Quarterly | 2019-03-31 | 1228000000.0 | +5.3% | USD | 10-Q | 2019-04-29 |
| Quarterly | 2019-06-30 | 1300000000.0 | +5.9% | USD | 10-Q | 2019-07-30 |
| Quarterly | 2019-09-30 | 1566000000.0 | +20.5% | USD | 10-Q | 2019-11-05 |
| Quarterly | 2019-12-31 | 1579000000.0 | +0.8% | USD | 10-Q | 2020-11-05 |
| Quarterly | 2020-03-31 | 1628000000.0 | +3.1% | USD | 10-Q | 2020-05-06 |
| Quarterly | 2020-06-30 | 1516000000.0 | -6.9% | USD | 10-Q | 2020-08-05 |
| Quarterly | 2020-09-30 | 1472000000.0 | -2.9% | USD | 10-Q | 2020-11-05 |
| Quarterly | 2020-12-31 | 1351000000.0 | -8.2% | USD | 10-Q | 2021-11-04 |
| Quarterly | 2021-03-31 | 1407000000.0 | +4.1% | USD | 10-Q | 2021-05-06 |
| Quarterly | 2021-06-30 | 1430000000.0 | +1.6% | USD | 10-Q | 2021-08-06 |
| Quarterly | 2021-09-30 | 1603000000.0 | +12.1% | USD | 10-Q | 2021-11-04 |
| Quarterly | 2021-12-31 | 1610000000.0 | +0.4% | USD | 10-Q | 2022-11-03 |
| Quarterly | 2022-03-31 | 1736000000.0 | +7.8% | USD | 10-Q | 2022-05-05 |
| Quarterly | 2022-06-30 | 1752000000.0 | +0.9% | USD | 10-Q | 2022-08-04 |
| Quarterly | 2022-09-30 | 1788000000.0 | +2.1% | USD | 10-Q | 2022-11-03 |
| Quarterly | 2022-12-31 | 1867000000.0 | +4.4% | USD | 10-Q | 2023-11-01 |
| Quarterly | 2023-03-31 | 2050000000.0 | +9.8% | USD | 10-Q | 2023-05-04 |
| Quarterly | 2023-06-30 | 2250000000.0 | +9.8% | USD | 10-Q | 2023-08-03 |
| Quarterly | 2023-09-30 | 2404000000.0 | +6.8% | USD | 10-Q | 2023-11-01 |
| Quarterly | 2023-12-31 | 2484000000.0 | +3.3% | USD | 10-Q | 2024-11-01 |
| Quarterly | 2024-03-31 | 2561000000.0 | +3.1% | USD | 10-Q | 2024-05-01 |
| Quarterly | 2024-06-30 | 2608000000.0 | +1.8% | USD | 10-Q | 2024-08-01 |
| Quarterly | 2024-09-30 | 2753000000.0 | +5.6% | USD | 10-Q | 2024-11-01 |
| Quarterly | 2024-12-31 | 2810000000.0 | +2.1% | USD | 10-Q | 2025-11-03 |
| Quarterly | 2025-03-31 | 2867000000.0 | +2.0% | USD | 10-Q | 2025-05-01 |
| Quarterly | 2025-06-30 | 2861000000.0 | -0.2% | USD | 10-Q | 2025-08-01 |
| Quarterly | 2025-09-30 | 2921000000.0 | +2.1% | USD | 10-Q | 2025-11-03 |
| Annual | 2016-12-31 | 955000000.0 | — | USD | 10-K | 2018-02-20 |
| Annual | 2017-12-31 | 1078000000.0 | +12.9% | USD | 10-K | 2019-02-19 |
| Annual | 2018-12-31 | 1166000000.0 | +8.2% | USD | 10-K | 2020-02-25 |
| Annual | 2019-12-31 | 1579000000.0 | +35.4% | USD | 10-K | 2021-02-23 |
| Annual | 2020-12-31 | 1351000000.0 | -14.4% | USD | 10-K | 2022-02-23 |
| Annual | 2021-12-31 | 1610000000.0 | +19.2% | USD | 10-K | 2023-02-23 |
| Annual | 2022-12-31 | 1867000000.0 | +16.0% | USD | 10-K | 2024-02-20 |
| Annual | 2023-12-31 | 2484000000.0 | +33.0% | USD | 10-K | 2025-02-18 |
| Annual | 2024-12-31 | 2810000000.0 | +13.1% | USD | 10-K | 2026-02-17 |
| Annual | 2025-12-31 | 2943000000.0 | +4.7% | USD | 10-K | 2026-02-17 |
Current Assets
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 3164000000.0 | — | USD | 10-Q | 2016-05-04 |
| Quarterly | 2016-06-30 | 3330000000.0 | +5.2% | USD | 10-Q | 2016-08-03 |
| Quarterly | 2016-09-30 | 3181000000.0 | -4.5% | USD | 10-Q | 2016-11-03 |
| Quarterly | 2016-12-31 | 3239000000.0 | +1.8% | USD | 10-Q | 2017-11-02 |
| Quarterly | 2017-03-31 | 3026000000.0 | -6.6% | USD | 10-Q | 2017-05-03 |
| Quarterly | 2017-06-30 | 3222000000.0 | +6.5% | USD | 10-Q | 2017-08-03 |
| Quarterly | 2017-09-30 | 3478000000.0 | +7.9% | USD | 10-Q | 2017-11-02 |
| Quarterly | 2017-12-31 | 3822000000.0 | +9.9% | USD | 10-Q | 2018-10-29 |
| Quarterly | 2018-03-31 | 4080000000.0 | +6.8% | USD | 10-Q | 2018-05-01 |
| Quarterly | 2018-06-30 | 3929000000.0 | -3.7% | USD | 10-Q | 2018-07-31 |
| Quarterly | 2018-09-30 | 3971000000.0 | +1.1% | USD | 10-Q | 2018-10-29 |
| Quarterly | 2018-12-31 | 4003000000.0 | +0.8% | USD | 10-Q | 2019-11-05 |
| Quarterly | 2019-03-31 | 6234000000.0 | +55.7% | USD | 10-Q | 2019-04-29 |
| Quarterly | 2019-06-30 | 6334000000.0 | +1.6% | USD | 10-Q | 2019-07-30 |
| Quarterly | 2019-09-30 | 4847000000.0 | -23.5% | USD | 10-Q | 2019-11-05 |
| Quarterly | 2019-12-31 | 4699000000.0 | -3.1% | USD | 10-Q | 2020-11-05 |
| Quarterly | 2020-03-31 | 4823000000.0 | +2.6% | USD | 10-Q | 2020-05-06 |
| Quarterly | 2020-06-30 | 5803000000.0 | +20.3% | USD | 10-Q | 2020-08-05 |
| Quarterly | 2020-09-30 | 6160000000.0 | +6.2% | USD | 10-Q | 2020-11-05 |
| Quarterly | 2020-12-31 | 6694000000.0 | +8.7% | USD | 10-Q | 2021-11-04 |
| Quarterly | 2021-03-31 | 6101000000.0 | -8.9% | USD | 10-Q | 2021-05-06 |
| Quarterly | 2021-06-30 | 6758000000.0 | +10.8% | USD | 10-Q | 2021-08-06 |
| Quarterly | 2021-09-30 | 6229000000.0 | -7.8% | USD | 10-Q | 2021-11-04 |
| Quarterly | 2021-12-31 | 6317000000.0 | +1.4% | USD | 10-Q | 2022-11-03 |
| Quarterly | 2022-03-31 | 5065000000.0 | -19.8% | USD | 10-Q | 2022-05-05 |
| Quarterly | 2022-06-30 | 5083000000.0 | +0.4% | USD | 10-Q | 2022-08-04 |
| Quarterly | 2022-09-30 | 5144000000.0 | +1.2% | USD | 10-Q | 2022-11-03 |
| Quarterly | 2022-12-31 | 5760000000.0 | +12.0% | USD | 10-Q | 2023-11-01 |
| Quarterly | 2023-03-31 | 5704000000.0 | -1.0% | USD | 10-Q | 2023-05-04 |
| Quarterly | 2023-06-30 | 5886000000.0 | +3.2% | USD | 10-Q | 2023-08-03 |
| Quarterly | 2023-09-30 | 6504000000.0 | +10.5% | USD | 10-Q | 2023-11-01 |
| Quarterly | 2023-12-31 | 6514000000.0 | +0.2% | USD | 10-Q | 2024-11-01 |
| Quarterly | 2024-03-31 | 8185000000.0 | +25.7% | USD | 10-Q | 2024-05-01 |
| Quarterly | 2024-06-30 | 8991000000.0 | +9.8% | USD | 10-Q | 2024-08-01 |
| Quarterly | 2024-09-30 | 8761000000.0 | -2.6% | USD | 10-Q | 2024-11-01 |
| Quarterly | 2024-12-31 | 6920000000.0 | -21.0% | USD | 10-Q | 2025-11-03 |
| Quarterly | 2025-03-31 | 7335000000.0 | +6.0% | USD | 10-Q | 2025-05-01 |
| Quarterly | 2025-06-30 | 7121000000.0 | -2.9% | USD | 10-Q | 2025-08-01 |
| Quarterly | 2025-09-30 | 8035000000.0 | +12.8% | USD | 10-Q | 2025-11-03 |
| Annual | 2016-12-31 | 3239000000.0 | — | USD | 10-K | 2018-02-20 |
| Annual | 2017-12-31 | 3822000000.0 | +18.0% | USD | 10-K | 2019-02-19 |
| Annual | 2018-12-31 | 4003000000.0 | +4.7% | USD | 10-K | 2020-02-25 |
| Annual | 2019-12-31 | 4699000000.0 | +17.4% | USD | 10-K | 2021-02-23 |
| Annual | 2020-12-31 | 6694000000.0 | +42.5% | USD | 10-K | 2022-02-23 |
| Annual | 2021-12-31 | 6317000000.0 | -5.6% | USD | 10-K | 2023-02-23 |
| Annual | 2022-12-31 | 5760000000.0 | -8.8% | USD | 10-K | 2024-02-20 |
| Annual | 2023-12-31 | 6514000000.0 | +13.1% | USD | 10-K | 2025-02-18 |
| Annual | 2024-12-31 | 6920000000.0 | +6.2% | USD | 10-K | 2026-02-17 |
| Annual | 2025-12-31 | 8794000000.0 | +27.1% | USD | 10-K | 2026-02-17 |
Total Assets
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 17718000000.0 | — | USD | 10-Q | 2016-05-04 |
| Quarterly | 2016-06-30 | 17838000000.0 | +0.7% | USD | 10-Q | 2016-08-03 |
| Quarterly | 2016-09-30 | 17697000000.0 | -0.8% | USD | 10-Q | 2016-11-03 |
| Quarterly | 2016-12-31 | 18096000000.0 | +2.3% | USD | 10-Q | 2017-11-02 |
| Quarterly | 2017-03-31 | 17943000000.0 | -0.8% | USD | 10-Q | 2017-05-03 |
| Quarterly | 2017-06-30 | 18382000000.0 | +2.4% | USD | 10-Q | 2017-08-03 |
| Quarterly | 2017-09-30 | 18636000000.0 | +1.4% | USD | 10-Q | 2017-11-02 |
| Quarterly | 2017-12-31 | 19042000000.0 | +2.2% | USD | 10-Q | 2018-10-29 |
| Quarterly | 2018-03-31 | 19202000000.0 | +0.8% | USD | 10-Q | 2018-05-01 |
| Quarterly | 2018-06-30 | 19615000000.0 | +2.2% | USD | 10-Q | 2018-07-31 |
| Quarterly | 2018-09-30 | 20379000000.0 | +3.9% | USD | 10-Q | 2018-10-29 |
| Quarterly | 2018-12-31 | 20999000000.0 | +3.0% | USD | 10-Q | 2019-11-05 |
| Quarterly | 2019-03-31 | 23802000000.0 | +13.3% | USD | 10-Q | 2019-04-29 |
| Quarterly | 2019-06-30 | 24309000000.0 | +2.1% | USD | 10-Q | 2019-07-30 |
| Quarterly | 2019-09-30 | 26756000000.0 | +10.1% | USD | 10-Q | 2019-11-05 |
| Quarterly | 2019-12-31 | 30565000000.0 | +14.2% | USD | 10-Q | 2020-11-05 |
| Quarterly | 2020-03-31 | 30113000000.0 | -1.5% | USD | 10-Q | 2020-05-06 |
| Quarterly | 2020-06-30 | 30823000000.0 | +2.4% | USD | 10-Q | 2020-08-05 |
| Quarterly | 2020-09-30 | 30845000000.0 | +0.1% | USD | 10-Q | 2020-11-05 |
| Quarterly | 2020-12-31 | 30777000000.0 | -0.2% | USD | 10-Q | 2021-11-04 |
| Quarterly | 2021-03-31 | 30900000000.0 | +0.4% | USD | 10-Q | 2021-05-06 |
| Quarterly | 2021-06-30 | 31168000000.0 | +0.9% | USD | 10-Q | 2021-08-06 |
| Quarterly | 2021-09-30 | 31877000000.0 | +2.3% | USD | 10-Q | 2021-11-04 |
| Quarterly | 2021-12-31 | 32229000000.0 | +1.1% | USD | 10-Q | 2022-11-03 |
| Quarterly | 2022-03-31 | 32337000000.0 | +0.3% | USD | 10-Q | 2022-05-05 |
| Quarterly | 2022-06-30 | 32189000000.0 | -0.5% | USD | 10-Q | 2022-08-04 |
| Quarterly | 2022-09-30 | 31947000000.0 | -0.8% | USD | 10-Q | 2022-11-03 |
| Quarterly | 2022-12-31 | 32469000000.0 | +1.6% | USD | 10-Q | 2023-11-01 |
| Quarterly | 2023-03-31 | 32892000000.0 | +1.3% | USD | 10-Q | 2023-05-04 |
| Quarterly | 2023-06-30 | 33601000000.0 | +2.2% | USD | 10-Q | 2023-08-03 |
| Quarterly | 2023-09-30 | 34043000000.0 | +1.3% | USD | 10-Q | 2023-11-01 |
| Quarterly | 2023-12-31 | 35136000000.0 | +3.2% | USD | 10-Q | 2024-11-01 |
| Quarterly | 2024-03-31 | 36669000000.0 | +4.4% | USD | 10-Q | 2024-05-01 |
| Quarterly | 2024-06-30 | 37108000000.0 | +1.2% | USD | 10-Q | 2024-08-01 |
| Quarterly | 2024-09-30 | 38078000000.0 | +2.6% | USD | 10-Q | 2024-11-01 |
| Quarterly | 2024-12-31 | 39395000000.0 | +3.5% | USD | 10-Q | 2025-11-03 |
| Quarterly | 2025-03-31 | 40140000000.0 | +1.9% | USD | 10-Q | 2025-05-01 |
| Quarterly | 2025-06-30 | 41559000000.0 | +3.5% | USD | 10-Q | 2025-08-01 |
| Quarterly | 2025-09-30 | 42707000000.0 | +2.8% | USD | 10-Q | 2025-11-03 |
| Annual | 2016-12-31 | 18096000000.0 | — | USD | 10-K | 2018-02-20 |
| Annual | 2017-12-31 | 19042000000.0 | +5.2% | USD | 10-K | 2019-02-19 |
| Annual | 2018-12-31 | 20999000000.0 | +10.3% | USD | 10-K | 2020-02-25 |
| Annual | 2019-12-31 | 30565000000.0 | +45.6% | USD | 10-K | 2021-02-23 |
| Annual | 2020-12-31 | 30777000000.0 | +0.7% | USD | 10-K | 2022-02-23 |
| Annual | 2021-12-31 | 32229000000.0 | +4.7% | USD | 10-K | 2023-02-23 |
| Annual | 2022-12-31 | 32469000000.0 | +0.7% | USD | 10-K | 2024-02-20 |
| Annual | 2023-12-31 | 35136000000.0 | +8.2% | USD | 10-K | 2025-02-18 |
| Annual | 2024-12-31 | 39395000000.0 | +12.1% | USD | 10-K | 2026-02-17 |
| Annual | 2025-12-31 | 43673000000.0 | +10.9% | USD | 10-K | 2026-02-17 |
Current Liabilities
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 2608000000.0 | — | USD | 10-Q | 2016-05-04 |
| Quarterly | 2016-06-30 | 3182000000.0 | +22.0% | USD | 10-Q | 2016-08-03 |
| Quarterly | 2016-09-30 | 3016000000.0 | -5.2% | USD | 10-Q | 2016-11-03 |
| Quarterly | 2016-12-31 | 3587000000.0 | +18.9% | USD | 10-Q | 2017-11-02 |
| Quarterly | 2017-03-31 | 3490000000.0 | -2.7% | USD | 10-Q | 2017-05-03 |
| Quarterly | 2017-06-30 | 4300000000.0 | +23.2% | USD | 10-Q | 2017-08-03 |
| Quarterly | 2017-09-30 | 4828000000.0 | +12.3% | USD | 10-Q | 2017-11-02 |
| Quarterly | 2017-12-31 | 5654000000.0 | +17.1% | USD | 10-Q | 2018-10-29 |
| Quarterly | 2018-03-31 | 4988000000.0 | -11.8% | USD | 10-Q | 2018-05-01 |
| Quarterly | 2018-06-30 | 4753000000.0 | -4.7% | USD | 10-Q | 2018-07-31 |
| Quarterly | 2018-09-30 | 5082000000.0 | +6.9% | USD | 10-Q | 2018-10-29 |
| Quarterly | 2018-12-31 | 5260000000.0 | +3.5% | USD | 10-Q | 2019-11-05 |
| Quarterly | 2019-03-31 | 4479000000.0 | -14.8% | USD | 10-Q | 2019-04-29 |
| Quarterly | 2019-06-30 | 4850000000.0 | +8.3% | USD | 10-Q | 2019-07-30 |
| Quarterly | 2019-09-30 | 4254000000.0 | -12.3% | USD | 10-Q | 2019-11-05 |
| Quarterly | 2019-12-31 | 4866000000.0 | +14.4% | USD | 10-Q | 2020-11-05 |
| Quarterly | 2020-03-31 | 3976000000.0 | -18.3% | USD | 10-Q | 2020-05-06 |
| Quarterly | 2020-06-30 | 3108000000.0 | -21.8% | USD | 10-Q | 2020-08-05 |
| Quarterly | 2020-09-30 | 3302000000.0 | +6.2% | USD | 10-Q | 2020-11-05 |
| Quarterly | 2020-12-31 | 3681000000.0 | +11.5% | USD | 10-Q | 2021-11-04 |
| Quarterly | 2021-03-31 | 3393000000.0 | -7.8% | USD | 10-Q | 2021-05-06 |
| Quarterly | 2021-06-30 | 4073000000.0 | +20.0% | USD | 10-Q | 2021-08-06 |
| Quarterly | 2021-09-30 | 4022000000.0 | -1.3% | USD | 10-Q | 2021-11-04 |
| Quarterly | 2021-12-31 | 4274000000.0 | +6.3% | USD | 10-Q | 2022-11-03 |
| Quarterly | 2022-03-31 | 4275000000.0 | +0.0% | USD | 10-Q | 2022-05-05 |
| Quarterly | 2022-06-30 | 3883000000.0 | -9.2% | USD | 10-Q | 2022-08-04 |
| Quarterly | 2022-09-30 | 3549000000.0 | -8.6% | USD | 10-Q | 2022-11-03 |
| Quarterly | 2022-12-31 | 3803000000.0 | +7.2% | USD | 10-Q | 2023-11-01 |
| Quarterly | 2023-03-31 | 4083000000.0 | +7.4% | USD | 10-Q | 2023-05-04 |
| Quarterly | 2023-06-30 | 4562000000.0 | +11.7% | USD | 10-Q | 2023-08-03 |
| Quarterly | 2023-09-30 | 4579000000.0 | +0.4% | USD | 10-Q | 2023-11-01 |
| Quarterly | 2023-12-31 | 4933000000.0 | +7.7% | USD | 10-Q | 2024-11-01 |
| Quarterly | 2024-03-31 | 4916000000.0 | -0.3% | USD | 10-Q | 2024-05-01 |
| Quarterly | 2024-06-30 | 5576000000.0 | +13.4% | USD | 10-Q | 2024-08-01 |
| Quarterly | 2024-09-30 | 5910000000.0 | +6.0% | USD | 10-Q | 2024-11-01 |
| Quarterly | 2024-12-31 | 6399000000.0 | +8.3% | USD | 10-Q | 2025-11-03 |
| Quarterly | 2025-03-31 | 5058000000.0 | -21.0% | USD | 10-Q | 2025-05-01 |
| Quarterly | 2025-06-30 | 5190000000.0 | +2.6% | USD | 10-Q | 2025-08-01 |
| Quarterly | 2025-09-30 | 5328000000.0 | +2.7% | USD | 10-Q | 2025-11-03 |
| Annual | 2016-12-31 | 3587000000.0 | — | USD | 10-K | 2018-02-20 |
| Annual | 2017-12-31 | 5654000000.0 | +57.6% | USD | 10-K | 2019-02-19 |
| Annual | 2018-12-31 | 5260000000.0 | -7.0% | USD | 10-K | 2020-02-25 |
| Annual | 2019-12-31 | 4866000000.0 | -7.5% | USD | 10-K | 2021-02-23 |
| Annual | 2020-12-31 | 3681000000.0 | -24.4% | USD | 10-K | 2022-02-23 |
| Annual | 2021-12-31 | 4274000000.0 | +16.1% | USD | 10-K | 2023-02-23 |
| Annual | 2022-12-31 | 3803000000.0 | -11.0% | USD | 10-K | 2024-02-20 |
| Annual | 2023-12-31 | 4933000000.0 | +29.7% | USD | 10-K | 2025-02-18 |
| Annual | 2024-12-31 | 6399000000.0 | +29.7% | USD | 10-K | 2026-02-17 |
| Annual | 2025-12-31 | 5439000000.0 | -15.0% | USD | 10-K | 2026-02-17 |
Total Liabilities
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|
Stockholders' Equity
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 6457000000.0 | — | USD | 10-Q | 2016-05-04 |
| Quarterly | 2016-06-30 | 6220000000.0 | -3.7% | USD | 10-Q | 2016-08-03 |
| Quarterly | 2016-09-30 | 6482000000.0 | +4.2% | USD | 10-Q | 2016-11-03 |
| Quarterly | 2016-12-31 | 6733000000.0 | +3.9% | USD | 10-Q | 2017-11-02 |
| Quarterly | 2017-03-31 | 7053000000.0 | +4.8% | USD | 10-Q | 2017-05-03 |
| Quarterly | 2017-06-30 | 7235000000.0 | +2.6% | USD | 10-Q | 2017-08-03 |
| Quarterly | 2017-09-30 | 7588000000.0 | +4.9% | USD | 10-Q | 2017-11-02 |
| Quarterly | 2017-12-31 | 7012000000.0 | -7.6% | USD | 10-Q | 2018-10-29 |
| Quarterly | 2018-03-31 | 7030000000.0 | +0.3% | USD | 10-Q | 2018-05-01 |
| Quarterly | 2018-06-30 | 7744000000.0 | +10.2% | USD | 10-Q | 2018-07-31 |
| Quarterly | 2018-09-30 | 8289000000.0 | +7.0% | USD | 10-Q | 2018-10-29 |
| Quarterly | 2018-12-31 | 8726000000.0 | +5.3% | USD | 10-Q | 2019-11-05 |
| Quarterly | 2019-03-31 | 9233000000.0 | +5.8% | USD | 10-Q | 2019-04-29 |
| Quarterly | 2019-06-30 | 9425000000.0 | +2.1% | USD | 10-Q | 2019-07-30 |
| Quarterly | 2019-09-30 | 9699000000.0 | +2.9% | USD | 10-Q | 2019-11-05 |
| Quarterly | 2019-12-31 | 13877000000.0 | +43.1% | USD | 10-Q | 2020-11-05 |
| Quarterly | 2020-03-31 | 13804000000.0 | -0.5% | USD | 10-Q | 2020-05-06 |
| Quarterly | 2020-06-30 | 15616000000.0 | +13.1% | USD | 10-Q | 2020-08-05 |
| Quarterly | 2020-09-30 | 15564000000.0 | -0.3% | USD | 10-Q | 2021-11-04 |
| Quarterly | 2020-12-31 | 15326000000.0 | -1.5% | USD | 10-Q | 2021-11-04 |
| Quarterly | 2021-03-31 | 15719000000.0 | +2.6% | USD | 10-Q | 2022-05-05 |
| Quarterly | 2021-06-30 | 15942000000.0 | +1.4% | USD | 10-Q | 2022-08-04 |
| Quarterly | 2021-09-30 | 16462000000.0 | +3.3% | USD | 10-Q | 2022-11-03 |
| Quarterly | 2021-12-31 | 16622000000.0 | +1.0% | USD | 10-Q | 2022-11-03 |
| Quarterly | 2022-03-31 | 16735000000.0 | +0.7% | USD | 10-Q | 2023-05-04 |
| Quarterly | 2022-06-30 | 17251000000.0 | +3.1% | USD | 10-Q | 2023-08-03 |
| Quarterly | 2022-09-30 | 17640000000.0 | +2.3% | USD | 10-Q | 2023-11-01 |
| Quarterly | 2022-12-31 | 17573000000.0 | -0.4% | USD | 10-Q | 2023-11-01 |
| Quarterly | 2023-03-31 | 18109000000.0 | +3.1% | USD | 10-Q | 2024-05-01 |
| Quarterly | 2023-06-30 | 18485000000.0 | +2.1% | USD | 10-Q | 2024-08-01 |
| Quarterly | 2023-09-30 | 19129000000.0 | +3.5% | USD | 10-Q | 2024-11-01 |
| Quarterly | 2023-12-31 | 19530000000.0 | +2.1% | USD | 10-Q | 2024-11-01 |
| Quarterly | 2024-03-31 | 20168000000.0 | +3.3% | USD | 10-Q | 2025-05-01 |
| Quarterly | 2024-06-30 | 20609000000.0 | +2.2% | USD | 10-Q | 2025-08-01 |
| Quarterly | 2024-09-30 | 20956000000.0 | +1.7% | USD | 10-Q | 2025-11-03 |
| Quarterly | 2024-12-31 | 22003000000.0 | +5.0% | USD | 10-Q | 2025-11-03 |
| Quarterly | 2025-03-31 | 22446000000.0 | +2.0% | USD | 10-Q | 2025-05-01 |
| Quarterly | 2025-06-30 | 22653000000.0 | +0.9% | USD | 10-Q | 2025-08-01 |
| Quarterly | 2025-09-30 | 23630000000.0 | +4.3% | USD | 10-Q | 2025-11-03 |
| Annual | 2016-12-31 | 6733000000.0 | — | USD | 10-K | 2018-02-20 |
| Annual | 2017-12-31 | 7012000000.0 | +4.1% | USD | 10-K | 2019-02-19 |
| Annual | 2018-12-31 | 8726000000.0 | +24.4% | USD | 10-K | 2020-02-25 |
| Annual | 2019-12-31 | 13877000000.0 | +59.0% | USD | 10-K | 2022-02-23 |
| Annual | 2020-12-31 | 15326000000.0 | +10.4% | USD | 10-K | 2023-02-23 |
| Annual | 2021-12-31 | 16622000000.0 | +8.5% | USD | 10-K | 2024-02-20 |
| Annual | 2022-12-31 | 17573000000.0 | +5.7% | USD | 10-K | 2025-02-18 |
| Annual | 2023-12-31 | 19530000000.0 | +11.1% | USD | 10-K | 2026-02-17 |
| Annual | 2024-12-31 | 22003000000.0 | +12.7% | USD | 10-K | 2026-02-17 |
| Annual | 2025-12-31 | 24472000000.0 | +11.2% | USD | 10-K | 2026-02-17 |
Long-Term Debt
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 5650000000.0 | — | USD | 10-Q | 2016-05-04 |
| Quarterly | 2016-06-30 | 5400000000.0 | -4.4% | USD | 10-Q | 2016-08-03 |
| Quarterly | 2016-09-30 | 5400000000.0 | +0.0% | USD | 10-Q | 2016-11-03 |
| Quarterly | 2016-12-31 | 5420000000.0 | +0.4% | USD | 10-Q | 2017-11-02 |
| Quarterly | 2017-03-31 | 5491000000.0 | +1.3% | USD | 10-Q | 2017-05-03 |
| Quarterly | 2017-06-30 | 4817000000.0 | -12.3% | USD | 10-Q | 2017-08-03 |
| Quarterly | 2017-09-30 | 4416000000.0 | -8.3% | USD | 10-Q | 2017-11-02 |
| Quarterly | 2017-12-31 | 3815000000.0 | -13.6% | USD | 10-Q | 2018-07-31 |
| Quarterly | 2018-03-31 | 4803000000.0 | +25.9% | USD | 10-Q | 2018-05-01 |
| Quarterly | 2018-06-30 | 4808000000.0 | +0.1% | USD | 10-Q | 2018-07-31 |
| Annual | 2016-12-31 | 5420000000.0 | — | USD | 10-K | 2018-02-20 |
| Annual | 2017-12-31 | 3815000000.0 | -29.6% | USD | 10-K | 2018-02-20 |
Cash Flow
Metrics: 4Operating Cash Flow
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 116000000.0 | — | USD | 10-Q | 2017-05-03 |
| Quarterly | 2016-06-30 | 537000000.0 | +362.9% | USD | 10-Q | 2017-08-03 |
| Quarterly | 2016-09-30 | 506000000.0 | -5.8% | USD | 10-Q | 2017-11-02 |
| Quarterly | 2017-03-31 | -7000000.0 | -101.4% | USD | 10-Q | 2018-05-01 |
| Quarterly | 2017-06-30 | 290000000.0 | +4242.9% | USD | 10-Q | 2018-07-31 |
| Quarterly | 2017-09-30 | 742000000.0 | +155.9% | USD | 10-Q | 2018-10-29 |
| Quarterly | 2018-03-31 | 193000000.0 | -74.0% | USD | 10-Q | 2019-04-29 |
| Quarterly | 2018-06-30 | -210000000.0 | -208.8% | USD | 10-Q | 2019-07-30 |
| Quarterly | 2018-09-30 | 291000000.0 | +238.6% | USD | 10-Q | 2019-11-05 |
| Quarterly | 2019-03-31 | 350000000.0 | +20.3% | USD | 10-Q | 2020-05-06 |
| Quarterly | 2019-06-30 | 642000000.0 | +83.4% | USD | 10-Q | 2020-08-05 |
| Quarterly | 2019-09-30 | 1144000000.0 | +78.2% | USD | 10-Q | 2020-11-05 |
| Quarterly | 2020-03-31 | -77000000.0 | -106.7% | USD | 10-Q | 2021-05-06 |
| Quarterly | 2020-06-30 | 192000000.0 | +349.4% | USD | 10-Q | 2021-08-06 |
| Quarterly | 2020-09-30 | 835000000.0 | +334.9% | USD | 10-Q | 2021-11-04 |
| Quarterly | 2021-03-31 | 284000000.0 | -66.0% | USD | 10-Q | 2022-05-05 |
| Quarterly | 2021-06-30 | 927000000.0 | +226.4% | USD | 10-Q | 2022-08-04 |
| Quarterly | 2021-09-30 | 1392000000.0 | +50.2% | USD | 10-Q | 2022-11-03 |
| Quarterly | 2022-03-31 | -58000000.0 | -104.2% | USD | 10-Q | 2023-05-04 |
| Quarterly | 2022-06-30 | 249000000.0 | +529.3% | USD | 10-Q | 2023-08-03 |
| Quarterly | 2022-09-30 | 719000000.0 | +188.8% | USD | 10-Q | 2023-11-01 |
| Quarterly | 2023-03-31 | 190000000.0 | -73.6% | USD | 10-Q | 2024-05-01 |
| Quarterly | 2023-06-30 | 848000000.0 | +346.3% | USD | 10-Q | 2024-08-01 |
| Quarterly | 2023-09-30 | 1546000000.0 | +82.3% | USD | 10-Q | 2024-11-01 |
| Quarterly | 2024-03-31 | 164000000.0 | -89.4% | USD | 10-Q | 2025-05-01 |
| Quarterly | 2024-06-30 | 977000000.0 | +495.7% | USD | 10-Q | 2025-08-01 |
| Quarterly | 2024-09-30 | 1979000000.0 | +102.6% | USD | 10-Q | 2025-11-03 |
| Quarterly | 2025-03-31 | 541000000.0 | -72.7% | USD | 10-Q | 2025-05-01 |
| Quarterly | 2025-06-30 | 1827000000.0 | +237.7% | USD | 10-Q | 2025-08-01 |
| Quarterly | 2025-09-30 | 3170000000.0 | +73.5% | USD | 10-Q | 2025-11-03 |
| Annual | 2016-12-31 | 1182000000.0 | — | USD | 10-K | 2019-02-19 |
| Annual | 2017-12-31 | 1426000000.0 | +20.6% | USD | 10-K | 2020-02-25 |
| Annual | 2018-12-31 | 310000000.0 | -78.3% | USD | 10-K | 2021-02-23 |
| Annual | 2019-12-31 | 1836000000.0 | +492.3% | USD | 10-K | 2022-02-23 |
| Annual | 2020-12-31 | 1508000000.0 | -17.9% | USD | 10-K | 2023-02-23 |
| Annual | 2021-12-31 | 1870000000.0 | +24.0% | USD | 10-K | 2024-02-20 |
| Annual | 2022-12-31 | 1526000000.0 | -18.4% | USD | 10-K | 2025-02-18 |
| Annual | 2023-12-31 | 2503000000.0 | +64.0% | USD | 10-K | 2026-02-17 |
| Annual | 2024-12-31 | 3435000000.0 | +37.2% | USD | 10-K | 2026-02-17 |
| Annual | 2025-12-31 | 4534000000.0 | +32.0% | USD | 10-K | 2026-02-17 |
Investing Cash Flow
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | -48000000.0 | — | USD | 10-Q | 2017-05-03 |
| Quarterly | 2016-06-30 | -150000000.0 | -212.5% | USD | 10-Q | 2017-08-03 |
| Quarterly | 2016-09-30 | -355000000.0 | -136.7% | USD | 10-Q | 2017-11-02 |
| Quarterly | 2017-03-31 | -140000000.0 | +60.6% | USD | 10-Q | 2018-05-01 |
| Quarterly | 2017-06-30 | -619000000.0 | -342.1% | USD | 10-Q | 2018-07-31 |
| Quarterly | 2017-09-30 | -721000000.0 | -16.5% | USD | 10-Q | 2018-10-29 |
| Quarterly | 2018-03-31 | -173000000.0 | +76.0% | USD | 10-Q | 2019-04-29 |
| Quarterly | 2018-06-30 | -664000000.0 | -283.8% | USD | 10-Q | 2019-07-30 |
| Quarterly | 2018-09-30 | -1326000000.0 | -99.7% | USD | 10-Q | 2019-11-05 |
| Quarterly | 2019-03-31 | -410000000.0 | +69.1% | USD | 10-Q | 2020-05-06 |
| Quarterly | 2019-06-30 | -1030000000.0 | -151.2% | USD | 10-Q | 2020-08-05 |
| Quarterly | 2019-09-30 | -4992000000.0 | -384.7% | USD | 10-Q | 2020-11-05 |
| Quarterly | 2020-03-31 | -76000000.0 | +98.5% | USD | 10-Q | 2021-05-06 |
| Quarterly | 2020-06-30 | -135000000.0 | -77.6% | USD | 10-Q | 2021-08-06 |
| Quarterly | 2020-09-30 | -264000000.0 | -95.6% | USD | 10-Q | 2021-11-04 |
| Quarterly | 2021-03-31 | 71000000.0 | +126.9% | USD | 10-Q | 2022-05-05 |
| Quarterly | 2021-06-30 | 71000000.0 | +0.0% | USD | 10-Q | 2022-08-04 |
| Quarterly | 2021-09-30 | -1136000000.0 | -1700.0% | USD | 10-Q | 2022-11-03 |
| Quarterly | 2022-03-31 | -1574000000.0 | -38.6% | USD | 10-Q | 2023-05-04 |
| Quarterly | 2022-06-30 | -1603000000.0 | -1.8% | USD | 10-Q | 2023-08-03 |
| Quarterly | 2022-09-30 | -1828000000.0 | -14.0% | USD | 10-Q | 2023-11-01 |
| Quarterly | 2023-03-31 | -484000000.0 | +73.5% | USD | 10-Q | 2024-05-01 |
| Quarterly | 2023-06-30 | -1324000000.0 | -173.6% | USD | 10-Q | 2024-08-01 |
| Quarterly | 2023-09-30 | -1521000000.0 | -14.9% | USD | 10-Q | 2024-11-01 |
| Quarterly | 2024-03-31 | -285000000.0 | +81.3% | USD | 10-Q | 2025-05-01 |
| Quarterly | 2024-06-30 | -556000000.0 | -95.1% | USD | 10-Q | 2025-08-01 |
| Quarterly | 2024-09-30 | -1983000000.0 | -256.7% | USD | 10-Q | 2025-11-03 |
| Quarterly | 2025-03-31 | -500000000.0 | +74.8% | USD | 10-Q | 2025-05-01 |
| Quarterly | 2025-06-30 | -1626000000.0 | -225.2% | USD | 10-Q | 2025-08-01 |
| Quarterly | 2025-09-30 | -2128000000.0 | -30.9% | USD | 10-Q | 2025-11-03 |
| Annual | 2016-12-31 | -887000000.0 | — | USD | 10-K | 2019-02-19 |
| Annual | 2017-12-31 | -1010000000.0 | -13.9% | USD | 10-K | 2020-02-25 |
| Annual | 2018-12-31 | -1921000000.0 | -90.2% | USD | 10-K | 2021-02-23 |
| Annual | 2019-12-31 | -5041000000.0 | -162.4% | USD | 10-K | 2022-02-23 |
| Annual | 2020-12-31 | -411000000.0 | +91.8% | USD | 10-K | 2023-02-23 |
| Annual | 2021-12-31 | -1597000000.0 | -288.6% | USD | 10-K | 2024-02-20 |
| Annual | 2022-12-31 | -2011000000.0 | -25.9% | USD | 10-K | 2025-02-18 |
| Annual | 2023-12-31 | -2574000000.0 | -28.0% | USD | 10-K | 2026-02-17 |
| Annual | 2024-12-31 | -5687000000.0 | -120.9% | USD | 10-K | 2026-02-17 |
| Annual | 2025-12-31 | -2640000000.0 | +53.6% | USD | 10-K | 2026-02-17 |
Financing Cash Flow
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | -51000000.0 | — | USD | 10-Q | 2017-05-03 |
| Quarterly | 2016-06-30 | -268000000.0 | -425.5% | USD | 10-Q | 2017-08-03 |
| Quarterly | 2016-09-30 | -234000000.0 | +12.7% | USD | 10-Q | 2017-11-02 |
| Quarterly | 2017-03-31 | -15000000.0 | +93.6% | USD | 10-Q | 2018-05-01 |
| Quarterly | 2017-06-30 | 317000000.0 | +2213.3% | USD | 10-Q | 2018-07-31 |
| Quarterly | 2017-09-30 | 178000000.0 | -43.8% | USD | 10-Q | 2018-10-29 |
| Quarterly | 2018-03-31 | 130000000.0 | -27.0% | USD | 10-Q | 2019-04-29 |
| Quarterly | 2018-06-30 | 856000000.0 | +558.5% | USD | 10-Q | 2019-07-30 |
| Quarterly | 2018-09-30 | 1007000000.0 | +17.6% | USD | 10-Q | 2019-11-05 |
| Quarterly | 2019-03-31 | 2127000000.0 | +111.2% | USD | 10-Q | 2020-05-06 |
| Quarterly | 2019-06-30 | 2383000000.0 | +12.0% | USD | 10-Q | 2020-08-05 |
| Quarterly | 2019-09-30 | 3697000000.0 | +55.1% | USD | 10-Q | 2020-11-05 |
| Quarterly | 2020-03-31 | 256000000.0 | -93.1% | USD | 10-Q | 2021-05-06 |
| Quarterly | 2020-06-30 | 1361000000.0 | +431.6% | USD | 10-Q | 2021-08-06 |
| Quarterly | 2020-09-30 | 1112000000.0 | -18.3% | USD | 10-Q | 2021-11-04 |
| Quarterly | 2021-03-31 | -95000000.0 | -108.5% | USD | 10-Q | 2022-05-05 |
| Quarterly | 2021-06-30 | -93000000.0 | +2.1% | USD | 10-Q | 2022-08-04 |
| Quarterly | 2021-09-30 | -87000000.0 | +6.5% | USD | 10-Q | 2022-11-03 |
| Quarterly | 2022-03-31 | -6000000.0 | +93.1% | USD | 10-Q | 2023-05-04 |
| Quarterly | 2022-06-30 | -350000000.0 | -5733.3% | USD | 10-Q | 2023-08-03 |
| Quarterly | 2022-09-30 | -549000000.0 | -56.9% | USD | 10-Q | 2023-11-01 |
| Quarterly | 2023-03-31 | -69000000.0 | +87.4% | USD | 10-Q | 2024-05-01 |
| Quarterly | 2023-06-30 | -26000000.0 | +62.3% | USD | 10-Q | 2024-08-01 |
| Quarterly | 2023-09-30 | -10000000.0 | +61.5% | USD | 10-Q | 2024-11-01 |
| Quarterly | 2024-03-31 | 1569000000.0 | +15790.0% | USD | 10-Q | 2025-05-01 |
| Quarterly | 2024-06-30 | 1593000000.0 | +1.5% | USD | 10-Q | 2025-08-01 |
| Quarterly | 2024-09-30 | 1600000000.0 | +0.4% | USD | 10-Q | 2025-11-03 |
| Quarterly | 2025-03-31 | 233000000.0 | -85.4% | USD | 10-Q | 2025-05-01 |
| Quarterly | 2025-06-30 | -107000000.0 | -145.9% | USD | 10-Q | 2025-08-01 |
| Quarterly | 2025-09-30 | -211000000.0 | -97.2% | USD | 10-Q | 2025-11-03 |
| Annual | 2016-12-31 | -206000000.0 | — | USD | 10-K | 2019-02-19 |
| Annual | 2017-12-31 | 110000000.0 | +153.4% | USD | 10-K | 2020-02-25 |
| Annual | 2018-12-31 | 1432000000.0 | +1201.8% | USD | 10-K | 2021-02-23 |
| Annual | 2019-12-31 | 2973000000.0 | +107.6% | USD | 10-K | 2022-02-23 |
| Annual | 2020-12-31 | 293000000.0 | -90.1% | USD | 10-K | 2023-02-23 |
| Annual | 2021-12-31 | -95000000.0 | -132.4% | USD | 10-K | 2024-02-20 |
| Annual | 2022-12-31 | -548000000.0 | -476.8% | USD | 10-K | 2025-02-18 |
| Annual | 2023-12-31 | 5000000.0 | +100.9% | USD | 10-K | 2026-02-17 |
| Annual | 2024-12-31 | 1814000000.0 | +36180.0% | USD | 10-K | 2026-02-17 |
| Annual | 2025-12-31 | -395000000.0 | -121.8% | USD | 10-K | 2026-02-17 |
Capital Expenditures
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 60000000.0 | — | USD | 10-Q | 2017-05-03 |
| Quarterly | 2016-06-30 | 138000000.0 | +130.0% | USD | 10-Q | 2017-08-03 |
| Quarterly | 2016-09-30 | 209000000.0 | +51.4% | USD | 10-Q | 2017-11-02 |
| Quarterly | 2017-03-31 | 112000000.0 | -46.4% | USD | 10-Q | 2018-05-01 |
| Quarterly | 2017-06-30 | 180000000.0 | +60.7% | USD | 10-Q | 2018-07-31 |
| Quarterly | 2017-09-30 | 240000000.0 | +33.3% | USD | 10-Q | 2018-10-29 |
| Quarterly | 2018-03-31 | 60000000.0 | -75.0% | USD | 10-Q | 2019-04-29 |
| Quarterly | 2018-06-30 | 134000000.0 | +123.3% | USD | 10-Q | 2019-07-30 |
| Quarterly | 2018-09-30 | 210000000.0 | +56.7% | USD | 10-Q | 2019-11-05 |
| Quarterly | 2019-03-31 | 63000000.0 | -70.0% | USD | 10-Q | 2020-05-06 |
| Quarterly | 2019-06-30 | 154000000.0 | +144.4% | USD | 10-Q | 2020-08-05 |
| Quarterly | 2019-09-30 | 275000000.0 | +78.6% | USD | 10-Q | 2020-11-05 |
| Quarterly | 2020-03-31 | 100000000.0 | -63.6% | USD | 10-Q | 2021-05-06 |
| Quarterly | 2020-06-30 | 168000000.0 | +68.0% | USD | 10-Q | 2021-08-06 |
| Quarterly | 2020-09-30 | 217000000.0 | +29.2% | USD | 10-Q | 2021-11-04 |
| Quarterly | 2021-03-31 | 75000000.0 | -65.4% | USD | 10-Q | 2022-05-05 |
| Quarterly | 2021-06-30 | 181000000.0 | +141.3% | USD | 10-Q | 2022-08-04 |
| Quarterly | 2021-09-30 | 288000000.0 | +59.1% | USD | 10-Q | 2022-11-03 |
| Quarterly | 2022-03-31 | 121000000.0 | -58.0% | USD | 10-Q | 2023-05-04 |
| Quarterly | 2022-06-30 | 226000000.0 | +86.8% | USD | 10-Q | 2023-08-03 |
| Quarterly | 2022-09-30 | 376000000.0 | +66.4% | USD | 10-Q | 2023-11-01 |
| Quarterly | 2023-03-31 | 111000000.0 | -70.5% | USD | 10-Q | 2024-05-01 |
| Quarterly | 2023-06-30 | 254000000.0 | +128.8% | USD | 10-Q | 2024-08-01 |
| Quarterly | 2023-09-30 | 444000000.0 | +74.8% | USD | 10-Q | 2024-11-01 |
| Quarterly | 2024-03-31 | 179000000.0 | -59.7% | USD | 10-Q | 2025-05-01 |
| Quarterly | 2024-06-30 | 334000000.0 | +86.6% | USD | 10-Q | 2025-08-01 |
| Quarterly | 2024-09-30 | 513000000.0 | +53.6% | USD | 10-Q | 2025-11-03 |
| Quarterly | 2025-03-31 | 187000000.0 | -63.5% | USD | 10-Q | 2025-05-01 |
| Quarterly | 2025-06-30 | 344000000.0 | +84.0% | USD | 10-Q | 2025-08-01 |
| Quarterly | 2025-09-30 | 525000000.0 | +52.6% | USD | 10-Q | 2025-11-03 |
| Annual | 2016-12-31 | 376000000.0 | — | USD | 10-K | 2019-02-19 |
| Annual | 2017-12-31 | 319000000.0 | -15.2% | USD | 10-K | 2020-02-25 |
| Annual | 2018-12-31 | 316000000.0 | -0.9% | USD | 10-K | 2021-02-23 |
| Annual | 2019-12-31 | 461000000.0 | +45.9% | USD | 10-K | 2022-02-23 |
| Annual | 2020-12-31 | 376000000.0 | -18.4% | USD | 10-K | 2023-02-23 |
| Annual | 2021-12-31 | 554000000.0 | +47.3% | USD | 10-K | 2024-02-20 |
| Annual | 2022-12-31 | 588000000.0 | +6.1% | USD | 10-K | 2025-02-18 |
| Annual | 2023-12-31 | 711000000.0 | +20.9% | USD | 10-K | 2026-02-17 |
| Annual | 2024-12-31 | 790000000.0 | +11.1% | USD | 10-K | 2026-02-17 |
| Annual | 2025-12-31 | 876000000.0 | +10.9% | USD | 10-K | 2026-02-17 |
Share Data
Metrics: 4Shares Outstanding
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 1354567488.0 | — | shares | 10-Q | 2016-05-04 |
| Quarterly | 2016-06-30 | 1358698563.0 | +0.3% | shares | 10-Q | 2016-08-03 |
| Quarterly | 2016-09-30 | 1361444063.0 | +0.2% | shares | 10-Q | 2016-11-03 |
| Quarterly | 2016-12-31 | 1362104547.0 | +0.0% | shares | 10-Q | 2017-11-02 |
| Quarterly | 2017-03-31 | 1369082488.0 | +0.5% | shares | 10-Q | 2017-05-03 |
| Quarterly | 2017-06-30 | 1370464555.0 | +0.1% | shares | 10-Q | 2017-08-03 |
| Quarterly | 2017-09-30 | 1372735769.0 | +0.2% | shares | 10-Q | 2017-11-02 |
| Quarterly | 2017-12-31 | 1373496628.0 | +0.1% | shares | 10-Q | 2018-10-29 |
| Quarterly | 2018-03-31 | 1379621739.0 | +0.4% | shares | 10-Q | 2018-05-01 |
| Quarterly | 2018-06-30 | 1381309982.0 | +0.1% | shares | 10-Q | 2018-07-31 |
| Quarterly | 2018-09-30 | 1383705013.0 | +0.2% | shares | 10-Q | 2018-10-29 |
| Quarterly | 2018-12-31 | 1384581760.0 | +0.1% | shares | 10-Q | 2019-11-05 |
| Quarterly | 2019-03-31 | 1390583103.0 | +0.4% | shares | 10-Q | 2019-04-29 |
| Quarterly | 2019-06-30 | 1391532660.0 | +0.1% | shares | 10-Q | 2019-07-30 |
| Quarterly | 2019-09-30 | 1393776239.0 | +0.2% | shares | 10-Q | 2019-11-05 |
| Quarterly | 2019-12-31 | 1394922641.0 | +0.1% | shares | 10-Q | 2020-05-06 |
| Quarterly | 2020-03-31 | 1399310972.0 | +0.3% | shares | 10-Q | 2020-05-06 |
| Annual | 2016-12-31 | 1362104547.0 | — | shares | 10-K | 2018-02-20 |
| Annual | 2017-12-31 | 1373496628.0 | +0.8% | shares | 10-K | 2019-02-19 |
| Annual | 2018-12-31 | 1384581760.0 | +0.8% | shares | 10-K | 2020-02-25 |
| Annual | 2019-12-31 | 1394922641.0 | +0.7% | shares | 10-K | 2020-02-25 |
Shares Issued
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 1602133758.0 | — | shares | 10-Q | 2016-05-04 |
| Quarterly | 2016-06-30 | 1606264833.0 | +0.3% | shares | 10-Q | 2016-08-03 |
| Quarterly | 2016-09-30 | 1609010333.0 | +0.2% | shares | 10-Q | 2016-11-03 |
| Quarterly | 2016-12-31 | 1609670817.0 | +0.0% | shares | 10-Q | 2017-11-02 |
| Quarterly | 2017-03-31 | 1616648758.0 | +0.4% | shares | 10-Q | 2017-05-03 |
| Quarterly | 2017-06-30 | 1618030825.0 | +0.1% | shares | 10-Q | 2017-08-03 |
| Quarterly | 2017-09-30 | 1620302039.0 | +0.1% | shares | 10-Q | 2017-11-02 |
| Quarterly | 2017-12-31 | 1621062898.0 | +0.0% | shares | 10-Q | 2018-10-29 |
| Quarterly | 2018-03-31 | 1627188009.0 | +0.4% | shares | 10-Q | 2018-05-01 |
| Quarterly | 2018-06-30 | 1628876252.0 | +0.1% | shares | 10-Q | 2018-07-31 |
| Quarterly | 2018-09-30 | 1631271283.0 | +0.1% | shares | 10-Q | 2018-10-29 |
| Quarterly | 2018-12-31 | 1632148030.0 | +0.1% | shares | 10-Q | 2019-11-05 |
| Quarterly | 2019-03-31 | 1638149373.0 | +0.4% | shares | 10-Q | 2019-04-29 |
| Quarterly | 2019-06-30 | 1639098930.0 | +0.1% | shares | 10-Q | 2019-07-30 |
| Quarterly | 2019-09-30 | 1641342509.0 | +0.1% | shares | 10-Q | 2020-05-06 |
| Quarterly | 2019-12-31 | 1642488911.0 | +0.1% | shares | 10-Q | 2020-11-05 |
| Quarterly | 2020-03-31 | 1646877242.0 | +0.3% | shares | 10-Q | 2020-05-06 |
| Quarterly | 2020-06-30 | 1676753566.0 | +1.8% | shares | 10-Q | 2020-08-05 |
| Quarterly | 2020-09-30 | 1679428209.0 | +0.2% | shares | 10-Q | 2020-11-05 |
| Quarterly | 2020-12-31 | 1679911918.0 | +0.0% | shares | 10-Q | 2021-11-04 |
| Quarterly | 2021-03-31 | 1683861226.0 | +0.2% | shares | 10-Q | 2022-05-05 |
| Quarterly | 2021-06-30 | 1685006608.0 | +0.1% | shares | 10-Q | 2022-08-04 |
| Quarterly | 2021-09-30 | 1688023638.0 | +0.2% | shares | 10-Q | 2022-11-03 |
| Quarterly | 2021-12-31 | 1688810052.0 | +0.0% | shares | 10-Q | 2023-11-01 |
| Quarterly | 2022-03-31 | 1692828987.0 | +0.2% | shares | 10-Q | 2023-08-03 |
| Quarterly | 2022-06-30 | 1693192785.0 | +0.0% | shares | 10-Q | 2023-11-01 |
| Quarterly | 2022-09-30 | 1695397636.0 | +0.1% | shares | 10-Q | 2023-11-01 |
| Quarterly | 2022-12-31 | 1696633993.0 | +0.1% | shares | 10-Q | 2024-08-01 |
| Quarterly | 2023-03-31 | 1700828873.0 | +0.2% | shares | 10-Q | 2023-08-03 |
| Quarterly | 2023-06-30 | 1725956141.0 | +1.5% | shares | 10-Q | 2024-08-01 |
| Quarterly | 2023-09-30 | 1728158524.0 | +0.1% | shares | 10-Q | 2023-11-01 |
| Quarterly | 2023-12-31 | 1729000224.0 | +0.0% | shares | 10-Q | 2024-11-01 |
| Quarterly | 2024-06-30 | 1734329744.0 | +0.3% | shares | 10-Q | 2024-08-01 |
| Quarterly | 2024-12-31 | 1737846196.0 | +0.2% | shares | 10-Q | 2025-11-03 |
| Quarterly | 2025-03-31 | 1742488328.0 | +0.3% | shares | 10-Q | 2025-05-01 |
| Quarterly | 2025-06-30 | 1743632871.0 | +0.1% | shares | 10-Q | 2025-08-01 |
| Quarterly | 2025-09-30 | 1745573129.0 | +0.1% | shares | 10-Q | 2025-11-03 |
| Annual | 2016-12-31 | 1609670817.0 | — | shares | 10-K | 2018-02-20 |
| Annual | 2017-12-31 | 1621062898.0 | +0.7% | shares | 10-K | 2019-02-19 |
| Annual | 2018-12-31 | 1632148030.0 | +0.7% | shares | 10-K | 2020-02-25 |
| Annual | 2019-12-31 | 1642488911.0 | +0.6% | shares | 10-K | 2021-02-23 |
| Annual | 2020-12-31 | 1679911918.0 | +2.3% | shares | 10-K | 2023-02-23 |
| Annual | 2021-12-31 | 1688810052.0 | +0.5% | shares | 10-K | 2024-02-20 |
| Annual | 2022-12-31 | 1696633993.0 | +0.5% | shares | 10-K | 2025-02-18 |
| Annual | 2023-12-31 | 1729000224.0 | +1.9% | shares | 10-K | 2026-02-17 |
| Annual | 2024-12-31 | 1737846196.0 | +0.5% | shares | 10-K | 2026-02-17 |
| Annual | 2025-12-31 | 1746290165.0 | +0.5% | shares | 10-K | 2026-02-17 |
Weighted Avg Shares Basic
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 1350400000.0 | — | shares | 10-Q | 2017-05-03 |
| Quarterly | 2016-06-30 | 1357400000.0 | +0.5% | shares | 10-Q | 2017-08-03 |
| Quarterly | 2016-09-30 | 1360600000.0 | +0.2% | shares | 10-Q | 2017-11-02 |
| Quarterly | 2017-03-31 | 1365400000.0 | +0.4% | shares | 10-Q | 2018-05-01 |
| Quarterly | 2017-06-30 | 1369800000.0 | +0.3% | shares | 10-Q | 2018-07-31 |
| Quarterly | 2017-09-30 | 1372000000.0 | +0.2% | shares | 10-Q | 2018-10-29 |
| Quarterly | 2018-03-31 | 1376500000.0 | +0.3% | shares | 10-Q | 2019-04-29 |
| Quarterly | 2018-06-30 | 1380500000.0 | +0.3% | shares | 10-Q | 2019-07-30 |
| Quarterly | 2018-09-30 | 1382800000.0 | +0.2% | shares | 10-Q | 2019-11-05 |
| Quarterly | 2019-03-31 | 1387700000.0 | +0.4% | shares | 10-Q | 2020-05-06 |
| Quarterly | 2019-06-30 | 1391000000.0 | +0.2% | shares | 10-Q | 2020-08-05 |
| Quarterly | 2019-09-30 | 1393100000.0 | +0.2% | shares | 10-Q | 2020-11-05 |
| Quarterly | 2020-03-31 | 1397400000.0 | +0.3% | shares | 10-Q | 2021-05-06 |
| Quarterly | 2020-06-30 | 1410900000.0 | +1.0% | shares | 10-Q | 2021-08-06 |
| Quarterly | 2020-09-30 | 1430900000.0 | +1.4% | shares | 10-Q | 2021-11-04 |
| Quarterly | 2021-03-31 | 1418700000.0 | -0.9% | shares | 10-Q | 2022-05-05 |
| Quarterly | 2021-06-30 | 1421300000.0 | +0.2% | shares | 10-Q | 2022-08-04 |
| Quarterly | 2021-09-30 | 1423800000.0 | +0.2% | shares | 10-Q | 2022-11-03 |
| Quarterly | 2022-03-31 | 1427800000.0 | +0.3% | shares | 10-Q | 2023-05-04 |
| Quarterly | 2022-06-30 | 1429700000.0 | +0.1% | shares | 10-Q | 2023-08-03 |
| Quarterly | 2022-09-30 | 1431600000.0 | +0.1% | shares | 10-Q | 2023-11-01 |
| Quarterly | 2023-03-31 | 1435800000.0 | +0.3% | shares | 10-Q | 2024-05-01 |
| Quarterly | 2023-06-30 | 1446200000.0 | +0.7% | shares | 10-Q | 2024-08-01 |
| Quarterly | 2023-09-30 | 1464500000.0 | +1.3% | shares | 10-Q | 2024-11-01 |
| Quarterly | 2024-03-31 | 1468400000.0 | +0.3% | shares | 10-Q | 2025-05-01 |
| Quarterly | 2024-06-30 | 1470600000.0 | +0.1% | shares | 10-Q | 2025-08-01 |
| Quarterly | 2024-09-30 | 1472700000.0 | +0.1% | shares | 10-Q | 2025-11-03 |
| Quarterly | 2025-03-31 | 1477200000.0 | +0.3% | shares | 10-Q | 2025-05-01 |
| Quarterly | 2025-06-30 | 1479900000.0 | +0.2% | shares | 10-Q | 2025-08-01 |
| Quarterly | 2025-09-30 | 1481700000.0 | +0.1% | shares | 10-Q | 2025-11-03 |
| Annual | 2016-12-31 | 1357600000.0 | — | shares | 10-K | 2019-02-19 |
| Annual | 2017-12-31 | 1370100000.0 | +0.9% | shares | 10-K | 2020-02-25 |
| Annual | 2018-12-31 | 1381000000.0 | +0.8% | shares | 10-K | 2021-02-23 |
| Annual | 2019-12-31 | 1391500000.0 | +0.8% | shares | 10-K | 2022-02-23 |
| Annual | 2020-12-31 | 1416700000.0 | +1.8% | shares | 10-K | 2023-02-23 |
| Annual | 2021-12-31 | 1422300000.0 | +0.4% | shares | 10-K | 2024-02-20 |
| Annual | 2022-12-31 | 1430500000.0 | +0.6% | shares | 10-K | 2025-02-18 |
| Annual | 2023-12-31 | 1453000000.0 | +1.6% | shares | 10-K | 2026-02-17 |
| Annual | 2024-12-31 | 1471500000.0 | +1.3% | shares | 10-K | 2026-02-17 |
| Annual | 2025-12-31 | 1480400000.0 | +0.6% | shares | 10-K | 2026-02-17 |
Weighted Avg Shares Diluted
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 1369900000.0 | — | shares | 10-Q | 2017-05-03 |
| Quarterly | 2016-06-30 | 1357400000.0 | -0.9% | shares | 10-Q | 2017-08-03 |
| Quarterly | 2016-09-30 | 1379700000.0 | +1.6% | shares | 10-Q | 2017-11-02 |
| Quarterly | 2017-03-31 | 1390200000.0 | +0.8% | shares | 10-Q | 2018-05-01 |
| Quarterly | 2017-06-30 | 1391100000.0 | +0.1% | shares | 10-Q | 2018-07-31 |
| Quarterly | 2017-09-30 | 1394100000.0 | +0.2% | shares | 10-Q | 2018-10-29 |
| Quarterly | 2018-03-31 | 1396800000.0 | +0.2% | shares | 10-Q | 2019-04-29 |
| Quarterly | 2018-06-30 | 1398900000.0 | +0.2% | shares | 10-Q | 2019-07-30 |
| Quarterly | 2018-09-30 | 1403900000.0 | +0.4% | shares | 10-Q | 2019-11-05 |
| Quarterly | 2019-03-31 | 1408400000.0 | +0.3% | shares | 10-Q | 2020-05-06 |
| Quarterly | 2019-06-30 | 1408600000.0 | +0.0% | shares | 10-Q | 2020-08-05 |
| Quarterly | 2019-09-30 | 1412200000.0 | +0.3% | shares | 10-Q | 2020-11-05 |
| Quarterly | 2020-03-31 | 1413500000.0 | +0.1% | shares | 10-Q | 2021-05-06 |
| Quarterly | 2020-06-30 | 1410900000.0 | -0.2% | shares | 10-Q | 2021-08-06 |
| Quarterly | 2020-09-30 | 1430900000.0 | +1.4% | shares | 10-Q | 2021-11-04 |
| Quarterly | 2021-03-31 | 1430800000.0 | -0.0% | shares | 10-Q | 2022-05-05 |
| Quarterly | 2021-06-30 | 1432500000.0 | +0.1% | shares | 10-Q | 2022-08-04 |
| Quarterly | 2021-09-30 | 1435600000.0 | +0.2% | shares | 10-Q | 2022-11-03 |
| Quarterly | 2022-03-31 | 1438400000.0 | +0.2% | shares | 10-Q | 2023-05-04 |
| Quarterly | 2022-06-30 | 1437800000.0 | -0.0% | shares | 10-Q | 2023-08-03 |
| Quarterly | 2022-09-30 | 1440000000.0 | +0.2% | shares | 10-Q | 2023-11-01 |
| Quarterly | 2023-03-31 | 1446000000.0 | +0.4% | shares | 10-Q | 2024-05-01 |
| Quarterly | 2023-06-30 | 1456200000.0 | +0.7% | shares | 10-Q | 2024-08-01 |
| Quarterly | 2023-09-30 | 1475000000.0 | +1.3% | shares | 10-Q | 2024-11-01 |
| Quarterly | 2024-03-31 | 1481700000.0 | +0.5% | shares | 10-Q | 2025-05-01 |
| Quarterly | 2024-06-30 | 1484200000.0 | +0.2% | shares | 10-Q | 2025-08-01 |
| Quarterly | 2024-09-30 | 1487400000.0 | +0.2% | shares | 10-Q | 2025-11-03 |
| Quarterly | 2025-03-31 | 1493100000.0 | +0.4% | shares | 10-Q | 2025-05-01 |
| Quarterly | 2025-06-30 | 1493500000.0 | +0.0% | shares | 10-Q | 2025-08-01 |
| Quarterly | 2025-09-30 | 1495500000.0 | +0.1% | shares | 10-Q | 2025-11-03 |
| Annual | 2016-12-31 | 1377200000.0 | — | shares | 10-K | 2019-02-19 |
| Annual | 2017-12-31 | 1392700000.0 | +1.1% | shares | 10-K | 2020-02-25 |
| Annual | 2018-12-31 | 1401400000.0 | +0.6% | shares | 10-K | 2021-02-23 |
| Annual | 2019-12-31 | 1410600000.0 | +0.7% | shares | 10-K | 2022-02-23 |
| Annual | 2020-12-31 | 1416700000.0 | +0.4% | shares | 10-K | 2023-02-23 |
| Annual | 2021-12-31 | 1433800000.0 | +1.2% | shares | 10-K | 2024-02-20 |
| Annual | 2022-12-31 | 1439700000.0 | +0.4% | shares | 10-K | 2025-02-18 |
| Annual | 2023-12-31 | 1463500000.0 | +1.7% | shares | 10-K | 2026-02-17 |
| Annual | 2024-12-31 | 1485900000.0 | +1.5% | shares | 10-K | 2026-02-17 |
| Annual | 2025-12-31 | 1494500000.0 | +0.6% | shares | 10-K | 2026-02-17 |
Credit and Bond Coverage
Company-levelMetrics
Metrics: 8Asset Turnover
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 0.1108 | — | ratio | 10-Q | 2017-05-03 |
| Quarterly | 2016-06-30 | 0.1192 | +7.5% | ratio | 10-Q | 2017-08-03 |
| Quarterly | 2016-09-30 | 0.1189 | -0.2% | ratio | 10-Q | 2017-11-02 |
| Quarterly | 2017-03-31 | 0.1204 | +1.2% | ratio | 10-Q | 2018-05-01 |
| Quarterly | 2017-06-30 | 0.1228 | +2.0% | ratio | 10-Q | 2018-07-31 |
| Quarterly | 2017-09-30 | 0.1192 | -2.9% | ratio | 10-Q | 2018-10-29 |
| Quarterly | 2018-03-31 | 0.1239 | +3.9% | ratio | 10-Q | 2019-04-29 |
| Quarterly | 2018-06-30 | 0.1269 | +2.5% | ratio | 10-Q | 2019-07-30 |
| Quarterly | 2018-09-30 | 0.1174 | -7.5% | ratio | 10-Q | 2019-11-05 |
| Quarterly | 2019-03-31 | 0.1047 | -10.8% | ratio | 10-Q | 2020-05-06 |
| Quarterly | 2019-06-30 | 0.1082 | +3.3% | ratio | 10-Q | 2020-08-05 |
| Quarterly | 2019-09-30 | 0.1012 | -6.5% | ratio | 10-Q | 2020-11-05 |
| Quarterly | 2020-03-31 | 0.0844 | -16.5% | ratio | 10-Q | 2021-05-06 |
| Quarterly | 2020-06-30 | 0.0650 | -23.0% | ratio | 10-Q | 2021-08-06 |
| Quarterly | 2020-09-30 | 0.0862 | +32.7% | ratio | 10-Q | 2021-11-04 |
| Quarterly | 2021-03-31 | 0.0891 | +3.3% | ratio | 10-Q | 2022-05-05 |
| Quarterly | 2021-06-30 | 0.0987 | +10.8% | ratio | 10-Q | 2022-08-04 |
| Quarterly | 2021-09-30 | 0.0920 | -6.8% | ratio | 10-Q | 2022-11-03 |
| Quarterly | 2022-03-31 | 0.0936 | +1.7% | ratio | 10-Q | 2023-05-04 |
| Quarterly | 2022-06-30 | 0.1008 | +7.7% | ratio | 10-Q | 2023-08-03 |
| Quarterly | 2022-09-30 | 0.0992 | -1.5% | ratio | 10-Q | 2023-11-01 |
| Quarterly | 2023-03-31 | 0.1030 | +3.8% | ratio | 10-Q | 2024-05-01 |
| Quarterly | 2023-06-30 | 0.1071 | +4.0% | ratio | 10-Q | 2024-08-01 |
| Quarterly | 2023-09-30 | 0.1036 | -3.3% | ratio | 10-Q | 2024-11-01 |
| Quarterly | 2024-03-31 | 0.1052 | +1.5% | ratio | 10-Q | 2025-05-01 |
| Quarterly | 2024-06-30 | 0.1110 | +5.6% | ratio | 10-Q | 2025-08-01 |
| Quarterly | 2024-09-30 | 0.1105 | -0.4% | ratio | 10-Q | 2025-11-03 |
| Quarterly | 2025-03-31 | 0.1162 | +5.1% | ratio | 10-Q | 2025-05-01 |
| Quarterly | 2025-06-30 | 0.1218 | +4.8% | ratio | 10-Q | 2025-08-01 |
| Quarterly | 2025-09-30 | 0.1186 | -2.6% | ratio | 10-Q | 2025-11-03 |
| Annual | 2016-12-31 | 0.4634 | — | ratio | 10-K | 2019-02-19 |
| Annual | 2017-12-31 | 0.4752 | +2.5% | ratio | 10-K | 2020-02-25 |
| Annual | 2018-12-31 | 0.4678 | -1.6% | ratio | 10-K | 2021-02-23 |
| Annual | 2019-12-31 | 0.3512 | -24.9% | ratio | 10-K | 2022-02-23 |
| Annual | 2020-12-31 | 0.3221 | -8.3% | ratio | 10-K | 2023-02-23 |
| Annual | 2021-12-31 | 0.3689 | +14.5% | ratio | 10-K | 2024-02-20 |
| Annual | 2022-12-31 | 0.3906 | +5.9% | ratio | 10-K | 2025-02-18 |
| Annual | 2023-12-31 | 0.4053 | +3.8% | ratio | 10-K | 2026-02-17 |
| Annual | 2024-12-31 | 0.4251 | +4.9% | ratio | 10-K | 2026-02-17 |
| Annual | 2025-12-31 | 0.4596 | +8.1% | ratio | 10-K | 2026-02-17 |
Current Ratio
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 1.2132 | — | ratio | 10-Q | 2016-05-04 |
| Quarterly | 2016-06-30 | 1.0465 | -13.7% | ratio | 10-Q | 2016-08-03 |
| Quarterly | 2016-09-30 | 1.0547 | +0.8% | ratio | 10-Q | 2016-11-03 |
| Quarterly | 2016-12-31 | 0.9030 | -14.4% | ratio | 10-Q | 2017-11-02 |
| Quarterly | 2017-03-31 | 0.8670 | -4.0% | ratio | 10-Q | 2017-05-03 |
| Quarterly | 2017-06-30 | 0.7493 | -13.6% | ratio | 10-Q | 2017-08-03 |
| Quarterly | 2017-09-30 | 0.7204 | -3.9% | ratio | 10-Q | 2017-11-02 |
| Quarterly | 2017-12-31 | 0.6760 | -6.2% | ratio | 10-Q | 2018-10-29 |
| Quarterly | 2018-03-31 | 0.8180 | +21.0% | ratio | 10-Q | 2018-05-01 |
| Quarterly | 2018-06-30 | 0.8266 | +1.1% | ratio | 10-Q | 2018-07-31 |
| Quarterly | 2018-09-30 | 0.7814 | -5.5% | ratio | 10-Q | 2018-10-29 |
| Quarterly | 2018-12-31 | 0.7610 | -2.6% | ratio | 10-Q | 2019-11-05 |
| Quarterly | 2019-03-31 | 1.3918 | +82.9% | ratio | 10-Q | 2019-04-29 |
| Quarterly | 2019-06-30 | 1.3060 | -6.2% | ratio | 10-Q | 2019-07-30 |
| Quarterly | 2019-09-30 | 1.1394 | -12.8% | ratio | 10-Q | 2019-11-05 |
| Quarterly | 2019-12-31 | 0.9657 | -15.2% | ratio | 10-Q | 2020-11-05 |
| Quarterly | 2020-03-31 | 1.2130 | +25.6% | ratio | 10-Q | 2020-05-06 |
| Quarterly | 2020-06-30 | 1.8671 | +53.9% | ratio | 10-Q | 2020-08-05 |
| Quarterly | 2020-09-30 | 1.8655 | -0.1% | ratio | 10-Q | 2020-11-05 |
| Quarterly | 2020-12-31 | 1.8185 | -2.5% | ratio | 10-Q | 2021-11-04 |
| Quarterly | 2021-03-31 | 1.7981 | -1.1% | ratio | 10-Q | 2021-05-06 |
| Quarterly | 2021-06-30 | 1.6592 | -7.7% | ratio | 10-Q | 2021-08-06 |
| Quarterly | 2021-09-30 | 1.5487 | -6.7% | ratio | 10-Q | 2021-11-04 |
| Quarterly | 2021-12-31 | 1.4780 | -4.6% | ratio | 10-Q | 2022-11-03 |
| Quarterly | 2022-03-31 | 1.1848 | -19.8% | ratio | 10-Q | 2022-05-05 |
| Quarterly | 2022-06-30 | 1.3090 | +10.5% | ratio | 10-Q | 2022-08-04 |
| Quarterly | 2022-09-30 | 1.4494 | +10.7% | ratio | 10-Q | 2022-11-03 |
| Quarterly | 2022-12-31 | 1.5146 | +4.5% | ratio | 10-Q | 2023-11-01 |
| Quarterly | 2023-03-31 | 1.3970 | -7.8% | ratio | 10-Q | 2023-05-04 |
| Quarterly | 2023-06-30 | 1.2902 | -7.6% | ratio | 10-Q | 2023-08-03 |
| Quarterly | 2023-09-30 | 1.4204 | +10.1% | ratio | 10-Q | 2023-11-01 |
| Quarterly | 2023-12-31 | 1.3205 | -7.0% | ratio | 10-Q | 2024-11-01 |
| Quarterly | 2024-03-31 | 1.6650 | +26.1% | ratio | 10-Q | 2024-05-01 |
| Quarterly | 2024-06-30 | 1.6124 | -3.2% | ratio | 10-Q | 2024-08-01 |
| Quarterly | 2024-09-30 | 1.4824 | -8.1% | ratio | 10-Q | 2024-11-01 |
| Quarterly | 2024-12-31 | 1.0814 | -27.0% | ratio | 10-Q | 2025-11-03 |
| Quarterly | 2025-03-31 | 1.4502 | +34.1% | ratio | 10-Q | 2025-05-01 |
| Quarterly | 2025-06-30 | 1.3721 | -5.4% | ratio | 10-Q | 2025-08-01 |
| Quarterly | 2025-09-30 | 1.5081 | +9.9% | ratio | 10-Q | 2025-11-03 |
| Annual | 2016-12-31 | 0.9030 | — | ratio | 10-K | 2018-02-20 |
| Annual | 2017-12-31 | 0.6760 | -25.1% | ratio | 10-K | 2019-02-19 |
| Annual | 2018-12-31 | 0.7610 | +12.6% | ratio | 10-K | 2020-02-25 |
| Annual | 2019-12-31 | 0.9657 | +26.9% | ratio | 10-K | 2021-02-23 |
| Annual | 2020-12-31 | 1.8185 | +88.3% | ratio | 10-K | 2022-02-23 |
| Annual | 2021-12-31 | 1.4780 | -18.7% | ratio | 10-K | 2023-02-23 |
| Annual | 2022-12-31 | 1.5146 | +2.5% | ratio | 10-K | 2024-02-20 |
| Annual | 2023-12-31 | 1.3205 | -12.8% | ratio | 10-K | 2025-02-18 |
| Annual | 2024-12-31 | 1.0814 | -18.1% | ratio | 10-K | 2026-02-17 |
| Annual | 2025-12-31 | 1.6168 | +49.5% | ratio | 10-K | 2026-02-17 |
Gross Margin
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 0.7082 | — | ratio | 10-Q | 2017-05-03 |
| Quarterly | 2016-06-30 | 0.6994 | -1.2% | ratio | 10-Q | 2017-08-03 |
| Quarterly | 2016-09-30 | 0.7178 | +2.6% | ratio | 10-Q | 2017-11-02 |
| Quarterly | 2017-03-31 | 0.6991 | -2.6% | ratio | 10-Q | 2018-05-01 |
| Quarterly | 2017-06-30 | 0.7200 | +3.0% | ratio | 10-Q | 2018-07-31 |
| Quarterly | 2017-09-30 | 0.7133 | -0.9% | ratio | 10-Q | 2018-10-29 |
| Quarterly | 2018-03-31 | 0.7175 | +0.6% | ratio | 10-Q | 2019-04-29 |
| Quarterly | 2018-06-30 | 0.7032 | -2.0% | ratio | 10-Q | 2019-07-30 |
| Quarterly | 2018-09-30 | 0.7188 | +2.2% | ratio | 10-Q | 2019-11-05 |
| Quarterly | 2019-03-31 | 0.7072 | -1.6% | ratio | 10-Q | 2020-05-06 |
| Quarterly | 2019-06-30 | 0.7119 | +0.7% | ratio | 10-Q | 2020-08-05 |
| Quarterly | 2019-09-30 | 0.7130 | +0.2% | ratio | 10-Q | 2020-11-05 |
| Quarterly | 2020-03-31 | 0.6831 | -4.2% | ratio | 10-Q | 2021-05-06 |
| Quarterly | 2020-06-30 | 0.6051 | -11.4% | ratio | 10-Q | 2021-08-06 |
| Quarterly | 2020-09-30 | 0.6732 | +11.3% | ratio | 10-Q | 2021-11-04 |
| Quarterly | 2021-03-31 | 0.6751 | +0.3% | ratio | 10-Q | 2022-05-05 |
| Quarterly | 2021-06-30 | 0.6929 | +2.6% | ratio | 10-Q | 2022-08-04 |
| Quarterly | 2021-09-30 | 0.6930 | +0.0% | ratio | 10-Q | 2022-11-03 |
| Quarterly | 2022-03-31 | 0.6844 | -1.2% | ratio | 10-Q | 2023-05-04 |
| Quarterly | 2022-06-30 | 0.6883 | +0.6% | ratio | 10-Q | 2023-08-03 |
| Quarterly | 2022-09-30 | 0.6912 | +0.4% | ratio | 10-Q | 2023-11-01 |
| Quarterly | 2023-03-31 | 0.6931 | +0.3% | ratio | 10-Q | 2024-05-01 |
| Quarterly | 2023-06-30 | 0.7063 | +1.9% | ratio | 10-Q | 2024-08-01 |
| Quarterly | 2023-09-30 | 0.6878 | -2.6% | ratio | 10-Q | 2024-11-01 |
| Quarterly | 2024-03-31 | 0.6867 | -0.2% | ratio | 10-Q | 2025-05-01 |
| Quarterly | 2024-06-30 | 0.6917 | +0.7% | ratio | 10-Q | 2025-08-01 |
| Quarterly | 2024-09-30 | 0.6883 | -0.5% | ratio | 10-Q | 2025-11-03 |
| Quarterly | 2025-03-31 | 0.6884 | +0.0% | ratio | 10-Q | 2025-05-01 |
| Quarterly | 2025-06-30 | 0.6765 | -1.7% | ratio | 10-Q | 2025-08-01 |
| Quarterly | 2025-09-30 | 0.6993 | +3.4% | ratio | 10-Q | 2025-11-03 |
| Annual | 2016-12-31 | 0.7109 | — | ratio | 10-K | 2019-02-19 |
| Annual | 2017-12-31 | 0.7134 | +0.3% | ratio | 10-K | 2020-02-25 |
| Annual | 2018-12-31 | 0.7137 | +0.0% | ratio | 10-K | 2021-02-23 |
| Annual | 2019-12-31 | 0.7098 | -0.5% | ratio | 10-K | 2022-02-23 |
| Annual | 2020-12-31 | 0.6505 | -8.4% | ratio | 10-K | 2023-02-23 |
| Annual | 2021-12-31 | 0.6878 | +5.7% | ratio | 10-K | 2024-02-20 |
| Annual | 2022-12-31 | 0.6881 | +0.0% | ratio | 10-K | 2025-02-18 |
| Annual | 2023-12-31 | 0.6949 | +1.0% | ratio | 10-K | 2026-02-17 |
| Annual | 2024-12-31 | 0.6861 | -1.3% | ratio | 10-K | 2026-02-17 |
| Annual | 2025-12-31 | 0.6901 | +0.6% | ratio | 10-K | 2026-02-17 |
Net Margin
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 0.1029 | — | ratio | 10-Q | 2017-05-03 |
| Quarterly | 2016-06-30 | -0.0974 | -194.7% | ratio | 10-Q | 2017-08-03 |
| Quarterly | 2016-09-30 | 0.1083 | +211.2% | ratio | 10-Q | 2017-11-02 |
| Quarterly | 2017-03-31 | 0.1343 | +24.0% | ratio | 10-Q | 2018-05-01 |
| Quarterly | 2017-06-30 | 0.0647 | -51.8% | ratio | 10-Q | 2018-07-31 |
| Quarterly | 2017-09-30 | 0.1274 | +96.9% | ratio | 10-Q | 2018-10-29 |
| Quarterly | 2018-03-31 | 0.1253 | -1.6% | ratio | 10-Q | 2019-04-29 |
| Quarterly | 2018-06-30 | 0.2229 | +77.9% | ratio | 10-Q | 2019-07-30 |
| Quarterly | 2018-09-30 | 0.1805 | -19.0% | ratio | 10-Q | 2019-11-05 |
| Quarterly | 2019-03-31 | 0.1701 | -5.8% | ratio | 10-Q | 2020-05-06 |
| Quarterly | 2019-06-30 | 0.0585 | -65.6% | ratio | 10-Q | 2020-08-05 |
| Quarterly | 2019-09-30 | 0.0465 | -20.5% | ratio | 10-Q | 2020-11-05 |
| Quarterly | 2020-03-31 | 0.0043 | -90.7% | ratio | 10-Q | 2021-05-06 |
| Quarterly | 2020-06-30 | -0.0734 | -1796.6% | ratio | 10-Q | 2021-08-06 |
| Quarterly | 2020-09-30 | -0.0583 | +20.6% | ratio | 10-Q | 2021-11-04 |
| Quarterly | 2021-03-31 | 0.1239 | +312.6% | ratio | 10-Q | 2022-05-05 |
| Quarterly | 2021-06-30 | 0.0604 | -51.2% | ratio | 10-Q | 2022-08-04 |
| Quarterly | 2021-09-30 | 0.1429 | +136.4% | ratio | 10-Q | 2022-11-03 |
| Quarterly | 2022-03-31 | 0.0364 | -74.6% | ratio | 10-Q | 2023-05-04 |
| Quarterly | 2022-06-30 | 0.0801 | +120.5% | ratio | 10-Q | 2023-08-03 |
| Quarterly | 2022-09-30 | 0.0593 | -26.0% | ratio | 10-Q | 2023-11-01 |
| Quarterly | 2023-03-31 | 0.0927 | +56.2% | ratio | 10-Q | 2024-05-01 |
| Quarterly | 2023-06-30 | 0.0750 | -19.0% | ratio | 10-Q | 2024-08-01 |
| Quarterly | 2023-09-30 | 0.1429 | +90.5% | ratio | 10-Q | 2024-11-01 |
| Quarterly | 2024-03-31 | 0.1279 | -10.5% | ratio | 10-Q | 2025-05-01 |
| Quarterly | 2024-06-30 | 0.0782 | -38.9% | ratio | 10-Q | 2025-08-01 |
| Quarterly | 2024-09-30 | 0.1112 | +42.3% | ratio | 10-Q | 2025-11-03 |
| Quarterly | 2025-03-31 | 0.1441 | +29.6% | ratio | 10-Q | 2025-05-01 |
| Quarterly | 2025-06-30 | 0.1571 | +9.0% | ratio | 10-Q | 2025-08-01 |
| Quarterly | 2025-09-30 | 0.1491 | -5.1% | ratio | 10-Q | 2025-11-03 |
| Annual | 2016-12-31 | 0.0414 | — | ratio | 10-K | 2019-02-19 |
| Annual | 2017-12-31 | 0.0115 | -72.2% | ratio | 10-K | 2020-02-25 |
| Annual | 2018-12-31 | 0.1701 | +1380.0% | ratio | 10-K | 2021-02-23 |
| Annual | 2019-12-31 | 0.4378 | +157.4% | ratio | 10-K | 2022-02-23 |
| Annual | 2020-12-31 | -0.0083 | -101.9% | ratio | 10-K | 2023-02-23 |
| Annual | 2021-12-31 | 0.0876 | +1158.6% | ratio | 10-K | 2024-02-20 |
| Annual | 2022-12-31 | 0.0550 | -37.1% | ratio | 10-K | 2025-02-18 |
| Annual | 2023-12-31 | 0.1118 | +103.1% | ratio | 10-K | 2026-02-17 |
| Annual | 2024-12-31 | 0.1102 | -1.4% | ratio | 10-K | 2026-02-17 |
| Annual | 2025-12-31 | 0.1441 | +30.7% | ratio | 10-K | 2026-02-17 |
Operating Margin
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 0.1492 | — | ratio | 10-Q | 2017-05-03 |
| Quarterly | 2016-06-30 | -0.1571 | -205.3% | ratio | 10-Q | 2017-08-03 |
| Quarterly | 2016-09-30 | 0.1653 | +205.2% | ratio | 10-Q | 2017-11-02 |
| Quarterly | 2017-03-31 | 0.1685 | +1.9% | ratio | 10-Q | 2018-05-01 |
| Quarterly | 2017-06-30 | 0.0997 | -40.8% | ratio | 10-Q | 2018-07-31 |
| Quarterly | 2017-09-30 | 0.1697 | +70.2% | ratio | 10-Q | 2018-10-29 |
| Quarterly | 2018-03-31 | 0.1711 | +0.8% | ratio | 10-Q | 2019-04-29 |
| Quarterly | 2018-06-30 | 0.1574 | -8.0% | ratio | 10-Q | 2019-07-30 |
| Quarterly | 2018-09-30 | 0.1621 | +3.0% | ratio | 10-Q | 2019-11-05 |
| Quarterly | 2019-03-31 | 0.2170 | +33.8% | ratio | 10-Q | 2020-05-06 |
| Quarterly | 2019-06-30 | 0.1460 | -32.7% | ratio | 10-Q | 2020-08-05 |
| Quarterly | 2019-09-30 | 0.1415 | -3.1% | ratio | 10-Q | 2020-11-05 |
| Quarterly | 2020-03-31 | 0.0574 | -59.4% | ratio | 10-Q | 2021-05-06 |
| Quarterly | 2020-06-30 | -0.0354 | -161.7% | ratio | 10-Q | 2021-08-06 |
| Quarterly | 2020-09-30 | -0.0771 | -117.5% | ratio | 10-Q | 2021-11-04 |
| Quarterly | 2021-03-31 | 0.1344 | +274.4% | ratio | 10-Q | 2022-05-05 |
| Quarterly | 2021-06-30 | 0.0851 | -36.7% | ratio | 10-Q | 2022-08-04 |
| Quarterly | 2021-09-30 | 0.1320 | +55.0% | ratio | 10-Q | 2022-11-03 |
| Quarterly | 2022-03-31 | 0.1540 | +16.7% | ratio | 10-Q | 2023-05-04 |
| Quarterly | 2022-06-30 | 0.1304 | -15.3% | ratio | 10-Q | 2023-08-03 |
| Quarterly | 2022-09-30 | 0.1129 | -13.4% | ratio | 10-Q | 2023-11-01 |
| Quarterly | 2023-03-31 | 0.1629 | +44.2% | ratio | 10-Q | 2024-05-01 |
| Quarterly | 2023-06-30 | 0.1428 | -12.3% | ratio | 10-Q | 2024-08-01 |
| Quarterly | 2023-09-30 | 0.1965 | +37.6% | ratio | 10-Q | 2024-11-01 |
| Quarterly | 2024-03-31 | 0.1751 | -10.9% | ratio | 10-Q | 2025-05-01 |
| Quarterly | 2024-06-30 | 0.1262 | -27.9% | ratio | 10-Q | 2025-08-01 |
| Quarterly | 2024-09-30 | 0.1742 | +38.0% | ratio | 10-Q | 2025-11-03 |
| Quarterly | 2025-03-31 | 0.1975 | +13.4% | ratio | 10-Q | 2025-05-01 |
| Quarterly | 2025-06-30 | 0.1618 | -18.1% | ratio | 10-Q | 2025-08-01 |
| Quarterly | 2025-09-30 | 0.2069 | +27.9% | ratio | 10-Q | 2025-11-03 |
| Annual | 2016-12-31 | 0.0533 | — | ratio | 10-K | 2019-02-19 |
| Annual | 2017-12-31 | 0.1420 | +166.4% | ratio | 10-K | 2020-02-25 |
| Annual | 2018-12-31 | 0.1533 | +8.0% | ratio | 10-K | 2021-02-23 |
| Annual | 2019-12-31 | 0.1414 | -7.8% | ratio | 10-K | 2022-02-23 |
| Annual | 2020-12-31 | -0.0081 | -105.7% | ratio | 10-K | 2023-02-23 |
| Annual | 2021-12-31 | 0.1009 | +1349.8% | ratio | 10-K | 2024-02-20 |
| Annual | 2022-12-31 | 0.1300 | +28.9% | ratio | 10-K | 2025-02-18 |
| Annual | 2023-12-31 | 0.1645 | +26.5% | ratio | 10-K | 2026-02-17 |
| Annual | 2024-12-31 | 0.1554 | -5.5% | ratio | 10-K | 2026-02-17 |
| Annual | 2025-12-31 | 0.1800 | +15.8% | ratio | 10-K | 2026-02-17 |
Quick Ratio
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 0.1296 | — | ratio | 10-Q | 2017-05-03 |
| Quarterly | 2016-06-30 | 0.1376 | +6.2% | ratio | 10-Q | 2017-08-03 |
| Quarterly | 2016-09-30 | 0.0786 | -42.9% | ratio | 10-Q | 2017-11-02 |
| Quarterly | 2016-12-31 | 0.0546 | -30.5% | ratio | 10-Q | 2017-11-02 |
| Quarterly | 2017-03-31 | 0.0447 | -18.2% | ratio | 10-Q | 2017-05-03 |
| Quarterly | 2017-06-30 | 0.0453 | +1.5% | ratio | 10-Q | 2018-07-31 |
| Quarterly | 2017-09-30 | 0.0435 | -4.1% | ratio | 10-Q | 2018-10-29 |
| Quarterly | 2017-12-31 | 0.0333 | -23.6% | ratio | 10-Q | 2018-10-29 |
| Quarterly | 2018-03-31 | 0.0575 | +73.0% | ratio | 10-Q | 2019-04-29 |
| Quarterly | 2018-06-30 | 0.0438 | -23.9% | ratio | 10-Q | 2019-07-30 |
| Quarterly | 2018-09-30 | 0.0331 | -24.5% | ratio | 10-Q | 2019-11-05 |
| Quarterly | 2018-12-31 | 0.0278 | -16.0% | ratio | 10-Q | 2019-11-05 |
| Quarterly | 2019-03-31 | 0.0310 | +11.8% | ratio | 10-Q | 2020-05-06 |
| Quarterly | 2019-06-30 | 0.0254 | -18.3% | ratio | 10-Q | 2020-08-05 |
| Quarterly | 2019-09-30 | 0.0651 | +156.8% | ratio | 10-Q | 2020-11-05 |
| Quarterly | 2019-12-31 | 0.0446 | -31.5% | ratio | 10-Q | 2020-11-05 |
| Quarterly | 2020-03-31 | 0.0931 | +108.7% | ratio | 10-Q | 2021-05-06 |
| Quarterly | 2020-06-30 | 0.5547 | +496.1% | ratio | 10-Q | 2021-08-06 |
| Quarterly | 2020-09-30 | 0.6124 | +10.4% | ratio | 10-Q | 2021-11-04 |
| Quarterly | 2020-12-31 | 0.4711 | -23.1% | ratio | 10-Q | 2021-11-04 |
| Quarterly | 2021-03-31 | 0.5942 | +26.1% | ratio | 10-Q | 2022-05-05 |
| Quarterly | 2021-06-30 | 0.6568 | +10.5% | ratio | 10-Q | 2022-08-04 |
| Quarterly | 2021-09-30 | 0.4841 | -26.3% | ratio | 10-Q | 2022-11-03 |
| Quarterly | 2021-12-31 | 0.4504 | -7.0% | ratio | 10-Q | 2022-11-03 |
| Quarterly | 2022-03-31 | 0.0760 | -83.1% | ratio | 10-Q | 2023-05-04 |
| Quarterly | 2022-06-30 | 0.0711 | -6.5% | ratio | 10-Q | 2023-08-03 |
| Quarterly | 2022-09-30 | 0.0952 | +34.0% | ratio | 10-Q | 2023-11-01 |
| Quarterly | 2022-12-31 | 0.2440 | +156.2% | ratio | 10-Q | 2023-11-01 |
| Quarterly | 2023-03-31 | 0.1396 | -42.8% | ratio | 10-Q | 2024-05-01 |
| Quarterly | 2023-06-30 | 0.0934 | -33.1% | ratio | 10-Q | 2024-08-01 |
| Quarterly | 2023-09-30 | 0.2079 | +122.6% | ratio | 10-Q | 2024-11-01 |
| Quarterly | 2023-12-31 | 0.1753 | -15.7% | ratio | 10-Q | 2024-11-01 |
| Quarterly | 2024-03-31 | 0.4738 | +170.2% | ratio | 10-Q | 2025-05-01 |
| Quarterly | 2024-06-30 | 0.5224 | +10.3% | ratio | 10-Q | 2025-08-01 |
| Quarterly | 2024-09-30 | 0.4234 | -19.0% | ratio | 10-Q | 2025-11-03 |
| Quarterly | 2024-12-31 | 0.0647 | -84.7% | ratio | 10-Q | 2025-11-03 |
| Quarterly | 2025-03-31 | 0.1433 | +121.5% | ratio | 10-Q | 2025-05-01 |
| Quarterly | 2025-06-30 | 0.1029 | -28.2% | ratio | 10-Q | 2025-08-01 |
| Quarterly | 2025-09-30 | 0.2393 | +132.6% | ratio | 10-Q | 2025-11-03 |
| Annual | 2016-12-31 | 0.0546 | — | ratio | 10-K | 2019-02-19 |
| Annual | 2017-12-31 | 0.0333 | -39.1% | ratio | 10-K | 2020-02-25 |
| Annual | 2018-12-31 | 0.0278 | -16.5% | ratio | 10-K | 2021-02-23 |
| Annual | 2019-12-31 | 0.0446 | +60.7% | ratio | 10-K | 2022-02-23 |
| Annual | 2020-12-31 | 0.4711 | +956.3% | ratio | 10-K | 2023-02-23 |
| Annual | 2021-12-31 | 0.4504 | -4.4% | ratio | 10-K | 2024-02-20 |
| Annual | 2022-12-31 | 0.2440 | -45.8% | ratio | 10-K | 2025-02-18 |
| Annual | 2023-12-31 | 0.1753 | -28.1% | ratio | 10-K | 2026-02-17 |
| Annual | 2024-12-31 | 0.0647 | -63.1% | ratio | 10-K | 2026-02-17 |
| Annual | 2025-12-31 | 0.3613 | +458.4% | ratio | 10-K | 2026-02-17 |
ROA
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 0.0114 | — | ratio | 10-Q | 2017-05-03 |
| Quarterly | 2016-06-30 | -0.0116 | -201.8% | ratio | 10-Q | 2017-08-03 |
| Quarterly | 2016-09-30 | 0.0129 | +211.0% | ratio | 10-Q | 2017-11-02 |
| Quarterly | 2017-03-31 | 0.0162 | +25.4% | ratio | 10-Q | 2018-05-01 |
| Quarterly | 2017-06-30 | 0.0079 | -50.9% | ratio | 10-Q | 2018-07-31 |
| Quarterly | 2017-09-30 | 0.0152 | +91.2% | ratio | 10-Q | 2018-10-29 |
| Quarterly | 2018-03-31 | 0.0155 | +2.2% | ratio | 10-Q | 2019-04-29 |
| Quarterly | 2018-06-30 | 0.0283 | +82.3% | ratio | 10-Q | 2019-07-30 |
| Quarterly | 2018-09-30 | 0.0212 | -25.1% | ratio | 10-Q | 2019-11-05 |
| Quarterly | 2019-03-31 | 0.0178 | -16.0% | ratio | 10-Q | 2020-05-06 |
| Quarterly | 2019-06-30 | 0.0063 | -64.4% | ratio | 10-Q | 2020-08-05 |
| Quarterly | 2019-09-30 | 0.0047 | -25.7% | ratio | 10-Q | 2020-11-05 |
| Quarterly | 2020-03-31 | 0.0004 | -92.2% | ratio | 10-Q | 2021-05-06 |
| Quarterly | 2020-06-30 | -0.0048 | -1405.6% | ratio | 10-Q | 2021-08-06 |
| Quarterly | 2020-09-30 | -0.0050 | -5.4% | ratio | 10-Q | 2021-11-04 |
| Quarterly | 2021-03-31 | 0.0110 | +319.6% | ratio | 10-Q | 2022-05-05 |
| Quarterly | 2021-06-30 | 0.0060 | -45.9% | ratio | 10-Q | 2022-08-04 |
| Quarterly | 2021-09-30 | 0.0131 | +120.3% | ratio | 10-Q | 2022-11-03 |
| Quarterly | 2022-03-31 | 0.0034 | -74.1% | ratio | 10-Q | 2023-05-04 |
| Quarterly | 2022-06-30 | 0.0081 | +137.5% | ratio | 10-Q | 2023-08-03 |
| Quarterly | 2022-09-30 | 0.0059 | -27.1% | ratio | 10-Q | 2023-11-01 |
| Quarterly | 2023-03-31 | 0.0095 | +62.2% | ratio | 10-Q | 2024-05-01 |
| Quarterly | 2023-06-30 | 0.0080 | -15.8% | ratio | 10-Q | 2024-08-01 |
| Quarterly | 2023-09-30 | 0.0148 | +84.2% | ratio | 10-Q | 2024-11-01 |
| Quarterly | 2024-03-31 | 0.0134 | -9.2% | ratio | 10-Q | 2025-05-01 |
| Quarterly | 2024-06-30 | 0.0087 | -35.5% | ratio | 10-Q | 2025-08-01 |
| Quarterly | 2024-09-30 | 0.0123 | +41.6% | ratio | 10-Q | 2025-11-03 |
| Quarterly | 2025-03-31 | 0.0167 | +36.2% | ratio | 10-Q | 2025-05-01 |
| Quarterly | 2025-06-30 | 0.0191 | +14.3% | ratio | 10-Q | 2025-08-01 |
| Quarterly | 2025-09-30 | 0.0177 | -7.6% | ratio | 10-Q | 2025-11-03 |
| Annual | 2016-12-31 | 0.0192 | — | ratio | 10-K | 2019-02-19 |
| Annual | 2017-12-31 | 0.0055 | -71.5% | ratio | 10-K | 2020-02-25 |
| Annual | 2018-12-31 | 0.0796 | +1357.0% | ratio | 10-K | 2021-02-23 |
| Annual | 2019-12-31 | 0.1538 | +93.2% | ratio | 10-K | 2022-02-23 |
| Annual | 2020-12-31 | -0.0027 | -101.7% | ratio | 10-K | 2023-02-23 |
| Annual | 2021-12-31 | 0.0323 | +1312.3% | ratio | 10-K | 2024-02-20 |
| Annual | 2022-12-31 | 0.0215 | -33.4% | ratio | 10-K | 2025-02-18 |
| Annual | 2023-12-31 | 0.0453 | +110.8% | ratio | 10-K | 2026-02-17 |
| Annual | 2024-12-31 | 0.0469 | +3.4% | ratio | 10-K | 2026-02-17 |
| Annual | 2025-12-31 | 0.0662 | +41.3% | ratio | 10-K | 2026-02-17 |
ROE
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 0.0313 | — | ratio | 10-Q | 2017-05-03 |
| Quarterly | 2016-06-30 | -0.0333 | -206.4% | ratio | 10-Q | 2017-08-03 |
| Quarterly | 2016-09-30 | 0.0352 | +205.7% | ratio | 10-Q | 2017-11-02 |
| Quarterly | 2017-03-31 | 0.0411 | +16.9% | ratio | 10-Q | 2018-05-01 |
| Quarterly | 2017-06-30 | 0.0202 | -50.9% | ratio | 10-Q | 2018-07-31 |
| Quarterly | 2017-09-30 | 0.0373 | +84.8% | ratio | 10-Q | 2018-10-29 |
| Quarterly | 2018-03-31 | 0.0424 | +13.7% | ratio | 10-Q | 2019-04-29 |
| Quarterly | 2018-06-30 | 0.0717 | +69.1% | ratio | 10-Q | 2019-07-30 |
| Quarterly | 2018-09-30 | 0.0521 | -27.3% | ratio | 10-Q | 2019-11-05 |
| Quarterly | 2019-03-31 | 0.0459 | -11.9% | ratio | 10-Q | 2020-05-06 |
| Quarterly | 2019-06-30 | 0.0163 | -64.4% | ratio | 10-Q | 2020-08-05 |
| Quarterly | 2019-09-30 | 0.0130 | -20.5% | ratio | 10-Q | 2020-11-05 |
| Quarterly | 2020-03-31 | 0.0008 | -93.9% | ratio | 10-Q | 2021-05-06 |
| Quarterly | 2020-06-30 | -0.0094 | -1281.3% | ratio | 10-Q | 2021-08-06 |
| Quarterly | 2020-09-30 | -0.0100 | -5.8% | ratio | 10-Q | 2021-11-04 |
| Quarterly | 2021-03-31 | 0.0217 | +317.8% | ratio | 10-Q | 2022-05-05 |
| Quarterly | 2021-06-30 | 0.0117 | -46.2% | ratio | 10-Q | 2022-08-04 |
| Quarterly | 2021-09-30 | 0.0255 | +118.2% | ratio | 10-Q | 2022-11-03 |
| Quarterly | 2022-03-31 | 0.0066 | -74.2% | ratio | 10-Q | 2023-05-04 |
| Quarterly | 2022-06-30 | 0.0151 | +129.3% | ratio | 10-Q | 2023-08-03 |
| Quarterly | 2022-09-30 | 0.0107 | -29.3% | ratio | 10-Q | 2023-11-01 |
| Quarterly | 2023-03-31 | 0.0173 | +62.7% | ratio | 10-Q | 2024-05-01 |
| Quarterly | 2023-06-30 | 0.0146 | -15.8% | ratio | 10-Q | 2024-08-01 |
| Quarterly | 2023-09-30 | 0.0263 | +80.4% | ratio | 10-Q | 2024-11-01 |
| Quarterly | 2024-03-31 | 0.0244 | -7.2% | ratio | 10-Q | 2025-05-01 |
| Quarterly | 2024-06-30 | 0.0156 | -36.1% | ratio | 10-Q | 2025-08-01 |
| Quarterly | 2024-09-30 | 0.0223 | +42.9% | ratio | 10-Q | 2025-11-03 |
| Quarterly | 2025-03-31 | 0.0299 | +34.1% | ratio | 10-Q | 2025-05-01 |
| Quarterly | 2025-06-30 | 0.0351 | +17.2% | ratio | 10-Q | 2025-08-01 |
| Quarterly | 2025-09-30 | 0.0320 | -9.0% | ratio | 10-Q | 2025-11-03 |
| Annual | 2016-12-31 | 0.0515 | — | ratio | 10-K | 2019-02-19 |
| Annual | 2017-12-31 | 0.0148 | -71.2% | ratio | 10-K | 2020-02-25 |
| Annual | 2018-12-31 | 0.1915 | +1191.1% | ratio | 10-K | 2021-02-23 |
| Annual | 2019-12-31 | 0.3387 | +76.9% | ratio | 10-K | 2022-02-23 |
| Annual | 2020-12-31 | -0.0054 | -101.6% | ratio | 10-K | 2023-02-23 |
| Annual | 2021-12-31 | 0.0626 | +1270.5% | ratio | 10-K | 2024-02-20 |
| Annual | 2022-12-31 | 0.0397 | -36.6% | ratio | 10-K | 2025-02-18 |
| Annual | 2023-12-31 | 0.0815 | +105.2% | ratio | 10-K | 2026-02-17 |
| Annual | 2024-12-31 | 0.0839 | +2.9% | ratio | 10-K | 2026-02-17 |
| Annual | 2025-12-31 | 0.1182 | +40.9% | ratio | 10-K | 2026-02-17 |
8-K Material Event Details
This 8-K section tracks corporate event disclosures, not insider buy/sell sentiment. Insider trading direction is shown in the insider section below.
Event Type Distribution
Count per 8-K itemInsider Transaction History
Net Insider Flow
Monthly open-market buy value minus open-market sell valueMonthly Insider Activity Mix
Share volume split between open-market trades, grants, and exercisesTransaction Value Timeline
All Transactions
| Date | Insider | Title | Type | Security | Shares | Price | Total Value | Post-Tx Shares |
|---|---|---|---|---|---|---|---|---|
| 2026-03-02 | Pegus Cheryl | Dir |
Equity grant / award
A · derivative
|
Deferred Stock Units | 24 | $0.00 | $0 | 5,917 |
| 2026-03-01 | Woodworth Emily | SVP, Global Controller and CAO |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 838 | $0.00 | $0 | 1,676 |
| 2026-03-01 | Woodworth Emily | SVP, Global Controller and CAO |
Other disposed transaction
F
|
Common Stock | 372 | $76.85 | $28,588 | 2,859 |
| 2026-03-01 | Woodworth Emily | SVP, Global Controller and CAO |
Exercise / conversion
M
|
Common Stock | 838 | $0.00 | $0 | 3,231 |
| 2026-02-19 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC |
Other acquired transaction
I
|
Common Stock | 6,851 | $75.76 | $519,032 | 20,205 |
| 2026-02-16 | O'Connor Padraig Andrew | EVP, Global Operations |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 905 | $0.00 | $0 | 0 |
| 2026-02-16 | O'Connor Padraig Andrew | EVP, Global Operations |
Other disposed transaction
F
|
Common Stock | 339 | $74.73 | $25,333 | 6,094 |
| 2026-02-16 | O'Connor Padraig Andrew | EVP, Global Operations |
Exercise / conversion
M
|
Common Stock | 905 | $0.00 | $0 | 6,433 |
| 2026-02-14 | O'Connor Padraig Andrew | EVP, Global Operations |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 1,190 | $0.00 | $0 | 1,190 |
| 2026-02-14 | O'Connor Padraig Andrew | EVP, Global Operations |
Other disposed transaction
F
|
Common Stock | 449 | $74.73 | $33,554 | 5,528 |
| 2026-02-14 | O'Connor Padraig Andrew | EVP, Global Operations |
Exercise / conversion
M
|
Common Stock | 1,190 | $0.00 | $0 | 5,977 |
| 2026-02-13 | O'Connor Padraig Andrew | EVP, Global Operations |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 500 | $0.00 | $0 | 1,502 |
| 2026-02-13 | O'Connor Padraig Andrew | EVP, Global Operations |
Other disposed transaction
F
|
Common Stock | 199 | $74.73 | $14,871 | 4,787 |
| 2026-02-13 | O'Connor Padraig Andrew | EVP, Global Operations |
Exercise / conversion
M
|
Common Stock | 500 | $0.00 | $0 | 4,986 |
| 2026-02-12 | O'Sullivan Miriam | SVP, Chief HR Officer |
Equity grant / award
A · derivative
|
Stock Option (Right to Buy) | 11,143 | $0.00 | $0 | 11,143 |
| 2026-02-12 | O'Sullivan Miriam | SVP, Chief HR Officer |
Equity grant / award
A · derivative
|
Restricted Stock Units | 4,722 | $0.00 | $0 | 4,722 |
| 2026-02-12 | O'Sullivan Miriam | SVP, Chief HR Officer |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 961 | $0.00 | $0 | 1,924 |
| 2026-02-12 | O'Sullivan Miriam | SVP, Chief HR Officer |
Other disposed transaction
F
|
Common Stock | 338 | $74.12 | $25,053 | 15,420 |
| 2026-02-12 | O'Sullivan Miriam | SVP, Chief HR Officer |
Exercise / conversion
M
|
Common Stock | 961 | $0.00 | $0 | 15,758 |
| 2026-02-02 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 49,407 | $0.00 | $0 | 98,814 |
| 2026-02-02 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 46,347 | $0.00 | $0 | 231,739 |
| 2026-02-02 | Mahoney Michael F | Chairman, President & CEO |
Open-market sell
S
|
Common Stock | 159,701 | $93.49 | $14,930,526 | 1,411,735 |
| 2026-02-02 | Mahoney Michael F | Chairman, President & CEO |
Open-market sell
S
|
Common Stock | 1,200 | $94.06 | $112,868 | 1,571,436 |
| 2026-02-02 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M
|
Common Stock | 46,347 | $27.09 | $1,255,540 | 1,572,636 |
| 2026-02-02 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M
|
Common Stock | 49,407 | $24.55 | $1,212,942 | 1,526,289 |
| 2025-12-01 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 3,177 | $0.00 | $0 | 0 |
| 2025-12-01 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 6,175 | $0.00 | $0 | 0 |
| 2025-12-01 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 1,009 | $0.00 | $0 | 0 |
| 2025-12-01 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 6,952 | $0.00 | $0 | 0 |
| 2025-12-01 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC |
Open-market sell
S
|
Common Stock | 17,313 | $101.55 | $1,758,189 | 23,600 |
| 2025-12-01 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC |
Exercise / conversion
M
|
Common Stock | 1,009 | $17.26 | $17,415 | 40,913 |
| 2025-12-01 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC |
Exercise / conversion
M
|
Common Stock | 3,177 | $22.71 | $72,150 | 39,904 |
| 2025-12-01 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC |
Exercise / conversion
M
|
Common Stock | 6,175 | $24.55 | $151,596 | 36,727 |
| 2025-12-01 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC |
Exercise / conversion
M
|
Common Stock | 6,952 | $27.09 | $188,330 | 30,552 |
| 2025-11-28 | O'Sullivan Miriam | SVP, Chief HR Officer |
Equity grant / award
G
|
Common Stock | 260 | $0.00 | $0 | 14,797 |
| 2025-11-14 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology |
Equity grant / award
G
|
Common Stock | 9,610 | $0.00 | $0 | 168,042 |
| 2025-11-12 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology |
Equity grant / award
G
|
Common Stock | 690 | $0.00 | $0 | 177,652 |
| 2025-11-06 | Zane Ellen M | Dir |
Open-market sell
S
|
Common Stock | 12,891 | $98.28 | $1,266,978 | 24,134 |
| 2025-11-03 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 50,000 | $0.00 | $0 | 0 |
| 2025-11-03 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology |
Open-market sell
S
|
Common Stock | 29,472 | $99.14 | $2,921,895 | 178,342 |
| 2025-11-03 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology |
Open-market sell
S
|
Common Stock | 16,928 | $99.76 | $1,688,749 | 207,814 |
| 2025-11-03 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology |
Open-market sell
S
|
Common Stock | 3,600 | $100.75 | $362,693 | 224,742 |
| 2025-11-03 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology |
Exercise / conversion
M
|
Common Stock | 50,000 | $26.15 | $1,307,500 | 228,342 |
| 2025-10-30 | Mahoney Michael F | Chairman, President & CEO |
Equity grant / award
G
|
Common Stock | 149,992 | $0.00 | $0 | 213,679 |
| 2025-10-29 | Mahoney Michael F | Chairman, President & CEO |
Equity grant / award
G
|
Common Stock | 73,996 | $0.00 | $0 | 363,671 |
| 2025-10-29 | Mahoney Michael F | Chairman, President & CEO |
Equity grant / award
G
|
Common Stock | 88,197 | $0.00 | $0 | 289,675 |
| 2025-10-28 | Zane Ellen M | Dir |
Open-market sell
S
|
Common Stock | 2,901 | $102.24 | $296,599 | 24,134 |
| 2025-10-27 | Zane Ellen M | Dir |
Open-market sell
S
|
Common Stock | 9,990 | $101.13 | $1,010,301 | 27,035 |
| 2025-10-01 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 50,000 | $0.00 | $0 | 50,000 |
| 2025-10-01 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology |
Open-market sell
S
|
Common Stock | 41,755 | $98.38 | $4,107,844 | 178,342 |
| 2025-10-01 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology |
Open-market sell
S
|
Common Stock | 8,245 | $98.91 | $815,482 | 220,097 |
| 2025-10-01 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology |
Exercise / conversion
M
|
Common Stock | 50,000 | $26.15 | $1,307,500 | 228,342 |
| 2025-09-02 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 50,000 | $0.00 | $0 | 100,000 |
| 2025-09-02 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology |
Open-market sell
S
|
Common Stock | 28,170 | $105.85 | $2,981,755 | 178,342 |
| 2025-09-02 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology |
Open-market sell
S
|
Common Stock | 21,830 | $104.89 | $2,289,661 | 206,512 |
| 2025-09-02 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology |
Exercise / conversion
M
|
Common Stock | 50,000 | $26.15 | $1,307,500 | 228,342 |
| 2025-08-02 | Monson Jonathan | EVP and CFO |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 1,090 | $0.00 | $0 | 0 |
| 2025-08-02 | Monson Jonathan | EVP and CFO |
Other disposed transaction
F
|
Common Stock | 528 | $105.41 | $55,656 | 35,289 |
| 2025-08-02 | Monson Jonathan | EVP and CFO |
Exercise / conversion
M
|
Common Stock | 1,090 | $0.00 | $0 | 35,817 |
| 2025-08-01 | LUDWIG EDWARD J | Dir |
Equity grant / award
G
|
Common Stock | 500 | $0.00 | $0 | 17,979 |
| 2025-07-29 | FUJIMORI YOSHIAKI | Dir |
Open-market sell
S
|
Common Stock | 2,901 | $106.99 | $310,378 | 2,081 |
| 2025-07-25 | LUDWIG EDWARD J | Dir |
Open-market sell
S
|
Common Stock | 4,000 | $106.03 | $424,120 | 18,479 |
| 2025-07-01 | Monson Jonathan | EVP and CFO |
Equity grant / award
A · derivative
|
Stock Option (Right to Buy) | 22,173 | $0.00 | $0 | 22,173 |
| 2025-07-01 | Monson Jonathan | EVP and CFO |
Equity grant / award
A · derivative
|
Restricted Stock Units | 8,350 | $0.00 | $0 | 8,350 |
| 2025-06-04 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 56,372 | $0.00 | $0 | 250,000 |
| 2025-06-04 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology |
Open-market sell
S
|
Common Stock | 56,372 | $102.88 | $5,799,630 | 178,342 |
| 2025-06-04 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology |
Exercise / conversion
M
|
Common Stock | 56,372 | $26.15 | $1,474,128 | 234,714 |
| 2025-06-02 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 49,407 | $0.00 | $0 | 148,221 |
| 2025-06-02 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 56,212 | $0.00 | $0 | 0 |
| 2025-06-02 | Mahoney Michael F | Chairman, President & CEO |
Open-market sell
S
|
Common Stock | 89,921 | $103.39 | $9,296,950 | 1,476,882 |
| 2025-06-02 | Mahoney Michael F | Chairman, President & CEO |
Open-market sell
S
|
Common Stock | 74,522 | $104.05 | $7,754,186 | 1,566,803 |
| 2025-06-02 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M
|
Common Stock | 49,407 | $24.55 | $1,212,942 | 1,641,325 |
| 2025-06-02 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M
|
Common Stock | 56,212 | $17.26 | $970,219 | 1,591,918 |
| 2025-05-29 | LUDWIG EDWARD J | Dir |
Open-market sell
S
|
Common Stock | 4,000 | $104.59 | $418,368 | 22,479 |
| 2025-05-21 | Brown Vance R | SVP, GC and Corp. Secretary |
Open-market sell
S
|
Common Stock | 4,826 | $106.42 | $513,583 | 31,367 |
| 2025-05-08 | Zane Ellen M | Dir |
Equity grant / award
A
|
Common Stock | 2,081 | $0.00 | $0 | 37,025 |
| 2025-05-05 | Sorenson John Bradley | EVP, Global Operations |
Open-market sell
S
|
Common Stock | 4,572 | $104.54 | $477,957 | 18,705 |
| 2025-05-02 | Sorenson John Bradley | EVP, Global Operations |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 4,204 | $0.00 | $0 | 4,204 |
| 2025-05-02 | Sorenson John Bradley | EVP, Global Operations |
Other disposed transaction
F
|
Common Stock | 1,918 | $104.93 | $201,256 | 23,277 |
| 2025-05-02 | Sorenson John Bradley | EVP, Global Operations |
Exercise / conversion
M
|
Common Stock | 4,204 | $0.00 | $0 | 25,195 |
| 2025-05-01 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 49,407 | $0.00 | $0 | 197,628 |
| 2025-05-01 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 56,212 | $0.00 | $0 | 56,212 |
| 2025-05-01 | Mahoney Michael F | Chairman, President & CEO |
Open-market sell
S
|
Common Stock | 91,282 | $102.13 | $9,322,266 | 1,535,706 |
| 2025-05-01 | Mahoney Michael F | Chairman, President & CEO |
Open-market sell
S
|
Common Stock | 73,161 | $102.92 | $7,529,708 | 1,626,988 |
| 2025-05-01 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M
|
Common Stock | 49,407 | $24.55 | $1,212,942 | 1,700,149 |
| 2025-05-01 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M
|
Common Stock | 56,212 | $17.26 | $970,219 | 1,650,742 |
| 2025-04-21 | Brown Vance R | SVP, GC and Corp. Secretary |
Open-market sell
S
|
Common Stock | 4,826 | $95.09 | $458,904 | 36,193 |
| 2025-04-01 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 49,407 | $0.00 | $0 | 247,035 |
| 2025-04-01 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 56,211 | $0.00 | $0 | 112,424 |
| 2025-04-01 | Mahoney Michael F | Chairman, President & CEO |
Open-market sell
S
|
Common Stock | 164,442 | $100.01 | $16,445,072 | 1,594,530 |
| 2025-04-01 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M
|
Common Stock | 49,407 | $24.55 | $1,212,942 | 1,758,972 |
| 2025-04-01 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M
|
Common Stock | 56,211 | $17.26 | $970,202 | 1,709,565 |
| 2025-03-21 | Brown Vance R | SVP, GC and Corp. Secretary |
Open-market sell
S
|
Common Stock | 4,826 | $100.85 | $486,702 | 41,019 |
| 2025-03-04 | Woodworth Emily | SVP, Global Controller and CAO |
Open-market sell
S
|
Common Stock | 482 | $104.63 | $50,432 | 432 |
| 2025-03-03 | Woodworth Emily | SVP, Global Controller and CAO |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 5,949 | $0.00 | $0 | 2,383 |
| 2025-03-03 | Woodworth Emily | SVP, Global Controller and CAO |
Open-market sell
S
|
Common Stock | 7,149 | $104.97 | $750,465 | 914 |
| 2025-03-03 | Woodworth Emily | SVP, Global Controller and CAO |
Exercise / conversion
M
|
Common Stock | 5,949 | $37.50 | $223,088 | 8,063 |
| 2025-03-01 | Woodworth Emily | SVP, Global Controller and CAO |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 837 | $0.00 | $0 | 2,514 |
| 2025-03-01 | Woodworth Emily | SVP, Global Controller and CAO |
Other disposed transaction
F
|
Common Stock | 355 | $103.79 | $36,845 | 2,114 |
| 2025-03-01 | Woodworth Emily | SVP, Global Controller and CAO |
Exercise / conversion
M
|
Common Stock | 837 | $0.00 | $0 | 2,469 |
| 2025-02-28 | Woodworth Emily | SVP, Global Controller and CAO |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 7,218 | $0.00 | $0 | 0 |
| 2025-02-28 | Woodworth Emily | SVP, Global Controller and CAO |
Open-market sell
S
|
Common Stock | 9,887 | $101.13 | $999,872 | 1,632 |
| 2025-02-28 | Woodworth Emily | SVP, Global Controller and CAO |
Exercise / conversion
M
|
Common Stock | 7,218 | $42.16 | $304,311 | 11,519 |
| 2025-02-25 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology |
Equity grant / award
G
|
Common Stock | 340 | $0.00 | $0 | 178,342 |
| 2025-02-24 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology |
Equity grant / award
G
|
Common Stock | 340 | $0.00 | $0 | 5,234 |
| 2025-02-24 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology |
Equity grant / award
G
|
Common Stock | 1,700 | $0.00 | $0 | 178,682 |
| 2025-02-21 | Brown Vance R | SVP, GC and Corp. Secretary |
Open-market sell
S
|
Common Stock | 4,826 | $104.64 | $504,993 | 45,845 |
| 2025-02-20 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology |
Equity grant / award
G
|
Common Stock | 1,000 | $0.00 | $0 | 180,382 |
| 2025-02-19 | Sorenson John Bradley | EVP, Global Operations |
Open-market sell
S
|
Common Stock | 3,303 | $105.19 | $347,443 | 20,991 |
| 2025-02-19 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent |
Open-market sell
S
|
Common Stock | 1,510 | $105.35 | $159,078 | 33,129 |
| 2025-02-18 | Sorenson John Bradley | EVP, Global Operations |
Open-market sell
S
|
Common Stock | 2,657 | $104.41 | $277,417 | 24,294 |
| 2025-02-17 | Woodworth Emily | SVP, Global Controller and CAO |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 667 | $0.00 | $0 | 0 |
| 2025-02-17 | Woodworth Emily | SVP, Global Controller and CAO |
Other disposed transaction
F
|
Common Stock | 283 | $106.11 | $30,029 | 4,301 |
| 2025-02-17 | Woodworth Emily | SVP, Global Controller and CAO |
Exercise / conversion
M
|
Common Stock | 667 | $0.00 | $0 | 4,584 |
| 2025-02-16 | Woodworth Emily | SVP, Global Controller and CAO |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 636 | $0.00 | $0 | 637 |
| 2025-02-16 | Woodworth Emily | SVP, Global Controller and CAO |
Other disposed transaction
F
|
Common Stock | 271 | $106.11 | $28,756 | 3,917 |
| 2025-02-16 | Woodworth Emily | SVP, Global Controller and CAO |
Exercise / conversion
M
|
Common Stock | 636 | $0.00 | $0 | 4,188 |
| 2025-02-14 | Woodworth Emily | SVP, Global Controller and CAO |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 661 | $0.00 | $0 | 1,322 |
| 2025-02-14 | Woodworth Emily | SVP, Global Controller and CAO |
Other disposed transaction
F
|
Common Stock | 315 | $106.11 | $33,425 | 3,552 |
| 2025-02-14 | Woodworth Emily | SVP, Global Controller and CAO |
Exercise / conversion
M
|
Common Stock | 661 | $0.00 | $0 | 3,867 |
| 2025-02-13 | Woodworth Emily | SVP, Global Controller and CAO |
Equity grant / award
A · derivative
|
Stock Option (Right to Buy) | 5,732 | $0.00 | $0 | 5,732 |
| 2025-02-13 | Woodworth Emily | SVP, Global Controller and CAO |
Equity grant / award
A · derivative
|
Restricted Stock Units | 5,652 | $0.00 | $0 | 5,652 |
| 2025-02-12 | Sorenson John Bradley | EVP, Global Operations |
Open-market sell
S
|
Common Stock | 6,389 | $105.06 | $671,249 | 24,293 |
| 2025-02-12 | Sorenson John Bradley | EVP, Global Operations |
Equity grant / award
G
|
Common Stock | 2,156 | $0.00 | $0 | 30,682 |
| 2025-02-12 | Woodworth Emily | SVP, Global Controller and CAO |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 480 | $0.00 | $0 | 1,443 |
| 2025-02-12 | Woodworth Emily | SVP, Global Controller and CAO |
Other disposed transaction
F
|
Common Stock | 231 | $105.77 | $24,433 | 3,206 |
| 2025-02-12 | Woodworth Emily | SVP, Global Controller and CAO |
Exercise / conversion
M
|
Common Stock | 480 | $0.00 | $0 | 3,437 |
| 2025-02-11 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology |
Other disposed transaction
F
|
Common Stock | 14,447 | $105.98 | $1,531,093 | 172,863 |
| 2025-02-11 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology |
Equity grant / award
A
|
Common Stock | 31,680 | $0.00 | $0 | 187,310 |
| 2025-02-11 | Sorenson John Bradley | EVP, Global Operations |
Other disposed transaction
F
|
Common Stock | 3,793 | $105.98 | $401,982 | 32,838 |
| 2025-02-11 | Sorenson John Bradley | EVP, Global Operations |
Equity grant / award
A
|
Common Stock | 10,182 | $0.00 | $0 | 36,631 |
| 2025-02-07 | Sorenson John Bradley | EVP, Global Operations |
Open-market sell
S
|
Common Stock | 6,528 | $104.97 | $685,244 | 26,449 |
| 2025-02-03 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 3,176 | $0.00 | $0 | 9,530 |
| 2025-02-03 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 6,176 | $0.00 | $0 | 18,527 |
| 2025-02-03 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 1,009 | $0.00 | $0 | 3,027 |
| 2025-02-03 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 6,952 | $0.00 | $0 | 20,856 |
| 2025-02-03 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC |
Open-market sell
S
|
Common Stock | 8,805 | $102.14 | $899,338 | 5,502 |
| 2025-02-03 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC |
Open-market sell
S
|
Common Stock | 8,508 | $101.45 | $863,169 | 14,307 |
| 2025-02-03 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC |
Exercise / conversion
M
|
Common Stock | 1,009 | $17.26 | $17,415 | 22,815 |
| 2025-02-03 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC |
Exercise / conversion
M
|
Common Stock | 3,176 | $22.71 | $72,127 | 21,806 |
| 2025-02-03 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC |
Exercise / conversion
M
|
Common Stock | 6,176 | $24.55 | $151,621 | 18,630 |
| 2025-02-03 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC |
Exercise / conversion
M
|
Common Stock | 6,952 | $27.09 | $188,330 | 12,454 |
| 2025-01-03 | Sorenson John Bradley | EVP, Global Operations |
Open-market sell
S
|
Common Stock | 2,342 | $89.86 | $210,449 | 32,977 |
| 2025-01-02 | Sorenson John Bradley | EVP, Global Operations |
Open-market sell
S
|
Common Stock | 4,119 | $90.02 | $370,792 | 35,319 |
| 2025-01-01 | Sorenson John Bradley | EVP, Global Operations |
Exercise / conversion
M · derivative
|
Performance Share Units | 4,469 | $0.00 | $0 | 0 |
| 2025-01-01 | Sorenson John Bradley | EVP, Global Operations |
Other disposed transaction
F
|
Common Stock | 2,127 | $89.32 | $189,984 | 39,438 |
| 2025-01-01 | Sorenson John Bradley | EVP, Global Operations |
Exercise / conversion
M
|
Common Stock | 4,469 | $0.00 | $0 | 41,565 |
| 2024-12-10 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology |
Open-market sell
S
|
Common Stock | 20 | $89.97 | $1,799 | 148,148 |
| 2024-12-03 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology |
Open-market buy
P
|
Common Stock | 50 | $90.29 | $4,515 | 148,168 |
| 2024-12-02 | Carruthers Wendy | EVP, Human Resources |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 1,197 | $0.00 | $0 | 13,183 |
| 2024-12-02 | Carruthers Wendy | EVP, Human Resources |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 3,066 | $0.00 | $0 | 0 |
| 2024-12-02 | Carruthers Wendy | EVP, Human Resources |
Open-market sell
S
|
Common Stock | 6,983 | $90.78 | $633,917 | 29,308 |
| 2024-12-02 | Carruthers Wendy | EVP, Human Resources |
Exercise / conversion
M
|
Common Stock | 1,197 | $24.55 | $29,386 | 36,291 |
| 2024-12-02 | Carruthers Wendy | EVP, Human Resources |
Exercise / conversion
M
|
Common Stock | 3,066 | $17.26 | $52,919 | 35,094 |
| 2024-11-27 | Woodworth Emily | SVP, Global Controller and CAO |
Open-market sell
S
|
Common Stock | 1,336 | $90.65 | $121,105 | 2,957 |
| 2024-11-26 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology |
Equity grant / award
G
|
Common Stock | 11,236 | $0.00 | $0 | 148,118 |
| 2024-11-26 | Mahoney Michael F | Chairman, President & CEO |
Equity grant / award
G
|
Common Stock | 7,800 | $0.00 | $0 | 201,478 |
| 2024-11-25 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology |
Equity grant / award
G
|
Common Stock | 1,113 | $0.00 | $0 | 159,354 |
| 2024-11-21 | LUDWIG EDWARD J | Dir |
Open-market sell
S
|
Common Stock | 4,877 | $91.63 | $446,902 | 39,398 |
| 2024-11-12 | Sorenson John Bradley | EVP, Global Operations |
Equity grant / award
G
|
Common Stock | 2,610 | $0.00 | $0 | 37,096 |
| 2024-11-08 | Sorenson John Bradley | EVP, Global Operations |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 17,362 | $0.00 | $0 | 0 |
| 2024-11-08 | Sorenson John Bradley | EVP, Global Operations |
Open-market sell
S
|
Common Stock | 30,580 | $87.66 | $2,680,572 | 39,706 |
| 2024-11-08 | Sorenson John Bradley | EVP, Global Operations |
Exercise / conversion
M
|
Common Stock | 17,362 | $24.55 | $426,237 | 70,286 |
| 2024-11-05 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 55,676 | $0.00 | $0 | 0 |
| 2024-11-05 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 56,211 | $0.00 | $0 | 168,635 |
| 2024-11-05 | Mahoney Michael F | Chairman, President & CEO |
Open-market sell
S
|
Common Stock | 160,182 | $84.74 | $13,573,743 | 1,521,205 |
| 2024-11-05 | Mahoney Michael F | Chairman, President & CEO |
Open-market sell
S
|
Common Stock | 2,596 | $85.17 | $221,108 | 1,681,387 |
| 2024-11-05 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M
|
Common Stock | 55,676 | $16.31 | $908,076 | 1,683,983 |
| 2024-11-05 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M
|
Common Stock | 56,211 | $17.26 | $970,202 | 1,628,307 |
| 2024-11-01 | Carruthers Wendy | EVP, Human Resources |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 1,197 | $0.00 | $0 | 14,380 |
| 2024-11-01 | Carruthers Wendy | EVP, Human Resources |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 3,066 | $0.00 | $0 | 3,066 |
| 2024-11-01 | Carruthers Wendy | EVP, Human Resources |
Open-market sell
S
|
Common Stock | 6,983 | $84.33 | $588,876 | 32,028 |
| 2024-11-01 | Carruthers Wendy | EVP, Human Resources |
Exercise / conversion
M
|
Common Stock | 1,197 | $24.55 | $29,386 | 39,011 |
| 2024-11-01 | Carruthers Wendy | EVP, Human Resources |
Exercise / conversion
M
|
Common Stock | 3,066 | $17.26 | $52,919 | 37,814 |
| 2024-10-07 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 55,675 | $0.00 | $0 | 55,676 |
| 2024-10-07 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 56,211 | $0.00 | $0 | 224,846 |
| 2024-10-07 | Mahoney Michael F | Chairman, President & CEO |
Open-market sell
S
|
Common Stock | 82,085 | $84.94 | $6,972,431 | 1,572,096 |
| 2024-10-07 | Mahoney Michael F | Chairman, President & CEO |
Open-market sell
S
|
Common Stock | 80,692 | $84.31 | $6,803,360 | 1,654,181 |
| 2024-10-07 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M
|
Common Stock | 55,675 | $16.31 | $908,059 | 1,734,873 |
| 2024-10-07 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M
|
Common Stock | 56,211 | $17.26 | $970,202 | 1,679,198 |
| 2024-10-01 | Carruthers Wendy | EVP, Human Resources |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 1,197 | $0.00 | $0 | 15,577 |
| 2024-10-01 | Carruthers Wendy | EVP, Human Resources |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 3,066 | $0.00 | $0 | 6,132 |
| 2024-10-01 | Carruthers Wendy | EVP, Human Resources |
Open-market sell
S
|
Common Stock | 6,983 | $83.86 | $585,594 | 34,748 |
| 2024-10-01 | Carruthers Wendy | EVP, Human Resources |
Exercise / conversion
M
|
Common Stock | 1,197 | $24.55 | $29,386 | 41,731 |
| 2024-10-01 | Carruthers Wendy | EVP, Human Resources |
Exercise / conversion
M
|
Common Stock | 3,066 | $17.26 | $52,919 | 40,534 |
| 2024-09-05 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 55,675 | $0.00 | $0 | 111,351 |
| 2024-09-05 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 56,211 | $0.00 | $0 | 281,057 |
| 2024-09-05 | Mahoney Michael F | Chairman, President & CEO |
Open-market sell
S
|
Common Stock | 162,777 | $81.17 | $13,212,544 | 1,622,987 |
| 2024-09-05 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M
|
Common Stock | 55,675 | $16.31 | $908,059 | 1,785,764 |
| 2024-09-05 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M
|
Common Stock | 56,211 | $17.26 | $970,202 | 1,730,089 |
| 2024-09-03 | Carruthers Wendy | EVP, Human Resources |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 1,197 | $0.00 | $0 | 16,774 |
| 2024-09-03 | Carruthers Wendy | EVP, Human Resources |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 3,066 | $0.00 | $0 | 9,198 |
| 2024-09-03 | Carruthers Wendy | EVP, Human Resources |
Open-market sell
S
|
Common Stock | 6,983 | $81.70 | $570,511 | 37,468 |
| 2024-09-03 | Carruthers Wendy | EVP, Human Resources |
Exercise / conversion
M
|
Common Stock | 1,197 | $24.55 | $29,386 | 44,451 |
| 2024-09-03 | Carruthers Wendy | EVP, Human Resources |
Exercise / conversion
M
|
Common Stock | 3,066 | $17.26 | $52,919 | 43,254 |
| 2024-08-30 | Mahoney Michael F | Chairman, President & CEO |
Equity grant / award
G
|
Common Stock | 176,245 | $0.00 | $0 | 209,278 |
| 2024-08-30 | Mahoney Michael F | Chairman, President & CEO |
Equity grant / award
G
|
Common Stock | 95,041 | $0.00 | $0 | 385,523 |
| 2024-08-30 | Mahoney Michael F | Chairman, President & CEO |
Equity grant / award
G
|
Common Stock | 114,237 | $0.00 | $0 | 290,482 |
| 2024-08-28 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology |
Open-market sell
S
|
Common Stock | 14,132 | $80.00 | $1,130,560 | 176,355 |
| 2024-08-26 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 3,176 | $0.00 | $0 | 15,883 |
| 2024-08-26 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 1,009 | $0.00 | $0 | 5,045 |
| 2024-08-26 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC |
Open-market sell
S
|
Common Stock | 14,012 | $79.25 | $1,110,515 | 10,802 |
| 2024-08-26 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC |
Exercise / conversion
M
|
Common Stock | 1,009 | $17.26 | $17,415 | 24,814 |
| 2024-08-26 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC |
Exercise / conversion
M
|
Common Stock | 3,176 | $22.71 | $72,127 | 23,805 |
| 2024-08-06 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC |
Other acquired transaction
I
|
Common Stock | 10,843 | $73.76 | $799,780 | 13,381 |
| 2024-08-01 | Habiger David C | Dir |
Equity grant / award
A
|
Common Stock | 1,252 | $0.00 | $0 | 3,547 |
| 2024-08-01 | Habiger David C | Dir |
Equity grant / award
A
|
Common Stock | 2,155 | $0.00 | $0 | 2,295 |
| 2024-07-01 | Brown Vance R | SVP, GC and Corp. Secretary |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 4,036 | $0.00 | $0 | 4,036 |
| 2024-07-01 | Brown Vance R | SVP, GC and Corp. Secretary |
Other disposed transaction
F
|
Common Stock | 1,952 | $76.41 | $149,152 | 34,410 |
| 2024-07-01 | Brown Vance R | SVP, GC and Corp. Secretary |
Exercise / conversion
M
|
Common Stock | 4,036 | $0.00 | $0 | 36,362 |
| 2024-06-03 | Pegus Cheryl | Dir |
Equity grant / award
A · derivative
|
Deferred Stock Units | 407 | $0.00 | $0 | 3,207 |
| 2024-06-03 | Pegus Cheryl | Dir |
Equity grant / award
A · derivative
|
Deferred Stock Units | 2,800 | $0.00 | $0 | 2,800 |
| 2024-05-29 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 33,726 | $0.00 | $0 | 0 |
| 2024-05-29 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent |
Open-market sell
S
|
Common Stock | 63,802 | $75.10 | $4,791,447 | 28,022 |
| 2024-05-29 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent |
Exercise / conversion
M
|
Common Stock | 33,726 | $17.26 | $582,111 | 91,824 |
| 2024-05-28 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 3,177 | $0.00 | $0 | 19,059 |
| 2024-05-28 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 1,009 | $0.00 | $0 | 6,054 |
| 2024-05-28 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC |
Open-market sell
S
|
Common Stock | 14,011 | $75.34 | $1,055,590 | 20,197 |
| 2024-05-28 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC |
Exercise / conversion
M
|
Common Stock | 1,009 | $17.26 | $17,415 | 34,208 |
| 2024-05-28 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC |
Exercise / conversion
M
|
Common Stock | 3,177 | $22.71 | $72,150 | 33,199 |
| 2024-05-23 | Brennan Daniel J. | EVP and CFO |
Open-market sell
S
|
Common Stock | 47,621 | $75.11 | $3,576,932 | 223,921 |
| 2024-05-22 | Brown Vance R | SVP, GC and Corp. Secretary |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 15,006 | $0.00 | $0 | 0 |
| 2024-05-22 | Brown Vance R | SVP, GC and Corp. Secretary |
Open-market sell
S
|
Common Stock | 15,006 | $76.01 | $1,140,633 | 32,326 |
| 2024-05-22 | Brown Vance R | SVP, GC and Corp. Secretary |
Exercise / conversion
M
|
Common Stock | 15,006 | $27.09 | $406,513 | 47,332 |
| 2024-05-22 | Brennan Daniel J. | EVP and CFO |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 15,086 | $0.00 | $0 | 15,087 |
| 2024-05-22 | Brennan Daniel J. | EVP and CFO |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 16,863 | $0.00 | $0 | 55,600 |
| 2024-05-22 | Brennan Daniel J. | EVP and CFO |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 15,642 | $0.00 | $0 | 46,927 |
| 2024-05-22 | Brennan Daniel J. | EVP and CFO |
Open-market sell
S
|
Common Stock | 64,454 | $75.91 | $4,892,819 | 271,542 |
| 2024-05-22 | Brennan Daniel J. | EVP and CFO |
Exercise / conversion
M
|
Common Stock | 15,086 | $16.31 | $246,053 | 335,996 |
| 2024-05-22 | Brennan Daniel J. | EVP and CFO |
Exercise / conversion
M
|
Common Stock | 15,642 | $27.09 | $423,742 | 320,910 |
| 2024-05-22 | Brennan Daniel J. | EVP and CFO |
Exercise / conversion
M
|
Common Stock | 16,863 | $17.26 | $291,055 | 305,268 |
| 2024-05-21 | Brown Vance R | SVP, GC and Corp. Secretary |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 18,037 | $0.00 | $0 | 0 |
| 2024-05-21 | Brown Vance R | SVP, GC and Corp. Secretary |
Open-market sell
S
|
Common Stock | 18,037 | $75.60 | $1,363,606 | 32,326 |
| 2024-05-21 | Brown Vance R | SVP, GC and Corp. Secretary |
Exercise / conversion
M
|
Common Stock | 18,037 | $24.55 | $442,808 | 50,363 |
| 2024-05-13 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology |
Equity grant / award
G
|
Common Stock | 2,380 | $0.00 | $0 | 190,487 |
| 2024-05-10 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 12,931 | $0.00 | $0 | 0 |
| 2024-05-10 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Open-market sell
S
|
Common Stock | 12,931 | $74.14 | $958,717 | 31,422 |
| 2024-05-10 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Exercise / conversion
M
|
Common Stock | 12,931 | $16.31 | $210,905 | 44,353 |
| 2024-05-09 | Zane Ellen M | Dir |
Equity grant / award
A
|
Common Stock | 2,901 | $0.00 | $0 | 48,530 |
| 2024-05-07 | Dockendorff Charles J | Dir |
Open-market sell
S
|
Common Stock | 3,946 | $72.70 | $286,874 | 0 |
| 2024-05-02 | Sorenson John Bradley | EVP, Global Operations |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 4,203 | $0.00 | $0 | 8,408 |
| 2024-05-02 | Sorenson John Bradley | EVP, Global Operations |
Other disposed transaction
F
|
Common Stock | 1,917 | $72.03 | $138,082 | 52,924 |
| 2024-05-02 | Sorenson John Bradley | EVP, Global Operations |
Exercise / conversion
M
|
Common Stock | 4,203 | $0.00 | $0 | 54,841 |
| 2024-05-01 | Sorenson John Bradley | EVP, Global Operations |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 17,587 | $0.00 | $0 | 0 |
| 2024-05-01 | Sorenson John Bradley | EVP, Global Operations |
Open-market sell
S
|
Common Stock | 17,587 | $71.50 | $1,257,488 | 50,638 |
| 2024-05-01 | Sorenson John Bradley | EVP, Global Operations |
Exercise / conversion
M
|
Common Stock | 17,587 | $17.26 | $303,552 | 68,225 |
| 2024-04-26 | LUDWIG EDWARD J | Dir |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 9,818 | $17.37 | $170,539 | 0 |
| 2024-04-26 | LUDWIG EDWARD J | Dir |
Open-market sell
S
|
Common Stock | 9,818 | $73.29 | $719,562 | 41,374 |
| 2024-04-26 | LUDWIG EDWARD J | Dir |
Exercise / conversion
M
|
Common Stock | 9,818 | $17.37 | $170,539 | 51,192 |
| 2024-04-01 | Sorenson John Bradley | EVP, Global Operations |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 16,351 | $0.00 | $0 | 0 |
| 2024-04-01 | Sorenson John Bradley | EVP, Global Operations |
Open-market sell
S
|
Common Stock | 16,351 | $69.30 | $1,133,069 | 50,638 |
| 2024-04-01 | Sorenson John Bradley | EVP, Global Operations |
Exercise / conversion
M
|
Common Stock | 16,351 | $16.31 | $266,685 | 66,989 |
| 2024-03-18 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent |
Open-market sell
S
|
Common Stock | 14,506 | $66.45 | $963,930 | 58,098 |
| 2024-03-01 | Woodworth Emily | SVP, Global Controller and CAO |
Equity grant / award
A · derivative
|
Stock Option (Right to Buy) | 3,421 | $0.00 | $0 | 3,421 |
| 2024-03-01 | Woodworth Emily | SVP, Global Controller and CAO |
Equity grant / award
A · derivative
|
Restricted Stock Units | 3,351 | $0.00 | $0 | 3,351 |
| 2024-02-26 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 3,176 | $0.00 | $0 | 22,236 |
| 2024-02-26 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 1,009 | $0.00 | $0 | 7,063 |
| 2024-02-26 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC |
Open-market sell
S
|
Common Stock | 9,335 | $67.07 | $626,098 | 28,937 |
| 2024-02-26 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC |
Exercise / conversion
M
|
Common Stock | 1,009 | $17.26 | $17,415 | 38,272 |
| 2024-02-26 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC |
Exercise / conversion
M
|
Common Stock | 3,176 | $22.71 | $72,127 | 37,263 |
| 2024-02-23 | Carruthers Wendy | EVP, Human Resources |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 1,197 | $0.00 | $0 | 25,153 |
| 2024-02-23 | Carruthers Wendy | EVP, Human Resources |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 3,066 | $0.00 | $0 | 30,660 |
| 2024-02-23 | Carruthers Wendy | EVP, Human Resources |
Open-market sell
S
|
Common Stock | 6,983 | $66.89 | $467,093 | 56,508 |
| 2024-02-23 | Carruthers Wendy | EVP, Human Resources |
Exercise / conversion
M
|
Common Stock | 1,197 | $24.55 | $29,386 | 63,491 |
| 2024-02-23 | Carruthers Wendy | EVP, Human Resources |
Exercise / conversion
M
|
Common Stock | 3,066 | $17.26 | $52,919 | 62,294 |
| 2024-02-21 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent |
Open-market sell
S
|
Common Stock | 4,960 | $66.35 | $329,096 | 72,604 |
| 2024-02-20 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology |
Other disposed transaction
I
|
Common Stock | 67,974 | $66.22 | $4,501,238 | 0 |
| 2024-02-18 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Exercise / conversion
M · derivative
|
Deferred Stock Units | 2,002 | $0.00 | $0 | 0 |
| 2024-02-18 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Other disposed transaction
F
|
Common Stock | 1,160 | $65.82 | $76,351 | 30,044 |
| 2024-02-18 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Exercise / conversion
M
|
Common Stock | 2,002 | $0.00 | $0 | 31,204 |
| 2024-02-17 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 2,500 | $0.00 | $0 | 2,500 |
| 2024-02-17 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Other disposed transaction
F
|
Common Stock | 1,448 | $65.82 | $95,307 | 29,202 |
| 2024-02-17 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Exercise / conversion
M
|
Common Stock | 2,500 | $0.00 | $0 | 30,650 |
| 2024-02-16 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 2,263 | $0.00 | $0 | 4,526 |
| 2024-02-16 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Other disposed transaction
F
|
Common Stock | 1,311 | $65.82 | $86,290 | 28,150 |
| 2024-02-16 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Exercise / conversion
M
|
Common Stock | 2,263 | $0.00 | $0 | 29,461 |
| 2024-02-14 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 2,379 | $0.00 | $0 | 7,138 |
| 2024-02-14 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Other disposed transaction
F
|
Common Stock | 1,378 | $65.95 | $90,879 | 27,198 |
| 2024-02-14 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Exercise / conversion
M
|
Common Stock | 2,379 | $0.00 | $0 | 28,576 |
| 2024-02-14 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Other disposed transaction
F
|
Common Stock | 0 | $65.95 | — | 28,576 |
| 2024-02-13 | LUDWIG EDWARD J | Dir |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 7,000 | $0.00 | $0 | 9,818 |
| 2024-02-13 | LUDWIG EDWARD J | Dir |
Open-market sell
S
|
Common Stock | 7,000 | $65.03 | $455,223 | 41,374 |
| 2024-02-13 | LUDWIG EDWARD J | Dir |
Exercise / conversion
M
|
Common Stock | 7,000 | $17.37 | $121,590 | 48,374 |
| 2024-02-12 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Equity grant / award
A · derivative
|
Restricted Stock Units | 7,693 | $0.00 | $0 | 7,693 |
| 2024-02-06 | Sorenson John Bradley | EVP, Global Operations |
Other disposed transaction
F
|
Common Stock | 5,472 | $0.00 | $0 | 47,336 |
| 2024-02-06 | Sorenson John Bradley | EVP, Global Operations |
Equity grant / award
A
|
Common Stock | 12,000 | $0.00 | $0 | 52,808 |
| 2024-01-12 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology |
Open-market sell
S
|
Common Stock | 11,660 | $60.00 | $699,600 | 173,472 |
| 2024-01-09 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 15,172 | $0.00 | $0 | 0 |
| 2024-01-09 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent |
Open-market sell
S
|
Common Stock | 15,172 | $59.25 | $898,941 | 56,588 |
| 2024-01-09 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent |
Exercise / conversion
M
|
Common Stock | 15,172 | $16.31 | $247,455 | 71,760 |
| 2024-01-04 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 15,000 | $0.00 | $0 | 15,172 |
| 2024-01-04 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent |
Open-market sell
S
|
Common Stock | 15,000 | $58.40 | $876,002 | 56,588 |
| 2024-01-04 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent |
Exercise / conversion
M
|
Common Stock | 15,000 | $16.31 | $244,650 | 71,588 |
| 2024-01-03 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent |
Open-market sell
S
|
Common Stock | 11,931 | $57.82 | $689,862 | 56,588 |
| 2024-01-01 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology |
Exercise / conversion
M · derivative
|
Performance Share Units | 21,799 | $0.00 | $0 | 0 |
| 2024-01-01 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology |
Other disposed transaction
F
|
Common Stock | 10,908 | $57.81 | $630,591 | 185,132 |
| 2024-01-01 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology |
Exercise / conversion
M
|
Common Stock | 21,799 | $0.00 | $0 | 196,040 |
| 2024-01-01 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Exercise / conversion
M · derivative
|
Performance Share Units | 13,080 | $0.00 | $0 | 0 |
| 2024-01-01 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Other disposed transaction
F
|
Common Stock | 7,573 | $57.81 | $437,795 | 17,776 |
| 2024-01-01 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Exercise / conversion
M
|
Common Stock | 13,080 | $0.00 | $0 | 25,349 |
| 2023-12-29 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 58,189 | $0.00 | $0 | 0 |
| 2023-12-29 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology |
Open-market sell
S
|
Common Stock | 81,940 | $57.50 | $4,711,550 | 174,241 |
| 2023-12-29 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology |
Exercise / conversion
M
|
Common Stock | 58,189 | $16.31 | $949,063 | 256,181 |
| 2023-12-15 | Carruthers Wendy | EVP, Human Resources |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 2,959 | $0.00 | $0 | 0 |
| 2023-12-15 | Carruthers Wendy | EVP, Human Resources |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 3,450 | $0.00 | $0 | 0 |
| 2023-12-15 | Carruthers Wendy | EVP, Human Resources |
Open-market sell
S
|
Common Stock | 11,672 | $55.61 | $649,075 | 41,269 |
| 2023-12-15 | Carruthers Wendy | EVP, Human Resources |
Exercise / conversion
M
|
Common Stock | 2,959 | $13.08 | $38,704 | 52,941 |
| 2023-12-15 | Carruthers Wendy | EVP, Human Resources |
Exercise / conversion
M
|
Common Stock | 3,450 | $16.31 | $56,270 | 49,982 |
| 2023-12-06 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent |
Open-market sell
S
|
Common Stock | 353 | $55.03 | $19,426 | 56,588 |
| 2023-12-03 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent |
Exercise / conversion
M · derivative
|
Deferred Stock Units | 649 | $0.00 | $0 | 0 |
| 2023-12-03 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent |
Other disposed transaction
F
|
Common Stock | 296 | $56.14 | $16,617 | 56,941 |
| 2023-12-03 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent |
Exercise / conversion
M
|
Common Stock | 649 | $0.00 | $0 | 57,237 |
| 2023-12-01 | Monson Jonathan | SVP, Global Controller and CAO |
Equity grant / award
A · derivative
|
Stock Option (Right to Buy) | 10,543 | $0.00 | $0 | 10,543 |
| 2023-12-01 | Monson Jonathan | SVP, Global Controller and CAO |
Equity grant / award
A · derivative
|
Restricted Stock Units | 3,562 | $0.00 | $0 | 3,562 |
| 2023-11-20 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 3,859 | $0.00 | $0 | 8,072 |
| 2023-11-20 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC |
Open-market sell
S
|
Common Stock | 8,278 | $54.06 | $447,509 | 6,977 |
| 2023-11-20 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC |
Exercise / conversion
M
|
Common Stock | 3,859 | $17.26 | $66,606 | 15,255 |
| 2023-11-15 | Carruthers Wendy | EVP, Human Resources |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 2,960 | $0.00 | $0 | 2,959 |
| 2023-11-15 | Carruthers Wendy | EVP, Human Resources |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 3,448 | $0.00 | $0 | 3,450 |
| 2023-11-15 | Carruthers Wendy | EVP, Human Resources |
Open-market sell
S
|
Common Stock | 11,671 | $54.17 | $632,269 | 46,532 |
| 2023-11-15 | Carruthers Wendy | EVP, Human Resources |
Exercise / conversion
M
|
Common Stock | 2,960 | $13.08 | $38,717 | 58,203 |
| 2023-11-15 | Carruthers Wendy | EVP, Human Resources |
Exercise / conversion
M
|
Common Stock | 3,448 | $16.31 | $56,237 | 55,243 |
| 2023-11-08 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent |
Equity grant / award
G
|
Common Stock | 4,000 | $0.00 | $0 | 56,588 |
| 2023-11-06 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 57,681 | $0.00 | $0 | 0 |
| 2023-11-06 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 55,675 | $0.00 | $0 | 167,026 |
| 2023-11-06 | Mahoney Michael F | Chairman, President & CEO |
Open-market sell
S
|
Common Stock | 113,356 | $52.51 | $5,951,983 | 1,498,922 |
| 2023-11-06 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M
|
Common Stock | 55,675 | $16.31 | $908,059 | 1,612,278 |
| 2023-11-06 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M
|
Common Stock | 57,681 | $13.08 | $754,467 | 1,556,603 |
| 2023-10-16 | Carruthers Wendy | EVP, Human Resources |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 2,960 | $0.00 | $0 | 5,919 |
| 2023-10-16 | Carruthers Wendy | EVP, Human Resources |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 3,448 | $0.00 | $0 | 6,898 |
| 2023-10-16 | Carruthers Wendy | EVP, Human Resources |
Open-market sell
S
|
Common Stock | 11,671 | $49.79 | $581,063 | 51,795 |
| 2023-10-16 | Carruthers Wendy | EVP, Human Resources |
Exercise / conversion
M
|
Common Stock | 2,960 | $13.08 | $38,717 | 63,466 |
| 2023-10-16 | Carruthers Wendy | EVP, Human Resources |
Exercise / conversion
M
|
Common Stock | 3,448 | $16.31 | $56,237 | 60,506 |
| 2023-10-09 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 57,680 | $0.00 | $0 | 57,681 |
| 2023-10-09 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 55,675 | $0.00 | $0 | 222,701 |
| 2023-10-09 | Mahoney Michael F | Chairman, President & CEO |
Open-market sell
S
|
Common Stock | 113,355 | $52.09 | $5,904,481 | 1,498,922 |
| 2023-10-09 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M
|
Common Stock | 55,675 | $16.31 | $908,059 | 1,612,277 |
| 2023-10-09 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M
|
Common Stock | 57,680 | $13.08 | $754,454 | 1,556,602 |
| 2023-09-20 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology |
Open-market sell
S
|
Common Stock | 15,867 | $55.00 | $872,685 | 197,992 |
| 2023-09-15 | Carruthers Wendy | EVP, Human Resources |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 2,960 | $0.00 | $0 | 8,879 |
| 2023-09-15 | Carruthers Wendy | EVP, Human Resources |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 3,448 | $0.00 | $0 | 10,346 |
| 2023-09-15 | Carruthers Wendy | EVP, Human Resources |
Open-market sell
S
|
Common Stock | 11,671 | $53.95 | $629,694 | 57,058 |
| 2023-09-15 | Carruthers Wendy | EVP, Human Resources |
Exercise / conversion
M
|
Common Stock | 2,960 | $13.08 | $38,717 | 68,729 |
| 2023-09-15 | Carruthers Wendy | EVP, Human Resources |
Exercise / conversion
M
|
Common Stock | 3,448 | $16.31 | $56,237 | 65,769 |
| 2023-09-12 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 57,680 | $0.00 | $0 | 115,361 |
| 2023-09-12 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 55,675 | $0.00 | $0 | 278,376 |
| 2023-09-12 | Mahoney Michael F | Chairman, President & CEO |
Open-market sell
S
|
Common Stock | 113,355 | $53.91 | $6,110,447 | 1,498,922 |
| 2023-09-12 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M
|
Common Stock | 55,675 | $16.31 | $908,059 | 1,612,277 |
| 2023-09-12 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M
|
Common Stock | 57,680 | $13.08 | $754,454 | 1,556,602 |
| 2023-08-31 | Mahoney Michael F | Chairman, President & CEO |
Equity grant / award
G
|
Common Stock | 1,095 | $0.00 | $0 | 176,245 |
| 2023-08-30 | Mahoney Michael F | Chairman, President & CEO |
Equity grant / award
G
|
Common Stock | 141,450 | $0.00 | $0 | 175,150 |
| 2023-08-30 | Mahoney Michael F | Chairman, President & CEO |
Equity grant / award
G
|
Common Stock | 318,218 | $0.00 | $0 | 1,498,922 |
| 2023-08-29 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent |
Open-market sell
S
|
Common Stock | 4,657 | $54.50 | $253,811 | 60,588 |
| 2023-08-28 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent |
Open-market sell
S
|
Common Stock | 13,971 | $53.14 | $742,419 | 65,245 |
| 2023-08-25 | Brown Vance R | SVP, GC and Corp. Secretary |
Open-market sell
S
|
Common Stock | 15,750 | $50.52 | $795,756 | 28,578 |
| 2023-08-21 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC |
Open-market sell
S
|
Common Stock | 6,600 | $50.40 | $332,661 | 11,396 |
| 2023-08-18 | Dockendorff Charles J | Dir |
Open-market sell
S
|
Common Stock | 17,079 | $50.74 | $866,631 | 3,946 |
| 2023-08-15 | Carruthers Wendy | EVP, Human Resources |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 2,960 | $0.00 | $0 | 11,839 |
| 2023-08-15 | Carruthers Wendy | EVP, Human Resources |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 3,448 | $0.00 | $0 | 13,794 |
| 2023-08-15 | Carruthers Wendy | EVP, Human Resources |
Open-market sell
S
|
Common Stock | 11,671 | $51.30 | $598,678 | 62,321 |
| 2023-08-15 | Carruthers Wendy | EVP, Human Resources |
Exercise / conversion
M
|
Common Stock | 2,960 | $13.08 | $38,717 | 73,992 |
| 2023-08-15 | Carruthers Wendy | EVP, Human Resources |
Exercise / conversion
M
|
Common Stock | 3,448 | $16.31 | $56,237 | 71,032 |
| 2023-08-02 | Monson Jonathan | SVP, Global Controller and CAO |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 1,090 | $0.00 | $0 | 2,180 |
| 2023-08-02 | Monson Jonathan | SVP, Global Controller and CAO |
Other disposed transaction
F
|
Common Stock | 487 | $50.62 | $24,652 | 35,874 |
| 2023-08-02 | Monson Jonathan | SVP, Global Controller and CAO |
Exercise / conversion
M
|
Common Stock | 1,090 | $0.00 | $0 | 36,361 |
| 2023-07-17 | Carruthers Wendy | EVP, Human Resources |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 2,960 | $0.00 | $0 | 14,799 |
| 2023-07-17 | Carruthers Wendy | EVP, Human Resources |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 3,448 | $0.00 | $0 | 17,242 |
| 2023-07-17 | Carruthers Wendy | EVP, Human Resources |
Open-market sell
S
|
Common Stock | 11,671 | $52.85 | $616,774 | 67,584 |
| 2023-07-17 | Carruthers Wendy | EVP, Human Resources |
Exercise / conversion
M
|
Common Stock | 2,960 | $13.08 | $38,717 | 79,255 |
| 2023-07-17 | Carruthers Wendy | EVP, Human Resources |
Exercise / conversion
M
|
Common Stock | 3,448 | $16.31 | $56,237 | 76,295 |
| 2023-07-03 | Morano Susan E | Dir |
Equity grant / award
A · derivative
|
Deferred Stock Units | 456 | $0.00 | $0 | 2,082 |
| 2023-07-03 | Morano Susan E | Dir |
Equity grant / award
A · derivative
|
Deferred Stock Units | 1,626 | $0.00 | $0 | 1,626 |
| 2023-07-03 | Morano Susan E | Dir |
Equity grant / award
A
|
Common Stock | 456 | $0.00 | $0 | 2,082 |
| 2023-07-03 | Morano Susan E | Dir |
Equity grant / award
A
|
Common Stock | 1,626 | $0.00 | $0 | 1,626 |
| 2023-07-01 | Monson Jonathan | SVP, Global Controller and CAO |
Exercise / conversion
M · derivative
|
Deferred Stock Units | 729 | $0.00 | $0 | 0 |
| 2023-07-01 | Monson Jonathan | SVP, Global Controller and CAO |
Other disposed transaction
F
|
Common Stock | 326 | $54.09 | $17,633 | 35,271 |
| 2023-07-01 | Monson Jonathan | SVP, Global Controller and CAO |
Exercise / conversion
M
|
Common Stock | 729 | $0.00 | $0 | 35,597 |
| 2023-06-21 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC |
Open-market sell
S
|
Common Stock | 6,697 | $53.80 | $360,298 | 17,453 |
| 2023-06-15 | Carruthers Wendy | EVP, Human Resources |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 2,960 | $0.00 | $0 | 17,759 |
| 2023-06-15 | Carruthers Wendy | EVP, Human Resources |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 3,448 | $0.00 | $0 | 20,690 |
| 2023-06-15 | Carruthers Wendy | EVP, Human Resources |
Open-market sell
S
|
Common Stock | 11,671 | $53.24 | $621,359 | 72,847 |
| 2023-06-15 | Carruthers Wendy | EVP, Human Resources |
Exercise / conversion
M
|
Common Stock | 2,960 | $13.08 | $38,717 | 84,518 |
| 2023-06-15 | Carruthers Wendy | EVP, Human Resources |
Exercise / conversion
M
|
Common Stock | 3,448 | $16.31 | $56,237 | 81,558 |
| 2023-05-16 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 56,921 | $0.00 | $0 | 0 |
| 2023-05-16 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology |
Open-market sell
S
|
Common Stock | 63,339 | $53.60 | $3,394,856 | 213,859 |
| 2023-05-16 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology |
Exercise / conversion
M
|
Common Stock | 56,921 | $13.08 | $744,527 | 277,198 |
| 2023-05-15 | Carruthers Wendy | EVP, Human Resources |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 2,960 | $0.00 | $0 | 20,719 |
| 2023-05-15 | Carruthers Wendy | EVP, Human Resources |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 3,448 | $0.00 | $0 | 24,138 |
| 2023-05-15 | Carruthers Wendy | EVP, Human Resources |
Open-market sell
S
|
Common Stock | 11,671 | $53.49 | $624,333 | 78,110 |
| 2023-05-15 | Carruthers Wendy | EVP, Human Resources |
Exercise / conversion
M
|
Common Stock | 2,960 | $13.08 | $38,717 | 89,781 |
| 2023-05-15 | Carruthers Wendy | EVP, Human Resources |
Exercise / conversion
M
|
Common Stock | 3,448 | $16.31 | $56,237 | 86,821 |
| 2023-05-04 | WICHMANN DAVID S | Dir |
Equity grant / award
A
|
Common Stock | 3,946 | $0.00 | $0 | 36,600 |
| 2023-05-02 | Sorenson John Bradley | EVP, Global Operations |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 4,203 | $0.00 | $0 | 12,611 |
| 2023-05-02 | Sorenson John Bradley | EVP, Global Operations |
Other disposed transaction
F
|
Common Stock | 1,917 | $52.90 | $101,409 | 36,689 |
| 2023-05-02 | Sorenson John Bradley | EVP, Global Operations |
Exercise / conversion
M
|
Common Stock | 4,203 | $0.00 | $0 | 38,606 |
| 2023-04-17 | Carruthers Wendy | EVP, Human Resources |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 2,960 | $0.00 | $0 | 23,679 |
| 2023-04-17 | Carruthers Wendy | EVP, Human Resources |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 3,448 | $0.00 | $0 | 27,586 |
| 2023-04-17 | Carruthers Wendy | EVP, Human Resources |
Open-market sell
S
|
Common Stock | 11,671 | $51.96 | $606,423 | 83,373 |
| 2023-04-17 | Carruthers Wendy | EVP, Human Resources |
Exercise / conversion
M
|
Common Stock | 2,960 | $13.08 | $38,717 | 95,044 |
| 2023-04-17 | Carruthers Wendy | EVP, Human Resources |
Exercise / conversion
M
|
Common Stock | 3,448 | $16.31 | $56,237 | 92,084 |
| 2023-04-05 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent |
Open-market sell
S
|
Common Stock | 4,903 | $50.40 | $247,111 | 78,673 |
| 2023-04-03 | WICHMANN DAVID S | Dir |
Equity grant / award
A
|
Common Stock | 41 | $0.00 | $0 | 32,654 |
| 2023-03-31 | Sorenson John Bradley | EVP, Global Operations |
Open-market sell
S
|
Common Stock | 4,000 | $50.00 | $200,000 | 34,403 |
| 2023-03-30 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent |
Open-market sell
S
|
Common Stock | 4,903 | $49.60 | $243,189 | 83,576 |
| 2023-03-23 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC |
Open-market sell
S
|
Common Stock | 6,703 | $47.97 | $321,543 | 22,981 |
| 2023-03-15 | Carruthers Wendy | EVP, Human Resources |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 2,960 | $0.00 | $0 | 26,639 |
| 2023-03-15 | Carruthers Wendy | EVP, Human Resources |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 3,448 | $0.00 | $0 | 31,034 |
| 2023-03-15 | Carruthers Wendy | EVP, Human Resources |
Open-market sell
S
|
Common Stock | 11,671 | $47.60 | $555,575 | 88,636 |
| 2023-03-15 | Carruthers Wendy | EVP, Human Resources |
Exercise / conversion
M
|
Common Stock | 2,960 | $13.08 | $38,717 | 100,307 |
| 2023-03-15 | Carruthers Wendy | EVP, Human Resources |
Exercise / conversion
M
|
Common Stock | 3,448 | $16.31 | $56,237 | 97,347 |
| 2023-03-02 | Brennan Daniel J. | EVP and CFO |
Open-market sell
S
|
Common Stock | 30,000 | $46.66 | $1,399,914 | 225,958 |
| 2023-03-01 | Brennan Daniel J. | EVP and CFO |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 13,661 | $0.00 | $0 | 13,662 |
| 2023-03-01 | Brennan Daniel J. | EVP and CFO |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 15,086 | $0.00 | $0 | 30,173 |
| 2023-03-01 | Brennan Daniel J. | EVP and CFO |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 16,863 | $0.00 | $0 | 33,728 |
| 2023-03-01 | Brennan Daniel J. | EVP and CFO |
Open-market sell
S
|
Common Stock | 75,610 | $46.64 | $3,526,337 | 255,958 |
| 2023-03-01 | Brennan Daniel J. | EVP and CFO |
Exercise / conversion
M
|
Common Stock | 13,661 | $13.08 | $178,686 | 331,568 |
| 2023-03-01 | Brennan Daniel J. | EVP and CFO |
Exercise / conversion
M
|
Common Stock | 15,086 | $16.31 | $246,053 | 317,907 |
| 2023-03-01 | Brennan Daniel J. | EVP and CFO |
Exercise / conversion
M
|
Common Stock | 16,863 | $17.26 | $291,055 | 302,821 |
| 2023-02-21 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Exercise / conversion
M · derivative
|
Deferred Stock Units | 1,714 | $0.00 | $0 | 0 |
| 2023-02-21 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Other disposed transaction
F
|
Common Stock | 993 | $46.23 | $45,906 | 64,982 |
| 2023-02-21 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Exercise / conversion
M
|
Common Stock | 1,714 | $0.00 | $0 | 65,975 |
| 2023-02-18 | Sorenson John Bradley | EVP, Global Operations |
Exercise / conversion
M · derivative
|
Deferred Stock Units | 1,186 | $0.00 | $0 | 1,186 |
| 2023-02-18 | Sorenson John Bradley | EVP, Global Operations |
Other disposed transaction
F
|
Common Stock | 541 | $46.54 | $25,178 | 37,810 |
| 2023-02-18 | Sorenson John Bradley | EVP, Global Operations |
Exercise / conversion
M
|
Common Stock | 1,186 | $0.00 | $0 | 38,351 |
| 2023-02-18 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Exercise / conversion
M · derivative
|
Deferred Stock Units | 2,001 | $0.00 | $0 | 2,002 |
| 2023-02-18 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Other disposed transaction
F
|
Common Stock | 1,159 | $46.54 | $53,940 | 64,261 |
| 2023-02-18 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Exercise / conversion
M
|
Common Stock | 2,001 | $0.00 | $0 | 65,420 |
| 2023-02-17 | Sorenson John Bradley | EVP, Global Operations |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 1,500 | $0.00 | $0 | 3,000 |
| 2023-02-17 | Sorenson John Bradley | EVP, Global Operations |
Other disposed transaction
F
|
Common Stock | 685 | $46.54 | $31,880 | 37,165 |
| 2023-02-17 | Sorenson John Bradley | EVP, Global Operations |
Exercise / conversion
M
|
Common Stock | 1,500 | $0.00 | $0 | 37,850 |
| 2023-02-16 | Sorenson John Bradley | EVP, Global Operations |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 1,272 | $0.00 | $0 | 3,819 |
| 2023-02-16 | Sorenson John Bradley | EVP, Global Operations |
Other disposed transaction
F
|
Common Stock | 581 | $46.48 | $27,005 | 36,350 |
| 2023-02-16 | Sorenson John Bradley | EVP, Global Operations |
Exercise / conversion
M
|
Common Stock | 1,272 | $0.00 | $0 | 36,931 |
| 2023-02-15 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Exercise / conversion
M · derivative
|
Deferred Stock Units | 1,846 | $0.00 | $0 | 0 |
| 2023-02-15 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Other disposed transaction
F
|
Common Stock | 1,069 | $47.29 | $50,553 | 61,415 |
| 2023-02-15 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Exercise / conversion
M
|
Common Stock | 1,846 | $0.00 | $0 | 62,484 |
| 2023-02-15 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology |
Other disposed transaction
F
|
Common Stock | 2,278 | $47.29 | $107,727 | 212,164 |
| 2023-02-14 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Equity grant / award
A · derivative
|
Stock Option (Right to Buy) | 24,765 | $0.00 | $0 | 24,765 |
| 2023-02-14 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Equity grant / award
A · derivative
|
Performance Share Units | 7,946 | $0.00 | $0 | 7,946 |
| 2023-02-03 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 10,822 | $0.00 | $0 | 0 |
| 2023-02-03 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 4,212 | $0.00 | $0 | 11,931 |
| 2023-02-03 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC |
Open-market sell
S
|
Common Stock | 27,000 | $48.74 | $1,316,037 | 23,392 |
| 2023-02-03 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC |
Exercise / conversion
M
|
Common Stock | 4,212 | $17.26 | $72,699 | 50,392 |
| 2023-02-03 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC |
Exercise / conversion
M
|
Common Stock | 10,822 | $16.31 | $176,507 | 46,180 |
| 2023-01-04 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent |
Open-market sell
S
|
Common Stock | 6,751 | $46.38 | $313,123 | 88,479 |
| 2023-01-01 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Exercise / conversion
M · derivative
|
Performance Share Units | 7,092 | $0.00 | $0 | 0 |
| 2023-01-01 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Other disposed transaction
F
|
Common Stock | 3,988 | $46.27 | $184,525 | 60,638 |
| 2023-01-01 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Exercise / conversion
M
|
Common Stock | 7,092 | $0.00 | $0 | 64,626 |
| 2022-12-15 | Carruthers Wendy | EVP, Human Resources |
Open-market sell
S
|
Common Stock | 7,500 | $46.62 | $349,668 | 87,413 |
| 2022-12-13 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 79,264 | $0.00 | $0 | 0 |
| 2022-12-13 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology |
Open-market sell
S
|
Common Stock | 79,264 | $47.78 | $3,787,234 | 216,871 |
| 2022-12-13 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology |
Exercise / conversion
M
|
Common Stock | 79,264 | $7.39 | $585,761 | 296,135 |
| 2022-12-12 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent |
Open-market sell
S
|
Common Stock | 11,080 | $46.75 | $517,990 | 88,479 |
| 2022-12-09 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 29,599 | $0.00 | $0 | 0 |
| 2022-12-09 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent |
Open-market sell
S
|
Common Stock | 41,032 | $46.15 | $1,893,504 | 99,559 |
| 2022-12-09 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent |
Exercise / conversion
M
|
Common Stock | 29,599 | $13.08 | $387,155 | 140,591 |
| 2022-12-03 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent |
Exercise / conversion
M · derivative
|
Deferred Stock Units | 649 | $0.00 | $0 | 649 |
| 2022-12-03 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent |
Other disposed transaction
F
|
Common Stock | 296 | $46.60 | $13,794 | 110,992 |
| 2022-12-03 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent |
Exercise / conversion
M
|
Common Stock | 649 | $0.00 | $0 | 111,288 |
| 2022-11-29 | Connors Nelda J | Dir |
Open-market sell
S
|
Common Stock | 18,196 | $44.47 | $809,243 | 27,246 |
| 2022-11-18 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Open-market sell
S
|
Common Stock | 14,952 | $42.72 | $638,773 | 57,534 |
| 2022-11-15 | Carruthers Wendy | EVP, Human Resources |
Open-market sell
S
|
Common Stock | 1,678 | $42.60 | $71,483 | 94,913 |
| 2022-11-07 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 82,567 | $0.00 | $0 | 0 |
| 2022-11-07 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 43,260 | $0.00 | $0 | 173,041 |
| 2022-11-07 | Mahoney Michael F | Chairman, President & CEO |
Open-market sell
S
|
Common Stock | 125,827 | $41.97 | $5,280,997 | 1,767,665 |
| 2022-11-07 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M
|
Common Stock | 43,260 | $13.08 | $565,841 | 1,893,492 |
| 2022-11-07 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M
|
Common Stock | 82,567 | $7.39 | $610,170 | 1,850,232 |
| 2022-11-01 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent |
Equity grant / award
G
|
Common Stock | 230 | $0.00 | $0 | 110,639 |
| 2022-10-17 | Carruthers Wendy | EVP, Human Resources |
Open-market sell
S
|
Common Stock | 13,322 | $40.52 | $539,743 | 96,591 |
| 2022-10-03 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 82,567 | $0.00 | $0 | 82,567 |
| 2022-10-03 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 43,260 | $0.00 | $0 | 216,301 |
| 2022-10-03 | Mahoney Michael F | Chairman, President & CEO |
Open-market sell
S
|
Common Stock | 125,827 | $39.34 | $4,949,556 | 1,767,665 |
| 2022-10-03 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M
|
Common Stock | 43,260 | $13.08 | $565,841 | 1,893,492 |
| 2022-10-03 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M
|
Common Stock | 82,567 | $7.39 | $610,170 | 1,850,232 |
| 2022-10-02 | Brown Vance R | SVP, GC and Corp. Secretary |
Exercise / conversion
M · derivative
|
Deferred Stock Units | 3,394 | $0.00 | $0 | 0 |
| 2022-10-02 | Brown Vance R | SVP, GC and Corp. Secretary |
Other disposed transaction
F
|
Common Stock | 997 | $38.73 | $38,614 | 38,002 |
| 2022-10-02 | Brown Vance R | SVP, GC and Corp. Secretary |
Exercise / conversion
M
|
Common Stock | 3,394 | $0.00 | $0 | 38,999 |
| 2022-09-15 | Carruthers Wendy | EVP, Human Resources |
Open-market sell
S
|
Common Stock | 7,500 | $42.21 | $316,586 | 109,913 |
| 2022-09-06 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 82,567 | $0.00 | $0 | 165,134 |
| 2022-09-06 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 43,261 | $0.00 | $0 | 259,561 |
| 2022-09-06 | Mahoney Michael F | Chairman, President & CEO |
Open-market sell
S
|
Common Stock | 125,828 | $40.49 | $5,094,310 | 1,767,665 |
| 2022-09-06 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M
|
Common Stock | 43,261 | $13.08 | $565,854 | 1,893,493 |
| 2022-09-06 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M
|
Common Stock | 82,567 | $7.39 | $610,170 | 1,850,232 |
| 2022-08-30 | Mahoney Michael F | Chairman, President & CEO |
Equity grant / award
G
|
Common Stock | 365,457 | $0.00 | $0 | 1,767,665 |
| 2022-08-15 | Carruthers Wendy | EVP, Human Resources |
Open-market sell
S
|
Common Stock | 7,500 | $42.03 | $315,260 | 117,413 |
| 2022-08-08 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 82,567 | $0.00 | $0 | 247,701 |
| 2022-08-08 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 43,261 | $0.00 | $0 | 302,822 |
| 2022-08-08 | Mahoney Michael F | Chairman, President & CEO |
Open-market sell
S
|
Common Stock | 125,828 | $40.97 | $5,154,682 | 2,133,122 |
| 2022-08-08 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M
|
Common Stock | 43,261 | $13.08 | $565,854 | 2,258,950 |
| 2022-08-08 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M
|
Common Stock | 82,567 | $7.39 | $610,170 | 2,215,689 |
| 2022-08-02 | Connors Nelda J | Dir |
Open-market sell
S
|
Common Stock | 16,088 | $41.58 | $668,939 | 4,877 |
| 2022-08-01 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Open-market sell
S
|
Common Stock | 20,676 | $40.99 | $847,509 | 72,486 |
| 2022-07-29 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology |
Equity grant / award
G
|
Common Stock | 1,000 | $0.00 | $0 | 216,871 |
| 2022-07-18 | Carruthers Wendy | EVP, Human Resources |
Open-market sell
S
|
Common Stock | 7,500 | $38.00 | $285,000 | 124,913 |
| 2022-07-01 | Monson Jonathan | SVP, Global Controller and CAO |
Exercise / conversion
M · derivative
|
Deferred Stock Units | 728 | $0.00 | $0 | 729 |
| 2022-07-01 | Monson Jonathan | SVP, Global Controller and CAO |
Other disposed transaction
F
|
Common Stock | 214 | $38.01 | $8,134 | 31,833 |
| 2022-07-01 | Monson Jonathan | SVP, Global Controller and CAO |
Exercise / conversion
M
|
Common Stock | 728 | $0.00 | $0 | 32,047 |
| 2022-06-24 | Carruthers Wendy | EVP, Human Resources |
Open-market sell
S
|
Common Stock | 7,500 | $38.00 | $285,000 | 132,413 |
| 2022-05-16 | Carruthers Wendy | EVP, Human Resources |
Open-market sell
S
|
Common Stock | 7,500 | $39.43 | $295,725 | 139,913 |
| 2022-05-16 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent |
Equity grant / award
G
|
Common Stock | 26 | $0.00 | $0 | 110,290 |
| 2022-05-05 | Dockendorff Charles J | Dir |
Equity grant / award
A
|
Common Stock | 4,877 | $0.00 | $0 | 17,079 |
| 2022-05-02 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC |
Equity grant / award
A · derivative
|
Stock Option (Right to Buy) | 22,267 | $0.00 | $0 | 22,267 |
| 2022-05-02 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC |
Equity grant / award
A · derivative
|
Restricted Stock Units | 8,407 | $0.00 | $0 | 8,407 |
| 2022-05-01 | Scanlon Meghan | SVP,Pres,Urology Pelvic Health |
Exercise / conversion
M · derivative
|
Deferred Stock Units | 2,062 | $0.00 | $0 | 2,062 |
| 2022-05-01 | Scanlon Meghan | SVP,Pres,Urology Pelvic Health |
Other disposed transaction
F
|
Common Stock | 606 | $42.11 | $25,519 | 24,461 |
| 2022-05-01 | Scanlon Meghan | SVP,Pres,Urology Pelvic Health |
Exercise / conversion
M
|
Common Stock | 2,062 | $0.00 | $0 | 25,067 |
| 2022-04-20 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent |
Open-market sell
S
|
Common Stock | 9,645 | $46.50 | $448,492 | 110,316 |
| 2022-04-19 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent |
Open-market sell
S
|
Common Stock | 10,989 | $45.50 | $500,000 | 119,961 |
| 2022-04-14 | Carruthers Wendy | EVP, Human Resources |
Open-market sell
S
|
Common Stock | 7,500 | $44.47 | $333,518 | 147,413 |
| 2022-04-01 | Eddy Jodi Euerle | SVP, Chief Info & Digital Off. |
Open-market sell
S
|
Common Stock | 2,779 | $45.00 | $125,055 | 23,263 |
| 2022-03-29 | Butcher Arthur C | EVP&Pres, Asia Pacific |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 5,411 | $0.00 | $0 | 10,822 |
| 2022-03-29 | Butcher Arthur C | EVP&Pres, Asia Pacific |
Open-market sell
S
|
Common Stock | 10,269 | $45.00 | $462,105 | 30,278 |
| 2022-03-29 | Butcher Arthur C | EVP&Pres, Asia Pacific |
Exercise / conversion
M
|
Common Stock | 5,411 | $16.31 | $88,253 | 40,547 |
| 2022-03-28 | Meredith Ian T | EVP Global Chief Med Officer |
Open-market sell
S
|
Common Stock | 6,588 | $43.68 | $287,764 | 28,082 |
| 2022-03-22 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent |
Open-market sell
S
|
Common Stock | 11,236 | $44.50 | $500,002 | 130,950 |
| 2022-03-15 | Carruthers Wendy | EVP, Human Resources |
Open-market sell
S
|
Common Stock | 7,500 | $42.34 | $317,587 | 154,913 |
| 2022-03-03 | Fitzgerald Joseph Michael | EVP & Pres, Cardiology |
Exercise / conversion
M · derivative
|
Deferred Stock Units | 3,603 | $0.00 | $0 | 0 |
| 2022-03-03 | Fitzgerald Joseph Michael | EVP & Pres, Cardiology |
Other disposed transaction
F
|
Common Stock | 1,779 | $43.96 | $78,205 | 217,871 |
| 2022-03-03 | Fitzgerald Joseph Michael | EVP & Pres, Cardiology |
Exercise / conversion
M
|
Common Stock | 3,603 | $0.00 | $0 | 219,650 |
| 2022-03-02 | Brennan Daniel J. | EVP and CFO |
Open-market sell
S
|
Common Stock | 11,029 | $44.03 | $485,650 | 264,290 |
| 2022-02-28 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Exercise / conversion
M · derivative
|
Deferred Stock Units | 1,833 | $0.00 | $0 | 0 |
| 2022-02-28 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Other disposed transaction
F
|
Common Stock | 1,031 | $44.17 | $45,539 | 93,162 |
| 2022-02-28 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Exercise / conversion
M
|
Common Stock | 1,833 | $0.00 | $0 | 94,193 |
| 2022-02-22 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Equity grant / award
A · derivative
|
Performance Share Units | 13,080 | $0.00 | $0 | 13,080 |
| 2022-02-21 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Exercise / conversion
M · derivative
|
Deferred Stock Units | 1,714 | $0.00 | $0 | 1,714 |
| 2022-02-21 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Other disposed transaction
F
|
Common Stock | 964 | $42.55 | $41,018 | 92,360 |
| 2022-02-21 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Exercise / conversion
M
|
Common Stock | 1,714 | $0.00 | $0 | 93,324 |
| 2022-02-18 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Exercise / conversion
M · derivative
|
Deferred Stock Units | 2,001 | $0.00 | $0 | 4,003 |
| 2022-02-18 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Other disposed transaction
F
|
Common Stock | 1,125 | $42.55 | $47,869 | 91,610 |
| 2022-02-18 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Exercise / conversion
M
|
Common Stock | 2,001 | $0.00 | $0 | 92,735 |
| 2022-02-17 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 2,500 | $0.00 | $0 | 7,500 |
| 2022-02-17 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Other disposed transaction
F
|
Common Stock | 1,406 | $42.83 | $60,219 | 90,734 |
| 2022-02-17 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Exercise / conversion
M
|
Common Stock | 2,500 | $0.00 | $0 | 92,140 |
| 2022-02-16 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Equity grant / award
A · derivative
|
Stock Option (Right to Buy) | 25,882 | $0.00 | $0 | 25,882 |
| 2022-02-16 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Equity grant / award
A · derivative
|
Restricted Stock Units | 9,051 | $0.00 | $0 | 9,051 |
| 2022-02-15 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Exercise / conversion
M · derivative
|
Deferred Stock Units | 1,846 | $0.00 | $0 | 1,846 |
| 2022-02-15 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Other disposed transaction
F
|
Common Stock | 1,038 | $44.01 | $45,682 | 89,640 |
| 2022-02-15 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Exercise / conversion
M
|
Common Stock | 1,846 | $0.00 | $0 | 90,678 |
| 2022-02-07 | Sorenson John Bradley | SVP, Global Supply Chain |
Open-market sell
S
|
Common Stock | 13,167 | $43.20 | $568,816 | 34,514 |
| 2022-02-01 | Meredith Ian T | EVP Global Chief Med Officer |
Exercise / conversion
M · derivative
|
Deferred Stock Units | 3,131 | $0.00 | $0 | 0 |
| 2022-02-01 | Meredith Ian T | EVP Global Chief Med Officer |
Other disposed transaction
F
|
Common Stock | 919 | $43.50 | $39,976 | 30,839 |
| 2022-02-01 | Meredith Ian T | EVP Global Chief Med Officer |
Exercise / conversion
M
|
Common Stock | 3,131 | $0.00 | $0 | 31,758 |
| 2022-01-04 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent |
Open-market sell
S
|
Common Stock | 6,840 | $43.54 | $297,806 | 133,153 |
| 2022-01-03 | Olson Scott | SVP & Pres, CRM, Diagnostics |
Open-market sell
S
|
Common Stock | 700 | $42.59 | $29,813 | 12,062 |
| 2022-01-01 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Exercise / conversion
M · derivative
|
Performance Share Units | 6,175 | $0.00 | $0 | 0 |
| 2022-01-01 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Other disposed transaction
F
|
Common Stock | 3,472 | $42.48 | $147,491 | 88,832 |
| 2022-01-01 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Exercise / conversion
M
|
Common Stock | 6,175 | $0.00 | $0 | 92,304 |
| 2021-12-28 | Meredith Ian T | EVP Global Chief Med Officer |
Open-market sell
S
|
Common Stock | 7,018 | $43.21 | $303,248 | 26,243 |
| 2021-12-20 | Pierce David A | EVP Pres MedSurg |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 42,934 | $0.00 | $0 | 0 |
| 2021-12-20 | Pierce David A | EVP Pres MedSurg |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 4,997 | $0.00 | $0 | 0 |
| 2021-12-20 | Pierce David A | EVP Pres MedSurg |
Open-market sell
S
|
Common Stock | 49,988 | $39.90 | $1,994,621 | 0 |
| 2021-12-20 | Pierce David A | EVP Pres MedSurg |
Exercise / conversion
M
|
Common Stock | 4,997 | $6.28 | $31,381 | 49,988 |
| 2021-12-20 | Pierce David A | EVP Pres MedSurg |
Exercise / conversion
M
|
Common Stock | 42,934 | $7.39 | $317,282 | 44,991 |
| 2021-12-15 | Carruthers Wendy | SVP, Human Resources |
Open-market sell
S
|
Common Stock | 3,321 | $40.83 | $135,596 | 154,609 |
| 2021-12-03 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent |
Exercise / conversion
M · derivative
|
Deferred Stock Units | 649 | $0.00 | $0 | 1,298 |
| 2021-12-03 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent |
Other disposed transaction
F
|
Common Stock | 296 | $39.46 | $11,680 | 133,153 |
| 2021-12-03 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent |
Exercise / conversion
M
|
Common Stock | 649 | $0.00 | $0 | 133,449 |
| 2021-11-15 | WICHMANN DAVID S | Dir |
Open-market buy
P
|
Common Stock | 25,000 | $41.98 | $1,049,450 | 25,000 |
| 2021-11-01 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 66,054 | $0.00 | $0 | 330,268 |
| 2021-11-01 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 134,988 | $0.00 | $0 | 0 |
| 2021-11-01 | Mahoney Michael F | Chairman, President & CEO |
Open-market sell
S
|
Common Stock | 201,042 | $43.05 | $8,655,682 | 2,081,822 |
| 2021-11-01 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M
|
Common Stock | 66,054 | $7.39 | $488,139 | 2,282,864 |
| 2021-11-01 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M
|
Common Stock | 134,988 | $6.28 | $847,725 | 2,216,810 |
| 2021-10-22 | Eddy Jodi Euerle | SVP, Chief Info & Digital Off. |
Open-market sell
S
|
Common Stock | 727 | $45.00 | $32,715 | 19,692 |
| 2021-10-15 | Carruthers Wendy | SVP, Human Resources |
Open-market sell
S
|
Common Stock | 3,322 | $43.58 | $144,773 | 161,251 |
| 2021-10-04 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 66,054 | $0.00 | $0 | 396,322 |
| 2021-10-04 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 134,988 | $0.00 | $0 | 134,988 |
| 2021-10-04 | Mahoney Michael F | Chairman, President & CEO |
Open-market sell
S
|
Common Stock | 103,204 | $43.39 | $4,477,929 | 2,081,822 |
| 2021-10-04 | Mahoney Michael F | Chairman, President & CEO |
Open-market sell
S
|
Common Stock | 97,838 | $42.43 | $4,151,110 | 2,185,026 |
| 2021-10-04 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M
|
Common Stock | 66,054 | $7.39 | $488,139 | 2,282,864 |
| 2021-10-04 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M
|
Common Stock | 134,988 | $6.28 | $847,725 | 2,216,810 |
| 2021-10-01 | Olson Scott | SVP & Pres, Rhythm Management |
Open-market sell
S
|
Common Stock | 700 | $43.49 | $30,443 | 12,762 |
| 2021-09-15 | Carruthers Wendy | SVP, Human Resources |
Open-market sell
S
|
Common Stock | 3,321 | $44.88 | $149,046 | 164,573 |
| 2021-09-07 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 66,053 | $0.00 | $0 | 462,376 |
| 2021-09-07 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 134,988 | $0.00 | $0 | 269,976 |
| 2021-09-07 | Mahoney Michael F | Chairman, President & CEO |
Open-market sell
S
|
Common Stock | 201,041 | $44.57 | $8,959,895 | 2,081,822 |
| 2021-09-07 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M
|
Common Stock | 66,053 | $7.39 | $488,132 | 2,282,863 |
| 2021-09-07 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M
|
Common Stock | 134,988 | $6.28 | $847,725 | 2,216,810 |
| 2021-09-01 | Eddy Jodi Euerle | SVP, Chief Info & Digital Off. |
Open-market sell
S
|
Common Stock | 728 | $45.33 | $33,000 | 20,419 |
| 2021-08-31 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent |
Equity grant / award
G
|
Common Stock | 135 | $0.00 | $0 | 132,800 |
| 2021-08-30 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent |
Equity grant / award
G
|
Common Stock | 183 | $0.00 | $0 | 132,935 |
| 2021-08-16 | Carruthers Wendy | SVP, Human Resources |
Open-market sell
S
|
Common Stock | 3,322 | $44.30 | $147,165 | 167,894 |
| 2021-08-10 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 20,000 | $0.00 | $0 | 0 |
| 2021-08-10 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Exercise / conversion
M
|
Common Stock | 20,000 | $13.08 | $261,600 | 86,129 |
| 2021-08-05 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Open-market sell
S
|
Common Stock | 41,741 | $44.14 | $1,842,306 | 66,129 |
| 2021-08-02 | Scanlon Meghan | SVP,Pres,Urology Pelvic Health |
Equity grant / award
A · derivative
|
Restricted Stock Units | 15,257 | $0.00 | $0 | 15,257 |
| 2021-07-27 | Eddy Jodi Euerle | SVP, Chief Info & Digital Off. |
Open-market sell
S
|
Common Stock | 728 | $45.00 | $32,760 | 20,777 |
| 2021-07-27 | Butcher Arthur C | EVP&Pres, Asia Pacific |
Open-market sell
S
|
Common Stock | 9,673 | $45.00 | $435,287 | 25,749 |
| 2021-07-27 | Scanlon Meghan | SVP,Pres,Urology Pelvic Health |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 13,850 | $0.00 | $0 | 0 |
| 2021-07-27 | Scanlon Meghan | SVP,Pres,Urology Pelvic Health |
Open-market sell
S
|
Common Stock | 13,850 | $45.01 | $623,388 | 19,142 |
| 2021-07-27 | Scanlon Meghan | SVP,Pres,Urology Pelvic Health |
Exercise / conversion
M
|
Common Stock | 13,850 | $23.41 | $324,228 | 32,992 |
| 2021-07-23 | Eddy Jodi Euerle | SVP, Chief Info & Digital Off. |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 3,000 | $0.00 | $0 | 0 |
| 2021-07-23 | Eddy Jodi Euerle | SVP, Chief Info & Digital Off. |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 8,348 | $0.00 | $0 | 8,349 |
| 2021-07-23 | Eddy Jodi Euerle | SVP, Chief Info & Digital Off. |
Open-market sell
S
|
Common Stock | 11,348 | $44.00 | $499,312 | 21,505 |
| 2021-07-23 | Eddy Jodi Euerle | SVP, Chief Info & Digital Off. |
Exercise / conversion
M
|
Common Stock | 3,000 | $13.08 | $39,240 | 32,853 |
| 2021-07-23 | Eddy Jodi Euerle | SVP, Chief Info & Digital Off. |
Exercise / conversion
M
|
Common Stock | 8,348 | $16.31 | $136,156 | 29,853 |
| 2021-07-15 | Carruthers Wendy | SVP, Human Resources |
Open-market sell
S
|
Common Stock | 3,321 | $42.42 | $140,877 | 171,216 |
| 2021-07-13 | BOSTON SCIENTIFIC CORP | 10% |
Open-market sell
S
|
Common Stock | 2,500,000 | $37.45 | $93,625,000 | 1,488,106 |
| 2021-07-06 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 66,053 | $0.00 | $0 | 594,483 |
| 2021-07-06 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 134,988 | $0.00 | $0 | 539,953 |
| 2021-07-06 | Mahoney Michael F | Chairman, President & CEO |
Open-market sell
S
|
Common Stock | 201,041 | $43.41 | $8,726,587 | 2,081,822 |
| 2021-07-06 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M
|
Common Stock | 66,053 | $7.39 | $488,132 | 2,282,863 |
| 2021-07-06 | Mahoney Michael F | Chairman, President & CEO |
Exercise / conversion
M
|
Common Stock | 134,988 | $6.28 | $847,725 | 2,216,810 |
| 2021-07-01 | WICHMANN DAVID S | Dir |
Equity grant / award
A · derivative
|
Deferred Stock Units | 2,296 | $0.00 | $0 | 6,389 |
| 2021-07-01 | WICHMANN DAVID S | Dir |
Equity grant / award
A · derivative
|
Deferred Stock Units | 4,093 | $0.00 | $0 | 4,093 |
| 2021-06-24 | Scanlon Meghan | SVP,Pres,Urology Pelvic Health |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 16,450 | $0.00 | $0 | 0 |
| 2021-06-24 | Scanlon Meghan | SVP,Pres,Urology Pelvic Health |
Open-market sell
S
|
Common Stock | 16,450 | $44.03 | $724,294 | 17,830 |
| 2021-06-24 | Scanlon Meghan | SVP,Pres,Urology Pelvic Health |
Exercise / conversion
M
|
Common Stock | 16,450 | $17.26 | $283,927 | 34,280 |
| 2021-06-16 | Monson Jonathan | VP, Global Controller and CAO |
Open-market sell
S
|
Common Stock | 8,833 | $42.76 | $377,734 | 28,229 |
| 2021-06-15 | Monson Jonathan | VP, Global Controller and CAO |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 7,901 | $0.00 | $0 | 10,000 |
| 2021-06-15 | Monson Jonathan | VP, Global Controller and CAO |
Open-market sell
S
|
Common Stock | 7,901 | $42.78 | $338,038 | 37,062 |
| 2021-06-15 | Monson Jonathan | VP, Global Controller and CAO |
Exercise / conversion
M
|
Common Stock | 7,901 | $12.89 | $101,844 | 44,963 |
| 2021-06-15 | Carruthers Wendy | SVP, Human Resources |
Open-market sell
S
|
Common Stock | 3,322 | $42.70 | $141,849 | 174,537 |
| 2021-06-14 | Monson Jonathan | VP, Global Controller and CAO |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 5,000 | $0.00 | $0 | 0 |
| 2021-06-14 | Monson Jonathan | VP, Global Controller and CAO |
Open-market sell
S
|
Common Stock | 5,000 | $42.94 | $214,700 | 37,062 |
| 2021-06-14 | Monson Jonathan | VP, Global Controller and CAO |
Exercise / conversion
M
|
Common Stock | 5,000 | $13.08 | $65,400 | 42,062 |
| 2021-06-03 | Pierce David A | EVP Pres MedSurg |
Open-market sell
S
|
Common Stock | 1,654 | $41.36 | $68,409 | 2,057 |
| 2021-06-01 | Pierce David A | EVP Pres MedSurg |
Exercise / conversion
M · derivative
|
Deferred Stock Units | 2,973 | $0.00 | $0 | 0 |
| 2021-06-01 | Pierce David A | EVP Pres MedSurg |
Other disposed transaction
F
|
Common Stock | 1,319 | $42.93 | $56,625 | 3,711 |
| 2021-06-01 | Pierce David A | EVP Pres MedSurg |
Exercise / conversion
M
|
Common Stock | 2,973 | $0.00 | $0 | 5,030 |
| 2021-05-28 | Nanavaty Maulik | SVP & Pres, Neuromodulation |
Open-market sell
S
|
Common Stock | 78,192 | $42.59 | $3,330,440 | 166,869 |
| 2021-05-14 | Mahoney Michael F | Chairman, President & CEO |
Equity grant / award
G
|
Common Stock | 34,965 | $0.00 | $0 | 2,081,822 |
| 2021-05-06 | Zane Ellen M | Dir |
Equity grant / award
A
|
Common Stock | 4,763 | $0.00 | $0 | 36,806 |
| 2021-05-01 | Scanlon Meghan | SVP,Pres,Urology Pelvic Health |
Exercise / conversion
M · derivative
|
Deferred Stock Units | 2,061 | $0.00 | $0 | 4,124 |
| 2021-05-01 | Scanlon Meghan | SVP,Pres,Urology Pelvic Health |
Other disposed transaction
F
|
Common Stock | 605 | $43.60 | $26,378 | 17,830 |
| 2021-05-01 | Scanlon Meghan | SVP,Pres,Urology Pelvic Health |
Exercise / conversion
M
|
Common Stock | 2,061 | $0.00 | $0 | 18,435 |
| 2021-04-30 | Sorenson John Bradley | SVP, Manuf & Sup Chn |
Equity grant / award
G
|
Common Stock | 1,786 | $0.00 | $0 | 45,134 |
| 2021-04-30 | Sorenson John Bradley | SVP, Manuf & Sup Chn |
Open-market sell
S
|
Common Stock | 3,572 | $43.51 | $155,400 | 46,920 |
| 2021-04-28 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 48,439 | $0.00 | $0 | 0 |
| 2021-04-28 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent |
Open-market sell
S
|
Common Stock | 48,439 | $43.98 | $2,130,347 | 139,158 |
| 2021-04-28 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent |
Exercise / conversion
M
|
Common Stock | 48,439 | $7.39 | $357,964 | 187,597 |
| 2021-04-15 | Butcher Arthur C | EVP&Pres, Asia Pacific |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 4,250 | $0.00 | $0 | 4,250 |
| 2021-04-15 | Butcher Arthur C | EVP&Pres, Asia Pacific |
Open-market sell
S
|
Common Stock | 9,676 | $40.00 | $387,040 | 29,398 |
| 2021-04-15 | Butcher Arthur C | EVP&Pres, Asia Pacific |
Exercise / conversion
M
|
Common Stock | 4,250 | $13.08 | $55,590 | 39,074 |
| 2021-04-06 | BOSTON SCIENTIFIC CORP | 10% |
Open-market sell
S
|
Common Stock | 650,000 | $43.60 | $28,340,000 | 3,988,106 |
| 2021-04-01 | Olson Scott | SVP & Pres, Rhythm Management |
Open-market sell
S
|
Common Stock | 700 | $38.61 | $27,027 | 12,844 |
| 2021-03-30 | BOSTON SCIENTIFIC CORP | 10% |
Open-market sell
S
|
Common Stock | 1,350,000 | $40.80 | $55,080,000 | 4,638,106 |
| 2021-03-16 | Pierce David A | EVP Pres MedSurg |
Open-market sell
S
|
Common Stock | 7,603 | $39.36 | $299,246 | 2,057 |
| 2021-03-03 | Fitzgerald Joseph Michael | EVP & Pres, Interven Cardio |
Exercise / conversion
M · derivative
|
Deferred Stock Units | 3,603 | $0.00 | $0 | 3,603 |
| 2021-03-03 | Fitzgerald Joseph Michael | EVP & Pres, Interven Cardio |
Other disposed transaction
F
|
Common Stock | 1,779 | $38.82 | $69,061 | 250,780 |
| 2021-03-03 | Fitzgerald Joseph Michael | EVP & Pres, Interven Cardio |
Exercise / conversion
M
|
Common Stock | 3,603 | $0.00 | $0 | 252,559 |
| 2021-03-02 | Pierce David A | EVP Pres MedSurg |
Open-market sell
S
|
Common Stock | 1,360 | $38.90 | $52,904 | 9,660 |
| 2021-02-28 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Exercise / conversion
M · derivative
|
Deferred Stock Units | 1,833 | $0.00 | $0 | 1,833 |
| 2021-02-28 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Other disposed transaction
F
|
Common Stock | 993 | $38.78 | $38,509 | 107,870 |
| 2021-02-28 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Exercise / conversion
M
|
Common Stock | 1,833 | $0.00 | $0 | 108,863 |
| 2021-02-23 | Pierce David A | EVP Pres MedSurg |
Open-market sell
S
|
Common Stock | 2,836 | $39.20 | $111,171 | 9,660 |
| 2021-02-22 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Equity grant / award
A · derivative
|
Performance Share Units | 7,092 | $0.00 | $0 | 7,092 |
| 2021-02-22 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Exercise / conversion
M · derivative
|
Deferred Stock Units | 2,028 | $0.00 | $0 | 0 |
| 2021-02-22 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Other disposed transaction
F
|
Common Stock | 1,099 | $39.20 | $43,081 | 107,030 |
| 2021-02-22 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Exercise / conversion
M
|
Common Stock | 2,028 | $0.00 | $0 | 108,129 |
| 2021-02-22 | Pierce David A | EVP Pres MedSurg |
Equity grant / award
A · derivative
|
Performance Share Units | 9,456 | $0.00 | $0 | 9,456 |
| 2021-02-22 | Pierce David A | EVP Pres MedSurg |
Exercise / conversion
M · derivative
|
Deferred Stock Units | 2,607 | $0.00 | $0 | 0 |
| 2021-02-22 | Pierce David A | EVP Pres MedSurg |
Other disposed transaction
F
|
Common Stock | 1,157 | $39.20 | $45,354 | 12,496 |
| 2021-02-22 | Pierce David A | EVP Pres MedSurg |
Exercise / conversion
M
|
Common Stock | 2,607 | $0.00 | $0 | 13,653 |
| 2021-02-21 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Exercise / conversion
M · derivative
|
Deferred Stock Units | 1,713 | $0.00 | $0 | 3,428 |
| 2021-02-21 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Other disposed transaction
F
|
Common Stock | 928 | $38.03 | $35,292 | 106,101 |
| 2021-02-21 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Exercise / conversion
M
|
Common Stock | 1,713 | $0.00 | $0 | 107,029 |
| 2021-02-21 | Pierce David A | EVP Pres MedSurg |
Exercise / conversion
M · derivative
|
Deferred Stock Units | 2,492 | $0.00 | $0 | 4,986 |
| 2021-02-21 | Pierce David A | EVP Pres MedSurg |
Other disposed transaction
F
|
Common Stock | 1,106 | $38.03 | $42,061 | 11,046 |
| 2021-02-21 | Pierce David A | EVP Pres MedSurg |
Exercise / conversion
M
|
Common Stock | 2,492 | $0.00 | $0 | 12,152 |
| 2021-02-19 | Pierce David A | EVP Pres MedSurg |
Open-market sell
S
|
Common Stock | 1,484 | $38.00 | $56,392 | 9,660 |
| 2021-02-18 | Scanlon Meghan | SVP,Pres,Urology Pelvic Health |
Exercise / conversion
M · derivative
|
Deferred Stock Units | 1,111 | $0.00 | $0 | 3,336 |
| 2021-02-18 | Scanlon Meghan | SVP,Pres,Urology Pelvic Health |
Other disposed transaction
F
|
Common Stock | 372 | $37.52 | $13,957 | 14,278 |
| 2021-02-18 | Scanlon Meghan | SVP,Pres,Urology Pelvic Health |
Exercise / conversion
M
|
Common Stock | 1,111 | $0.00 | $0 | 14,650 |
| 2021-02-17 | Scanlon Meghan | SVP,Pres,Urology Pelvic Health |
Equity grant / award
A · derivative
|
Stock Option (Right to Buy) | 20,368 | $0.00 | $0 | 20,368 |
| 2021-02-17 | Scanlon Meghan | SVP,Pres,Urology Pelvic Health |
Equity grant / award
A · derivative
|
Restricted Stock Units | 6,333 | $0.00 | $0 | 6,333 |
| 2021-02-15 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Exercise / conversion
M · derivative
|
Deferred Stock Units | 1,846 | $0.00 | $0 | 3,692 |
| 2021-02-15 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Other disposed transaction
F
|
Common Stock | 1,000 | $38.39 | $38,390 | 72,046 |
| 2021-02-15 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Exercise / conversion
M
|
Common Stock | 1,846 | $0.00 | $0 | 73,046 |
| 2021-02-15 | Sorenson John Bradley | SVP, Manuf & Sup Chn |
Exercise / conversion
M · derivative
|
Deferred Stock Units | 1,200 | $0.00 | $0 | 2,400 |
| 2021-02-15 | Sorenson John Bradley | SVP, Manuf & Sup Chn |
Other disposed transaction
F
|
Common Stock | 368 | $38.39 | $14,128 | 46,960 |
| 2021-02-15 | Sorenson John Bradley | SVP, Manuf & Sup Chn |
Exercise / conversion
M
|
Common Stock | 1,200 | $0.00 | $0 | 47,328 |
| 2021-02-12 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Open-market sell
S
|
Common Stock | 28,883 | $38.65 | $1,116,354 | 71,200 |
| 2021-02-10 | Fitzgerald Joseph Michael | EVP & Pres, Interven Cardio |
Other disposed transaction
F
|
Common Stock | 8,881 | $38.85 | $345,027 | 240,717 |
| 2021-02-10 | Fitzgerald Joseph Michael | EVP & Pres, Interven Cardio |
Equity grant / award
A
|
Common Stock | 17,995 | $0.00 | $0 | 249,598 |
| 2021-02-08 | Butcher Arthur C | EVP&Pres, Asia Pacific |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 9,000 | $0.00 | $0 | 8,500 |
| 2021-02-08 | Butcher Arthur C | EVP&Pres, Asia Pacific |
Open-market sell
S
|
Common Stock | 16,902 | $39.39 | $665,812 | 28,123 |
| 2021-02-08 | Butcher Arthur C | EVP&Pres, Asia Pacific |
Exercise / conversion
M
|
Common Stock | 9,000 | $13.08 | $117,720 | 45,025 |
| 2021-02-08 | Fitzgerald Joseph Michael | EVP & Pres, Interven Cardio |
Equity grant / award
G
|
Common Stock | 1,520 | $0.00 | $0 | 6,038 |
| 2021-02-08 | Fitzgerald Joseph Michael | EVP & Pres, Interven Cardio |
Equity grant / award
G
|
Common Stock | 3,040 | $0.00 | $0 | 231,603 |
| 2021-02-04 | Pierce David A | EVP Pres MedSurg |
Open-market sell
S
|
Common Stock | 11,317 | $38.00 | $430,046 | 2,057 |
| 2021-02-01 | Meredith Ian T | EVP Global Chief Med Officer |
Exercise / conversion
M · derivative
|
Deferred Stock Units | 3,130 | $0.00 | $0 | 3,131 |
| 2021-02-01 | Meredith Ian T | EVP Global Chief Med Officer |
Other disposed transaction
F
|
Common Stock | 919 | $35.95 | $33,038 | 26,556 |
| 2021-02-01 | Meredith Ian T | EVP Global Chief Med Officer |
Exercise / conversion
M
|
Common Stock | 3,130 | $0.00 | $0 | 27,475 |
| 2021-01-05 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent |
Open-market sell
S
|
Common Stock | 8,108 | $35.31 | $286,333 | 131,636 |
| 2021-01-04 | Olson Scott | SVP & Pres, Rhythm Management |
Open-market sell
S
|
Common Stock | 700 | $36.08 | $25,256 | 11,181 |
| 2021-01-01 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Exercise / conversion
M · derivative
|
Performance Share Units | 10,879 | $0.00 | $0 | 0 |
| 2021-01-01 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Other disposed transaction
F
|
Common Stock | 5,891 | $35.95 | $211,781 | 96,784 |
| 2021-01-01 | Thepaut Eric Francis Yves | EVP & Pres, Eur, Mid-East, Afr |
Exercise / conversion
M
|
Common Stock | 10,879 | $0.00 | $0 | 102,675 |
| 2020-12-03 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent |
Exercise / conversion
M · derivative
|
Deferred Stock Units | 649 | $0.00 | $0 | 1,947 |
| 2020-12-03 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent |
Other disposed transaction
F
|
Common Stock | 296 | $33.81 | $10,008 | 131,836 |
| 2020-12-03 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent |
Exercise / conversion
M
|
Common Stock | 649 | $0.00 | $0 | 132,132 |
| 2020-12-01 | Olson Scott | SVP & Pres, Rhythm Management |
Exercise / conversion
M · derivative
|
Deferred Stock Units | 1,485 | $0.00 | $0 | 0 |
| 2020-12-01 | Olson Scott | SVP & Pres, Rhythm Management |
Other disposed transaction
F
|
Common Stock | 733 | $33.65 | $24,665 | 11,881 |
| 2020-12-01 | Olson Scott | SVP & Pres, Rhythm Management |
Exercise / conversion
M
|
Common Stock | 1,485 | $0.00 | $0 | 12,614 |
| 2020-11-09 | Pierce David A | EVP Pres MedSurg |
Open-market sell
S
|
Common Stock | 2,028 | $39.00 | $79,092 | 662 |
| 2020-11-03 | Mahoney Michael F | Chairman, President & CEO |
Open-market sell
S
|
Common Stock | 259,207 | $35.06 | $9,087,227 | 1,960,421 |
| 2020-10-05 | BOSTON SCIENTIFIC CORP | 10% |
Exercise / conversion
C · derivative
|
Series G-1 Preferred Stock | 2,081,909 | $0.00 | $0 | 0 |
| 2020-10-05 | BOSTON SCIENTIFIC CORP | 10% |
Exercise / conversion
C · derivative
|
Series F-1 Preferred Stock | 3,787,878 | $0.00 | $0 | 0 |
| 2020-10-05 | BOSTON SCIENTIFIC CORP | 10% |
Exercise / conversion
C · derivative
|
Series E-1 Preferred Stock | 6,215 | $0.00 | $0 | 0 |
| 2020-10-05 | BOSTON SCIENTIFIC CORP | 10% |
Exercise / conversion
C · derivative
|
Series D-1 Preferred Stock | 542 | $0.00 | $0 | 0 |
| 2020-10-05 | BOSTON SCIENTIFIC CORP | 10% |
Exercise / conversion
C · derivative
|
Series C-1 Preferred Stock | 23,180 | $0.00 | $0 | 0 |
| 2020-10-05 | BOSTON SCIENTIFIC CORP | 10% |
Exercise / conversion
C · derivative
|
Series B-1 Preferred Stock | 47,536 | $0.00 | $0 | 0 |
| 2020-10-05 | BOSTON SCIENTIFIC CORP | 10% |
Exercise / conversion
C · derivative
|
Series A-1 Preferred Stock | 40,705 | $0.00 | $0 | 0 |
| 2020-10-05 | BOSTON SCIENTIFIC CORP | 10% |
Exercise / conversion
C
|
Common Stock | 542 | $0.00 | $0 | 5,988,106 |
| 2020-10-05 | BOSTON SCIENTIFIC CORP | 10% |
Exercise / conversion
C
|
Common Stock | 6,215 | $0.00 | $0 | 5,987,564 |
| 2020-10-05 | BOSTON SCIENTIFIC CORP | 10% |
Exercise / conversion
C
|
Common Stock | 23,180 | $0.00 | $0 | 5,981,349 |
| 2020-10-05 | BOSTON SCIENTIFIC CORP | 10% |
Exercise / conversion
C
|
Common Stock | 40,705 | $0.00 | $0 | 5,958,169 |
| 2020-10-05 | BOSTON SCIENTIFIC CORP | 10% |
Exercise / conversion
C
|
Common Stock | 47,536 | $0.00 | $0 | 5,917,464 |
| 2020-10-05 | BOSTON SCIENTIFIC CORP | 10% |
Exercise / conversion
C
|
Common Stock | 2,081,909 | $0.00 | $0 | 5,869,928 |
| 2020-10-05 | BOSTON SCIENTIFIC CORP | 10% |
Exercise / conversion
C
|
Common Stock | 3,787,878 | $0.00 | $0 | 3,788,019 |
| 2020-10-01 | MACMILLAN STEPHEN P | Dir |
Equity grant / award
A
|
Common Stock | 498 | $0.00 | $0 | 8,000 |
| 2020-09-11 | Fitzgerald Joseph Michael | EVP & Pres, Interven Cardio |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 77,640 | $0.00 | $0 | 0 |
| 2020-09-11 | Fitzgerald Joseph Michael | EVP & Pres, Interven Cardio |
Open-market sell
S
|
Common Stock | 77,640 | $40.76 | $3,164,653 | 221,048 |
| 2020-09-11 | Fitzgerald Joseph Michael | EVP & Pres, Interven Cardio |
Exercise / conversion
M
|
Common Stock | 77,640 | $7.16 | $555,902 | 298,688 |
| 2020-09-03 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent |
Open-market sell
S
|
Common Stock | 9,139 | $42.31 | $386,671 | 106,483 |
| 2020-09-01 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 60,000 | $0.00 | $0 | 0 |
| 2020-09-01 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent |
Open-market sell
S
|
Common Stock | 60,000 | $40.93 | $2,456,028 | 115,622 |
| 2020-09-01 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent |
Exercise / conversion
M
|
Common Stock | 60,000 | $6.31 | $378,600 | 175,622 |
| 2020-08-28 | Nanavaty Maulik | SVP & Pres, Neuromodulation |
Exercise / conversion
M · derivative
|
Stock Option (Right to Buy) | 6,851 | $0.00 | $0 | 0 |
| 2020-08-28 | Nanavaty Maulik | SVP & Pres, Neuromodulation |
Open-market sell
S
|
Common Stock | 38,000 | $40.45 | $1,537,165 | 228,993 |
| 2020-08-28 | Nanavaty Maulik | SVP & Pres, Neuromodulation |
Exercise / conversion
M
|
Common Stock | 6,851 | $17.26 | $118,248 | 266,993 |
| 2020-08-26 | Carruthers Wendy | SVP, Human Resources |
Open-market sell
S
|
Common Stock | 10,200 | $39.16 | $399,401 | 178,973 |
| 2020-08-20 | Ralls-Morrison Desiree | SVP, GC and Corp Secretary |
Open-market sell
S
|
Common Stock | 1,182 | $39.00 | $46,098 | 11,450 |
| 2020-08-03 | Eddy Jodi Euerle | SVP and CIO |
Equity grant / award
A · derivative
|
Stock Option (Right to Buy) | 32,930 | $0.00 | $0 | 32,930 |
| 2020-08-03 | Eddy Jodi Euerle | SVP and CIO |
Equity grant / award
A · derivative
|
Deferred Stock Units | 7,894 | $0.00 | $0 | 7,894 |
| 2020-07-22 | Pierce David A | EVP Pres MedSurg |
Open-market sell
S
|
Common Stock | 2,170 | $38.00 | $82,460 | 9,401 |
| 2020-07-01 | Scanlon Meghan | SVP,Pres,Urology Pelvic Health |
Exercise / conversion
M · derivative
|
Deferred Stock Units | 854 | $0.00 | $0 | 855 |
| 2020-07-01 | Scanlon Meghan | SVP,Pres,Urology Pelvic Health |
Other disposed transaction
F
|
Common Stock | 260 | $35.28 | $9,173 | 12,269 |
| 2020-07-01 | Scanlon Meghan | SVP,Pres,Urology Pelvic Health |
Exercise / conversion
M
|
Common Stock | 854 | $0.00 | $0 | 12,529 |
| 2020-06-03 | Pierce David A | EVP Pres MedSurg |
Open-market sell
S
|
Common Stock | 1,624 | $38.00 | $61,712 | 11,571 |
| 2020-06-01 | Pierce David A | EVP Pres MedSurg |
Exercise / conversion
M · derivative
|
Deferred Stock Units | 2,972 | $0.00 | $0 | 2,973 |
| 2020-06-01 | Pierce David A | EVP Pres MedSurg |
Open-market sell
S
|
Common Stock | 1,969 | $38.00 | $74,822 | 13,195 |
| 2020-06-01 | Pierce David A | EVP Pres MedSurg |
Other disposed transaction
F
|
Common Stock | 1,348 | $37.50 | $50,550 | 15,164 |
| 2020-06-01 | Pierce David A | EVP Pres MedSurg |
Exercise / conversion
M
|
Common Stock | 2,972 | $0.00 | $0 | 16,512 |
| 2020-05-20 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent |
Equity grant / award
G
|
Common Stock | 165 | $0.00 | $0 | 115,622 |
| 2020-05-08 | Pierce David A | EVP Pres MedSurg |
Open-market sell
S
|
Common Stock | 2,057 | $38.00 | $78,166 | 13,540 |
| 2020-05-07 | ROUX DAVID J | Dir |
Equity grant / award
A
|
Common Stock | 5,000 | $0.00 | $0 | 60,005 |